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ABSTRACT
Sepsis is one of the oldest and most elusive syndromes in medicine. It is
characterized by a systemic inflammatory response leading to acute organ
dysfunction. In the United States alone there are over 750,000 cases of sepsis each
year, with a mortality rate between 20-50%. Sepsis is the second leading cause of
death in the ICU and the tenth leading cause of death overall in the United States.
Over half of all ICU resources are consumed in the treatment of sepsis. There are
currently no effective therapies available against sepsis, all attempts to develop an
effective therapy have failed. Respiratory infections are the leading cause of sepsis,
leading to what is called pneumonic sepsis. The Gram-negative bacteria Klebsiella
pneumoniae (KPn) is associated with upwards of 20% of all pneumonic sepsis
cases. Utilizing a mouse model of pneumonic sepsis induced by intranasal infection
of KPn, I studied the role that mammalian C-type lectin receptors (CLRs) play in
the development and clearance of pneumonic sepsis. CLRs are primarily expressed
on phagocytic immune cells of myeloid origin and are considered pattern
recognition receptors that have the ability to shape the immune response by
recognizing both pathogen associated molecular patterns and host damage
associated molecular patterns in many different pathological conditions. From the
pathogen perspective, I studied the effect KPn has on the immune cells and how
that may impact the ability of KPn establish the infection.
viii

In my first project, I examined the role of two CLRs, Macrophage Galactose Type
Lectin 1 (MGL1) and Clec4e otherwise known as Mincle, in the development and
clearance of pneumonic sepsis caused by KPn. This project was built on previous
observations made by my advisor Dr. Jyotika Sharma which showed these two
CLRs upregulated in the lung during KPn induced pneumonic sepsis. In regards to
MGL1, I am the first author on the paper that we recently published in the Journal
of Immunology “Macrophage Galactose-Type Lectin-1 Deficiency Is Associated with
Increased Neutrophilia and Hyperinflammation in Gram-Negative Pneumonia” (J
Immunol. 2016 Apr 1;196(7):3088-96. doi: 10.4049/jimmunol.1501790.). In this
paper we showed that MGL1-/- mice were more susceptible to KPn infection, a
phenotype that did not correlate with the systemic and local bacterial burden; the
ability of macrophages and neutrophils to phagocytose and kill bacteria or
neutrophil NETs. We demonstrated that the mechanism underlying the increased
mortality of MGL1-/- mice was increased ability of neutrophils to infiltrate the lungs
causing their overwhelming accumulation and severe neutrophil-mediated
pathology in the lungs in the absence of MGL1. Mechanistic insights into the
potential negative regulatory function of MGL1 in neutrophil infiltration, their
clearance by efferocytosis as well as the process of granulopoiesis are some of the
future directions of this work that are being perused in the laboratory. In the paper
I co-authored on Mincle, “Protective Role of Mincle in Bacterial Pneumonia by
Regulation of Neutrophil Mediated Phagocytosis and Extracellular Trap
Formation” (Infect Dis. (2014) 209 (11): 1837-1846.doi: 10.1093/infdis/jit820),
we showed that Mincle mediates two important bacterial clearance mechanisms i.e.
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bacterial phagocytosis and extracellular trap (NET) formation by neutrophils. As a
result, Mincle-/- mice are more susceptible to KPn infection as compared to the
Mincle sufficient wild-type mice. This project is being led by Dr. Atul Sharma, a
postdoctoral fellow in the lab.

My second project examined the effect of KPn infection on the clearance of
neutrophils by a process called efferocytosis. While performing experiments for the
role of MGL1 in efferocytosis, I found that in comparison with the uninfected
neutrophils, KPn infected cells were engulfed less efficiently by macrophages. As
efferocytosis is a receptor mediated process, I discovered that while KPn infection
increases the expression of repressive molecules called “Don’t Eat Me” signals on
neutrophils, it is the modulation of distribution of a key “Eat Me” signal,
phosphatidylserine (PtdSer) and the subsequent delay of apoptosis in neutrophils
that is partially involved in KPn mediated inhibition of efferocytosis. Accordingly,
KPn infected neutrophils also induce an alternative rout of programmed cell death
called necroptosis. It is the combination of the “eat me” signal downregulation and
the induction of necroptosis in KPn infected neutrophils that inhibit their efferocytic
uptake by macrophages. A part of this data has been communicated for publication.
Current work that I have led in the lab on this project involves determining what
signaling mechanisms KPn is activating to decrease PtdSer as well as activation of
necroptosis to inhibit the efferocytosis of infected PMNs.

The overarching goal of this work was to increase the overall knowledge on the
role CLRs play in pneumonic sepsis in terms of neutrophil turnover and how KPn
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subverts these processes to its own advantage. I believe that this knowledge can be
used to identify novel targets for effective therapy of sepsis as well as other
inflammatory conditions.
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CHAPTER 1
INTRODUCTION
Sepsis and Pneumonia: Healthcare burden and treatment
Sepsis has been described for thousands of years and despite massive amounts of effort to
better understand and treat sepsis, it is still a major challenge in medicine (1, 2). A recent
study determined that there were over 31.5 million cases of sepsis worldwide, of which
19.4 were severe sepsis, resulting in 5.3 million deaths annually (3). In the United States
sepsis is the 11th leading cause of death and is considered a major healthcare burden by the
Centers for Disease Control and Prevention, causing over an estimated 750,00 cases
annually with a mortality rate of 20-50% depending on certain risk factors. Sepsis is the
leading cause of death in non-coronary ICU patients in the US and effects 1 out of 3 ICU
patients. An estimated $24.3 billion dollars is spent each year treating sepsis (2, 4-10).
Patients who are immune-compromised, have chronic diseases such as cancer, diabetes,
liver disease, or chronic obstructive pulmonary disease, as well as elderly individuals have
the highest risk of developing sepsis or severe sepsis (11).
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Respiratory infections and pneumonia in the lungs are the most common site of infection
for sepsis, accounting for 40%-50% of all sepsis cases (2, 12, 13). Both Gram-positive and
Gram-negative bacteria can cause sepsis, but in the lung Gram negative bacteria are the
primary cause of infection. Gram negative infections also have the highest rate of mortality
(14-16). Gram negative bacteria that belong to the Enterobacteriaceae family, such as E.
coli and Klebsiella species are the leading cause of sepsis (12, 17, 18).
The incidence of sepsis is on the rise with a 13% increase annually in the number of sepsis
cases seen (11, 19, 20). While there has been an increase in the occurrence of sepsis over
the past two decades, there has also been a decrease in the mortality rate of sepsis going
down from 46.9% from 1991-1995 to 29% from 2006-2009 (10). The decrease in mortality
rates has partially been due to advances in supportive care as well as better recognition of
early sepsis due the improved definition of sepsis by the American College of Chest
Physicians and Society for Critical Care Medicine Consensus Conference in 1991 and
2001. The 1991 conference defined systemic inflammatory response syndrome (SIRS),
sepsis, severe sepsis, and septic shock as a disease complex with varying degrees of
severity based on a number of different criteria such as inflammation and organ failure.
The 2001 conference revised the criteria for sepsis making it more specific by using clinical
and laboratory criteria to identify sepsis (11, 21, 22). Despite this decrease in mortality
rate, the morbidity associated with sepsis and the development of antibiotic resistance by
bacterial pathogens continues to pose a healthcare threat and highlight the importance of
understanding immune responses in order to identify new avenues for treatment strategies.
The clinical signs of sepsis today include but are not limited to, increase or decrease in
body temperature, heart rate, or white blood cell count, and elevated levels of plasma C2

reactive protein due to an infection and systemic inflammation. Sepsis progresses to severe
sepsis when organ dysfunction is seen. Septic shock occurs when there is a dangerous drop
in blood pressure, due to complications of severe sepsis (11, 21, 22). Hallmarks used in the
lab to identify sepsis include hypercytokinemia, with an initial increase in proinflammatory cytokines and later increase in anti-inflammatory cytokines in conjunction
with high pro-inflammatory cytokine levels, indicating a dysregulation of the immune
response. The cytokine storm is followed closely by a dysregulation of the complement
and coagulation systems, the dysregulation of the coagulation system can lead to vascular
injury caused by disseminated intravascular coagulation (DIC). Vascular injury along with
other organ dysfunctions leads to bacteremia or the presence of bacteria in the blood, as
well as cell death. Bacteremia can spread the infection to other organs further driving the
development of sepsis. Cell death causes the release of damage associated molecular
patterns (DAMPs) and alarmins, endogenous molecules that are released upon tissue
damage, which further drives inflammation and recruits cells neutrophils and other innate
immune cells causing further sepsis development (Figure 1). All of these outcomes if not
identified and treated quickly, ultimately leads to organ failure culminating in death. The
development of sepsis occurs in a feed forward loop. As the disease progresses, the result
of the initial inflammation recruits more innate immune cells, which lead to exaggeration
of inflammation, cell death, and tissue injury. That in turn drives further inflammation and
dysregulation of the immune system. This cycle will continue to feed on itself, until death
or the cycle is broken in some way via treatment (1, 23).
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Figure 1. The inflammatory network in sepsis
During sepsis, homeostasis between the various biological systems of the inflammatory
network is highly imbalanced. In the initiation of sepsis, the release of a large amount of
damage-associated molecular patterns (DAMPs) from invading microorganisms and/or
damaged host tissue results in the overstimulation of pattern-recognition receptors (PRRs)
on immune cells. Activated immune cells release excessive amounts of pro-inflammatory
mediators (resulting in a ‘cytokine storm’), free radicals and enzymes, which converts the
normally beneficial effects of inflammation into an excessive response that damages the
host. Activation of the adrenergic branch of the autonomic nervous system (ANS) and/or
decreased activity of the cholinergic anti-inflammatory pathway (of the parasympathetic
branch of the ANS) further amplifies the pro-inflammatory responses of neutrophils,
macrophages and dendritic cells in sepsis. The presence of invading microorganisms or
their products in the blood can cause systemic activation of the complement system, which
results in the excessive generation of complement anaphylatoxins, which, at high
concentrations, induce numerous harmful effects. Simultaneous activation of the
coagulation system and the inhibition of fibrinolysis as a result of the pro-inflammatory
environment and/or damaged endothelium can result in disseminated intravascular
coagulation (DIC), which is a major complication of sepsis, and in the amplification of the
inflammatory response. The complement, coagulation and fibrinolysis systems are tightly
connected through direct interactions of serine proteases, and imbalances in each cascade
are intensified in a positive-feedback loop.
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Figure 1 cont. The inflammatory network in sepsis
Finally, the sustained pro-inflammatory environment affects the functional state of immune
effector cells, eventually causing the dysfunction of neutrophils and immunoparalysis.
Alterations in leukocyte apoptosis in the later stages of sepsis further account for
immunosuppression, which increases the susceptibility to secondary infections.
Reproduced with permission from Nature Reviews Immunology. Permission #
4126831477050 (23).

Current treatment guidelines for sepsis dictate that antibiotic therapy be started within one
hour of diagnosis and mortality increases by 6% every hour after that. Beyond, early
recognition, broad-spectrum antibiotic therapy, and treatment of any symptoms, there are
no other treatment options. There have been over 100 Phase II and Phase III clinical trials
in the past 40 years and yet no FDA-approved drug for the use in treatment of sepsis has
passed clinical trials (24-27). Despite significant efforts, the field is still a long way off
from finding a treatment for this complex and deadly disorder. Sepsis, a complex immune
disorder, is associated with dysregulation of many immune regulatory processes, which are
not completely understood (23, 26-29). The majority of clinical trials have focused on one
aspect of what causes sepsis, either the hyperimmune response, dysregulation of the
coagulation system, or attempting to stimulate a specific immune function, all have failed.
There have been 15 clinical trials utilizing anti-tumor necrosis-α (TNF-α) antibodies, due
to the central role played by TNF- α in mediating inflammation. These studies were
designed to target and prevent the “cytokine storm or hypercytokinemia” observed in sepsis
patients, which is characterized by dysregulation and massive upregulation of both pro6

and anti-inflammatory cytokines (23, 27, 30). All these studies failed because they did not
recognize the complexity of the disease, especially given the heterogenous patient
population(28, 29). Xigris, an FDA approved drug to treat sepsis, was a recombinant
activated protein C (APC) that targeted the disseminated intravascular coagulation (DIC),
that caused vascular injury, a contributing factor to sepsis development. Unfortunately, in
October 2011, the results of the PROWESS-SHOCK clinical trial were revealed, which
failed to show overall efficacy of this drug for APC, and Xigris was pulled from the market
(18, 27, 31). All this goes to show that sepsis as an immune disorder is too complex to be
treated by targeting only one aspect of the dysfunction. There, there is a critical need to
identify additional targets for drug development, which can be used as combination
therapies to treat this complex immune disorder, as single molecule therapies have failed.

Inflammatory Mechanisms in Sepsis
Sepsis is characterized as an initial hyperimmune response; therefore, it is essential to
understand the innate immune components that play a role in inflammation. The
inflammatory response against an invading pathogen is initiated when pathogen associated
molecular patterns (PAMPs) on the bacteria are recognized by pattern recognition receptors
(PRRs) on tissue resident cells. The recognition of PAMPs by PRRs causes PRR-induced
signal transduction pathways to be activated with the end result being the release of
chemokines and cytokines, which recruit and stimulate the innate immune cells needed to
fight of the infection. The innate immune cells recruited to the site of infection by the
released chemokines are phagocytes and antigen-presenting cells (APCs) such as
neutrophils, macrophages, and dendritic cells (DCs). Those cells work in conjunction with
one another to kill the pathogen intracellularly by phagocytosis or extracellularly by
7

releasing DNA traps and other noxious cargo, present antigen to activate the adaptive
immune response, and clear dead/dying cells via efferocytosis to prevent further
inflammation (32-34).
Neutrophils are the first responders for any infection and while circulating they are
constantly probing the endothelial cells of the vasculature searching for stimulated
endothelial cells, which indicate sites of inflammation (35-38). The neutrophils then cross
the endothelial barrier and becomes activated while making its way to the site of infection
by following a chemoattractant gradient (39, 40). During the activation process, a number
of pattern recognition receptors (PRRs) are activated, which also aids in the activation and
induction of oxidative burst, degranulation is also initiated during PRR activation (41-45).
This activation process during migration along the chemoattractant gradient allows for the
neutrophil to be primed and ready to kill when it reaches the site of infection. Once at the
site of infection the neutrophil has a few different antimicrobial weapons at its disposal.
Phagocytosis, a receptor mediated process, that leads to the engulfment and internalization
of bacteria and cellular debris into a phagosome is main mechanism utilized by neutrophils
to clear pathogens (38, 46, 47). After entrapment of the pathogen inside the phagosome,
the phagosome must undergo a maturation process in order to kill the pathogen. During
that maturation process, granules filled with antimicrobial peptides, that aid in the killing
of the pathogen, fuse to the phagosome (48). These granules also contain components of
the NADPH oxidase machinery in its membrane, which is required for oxidative burst and
the production of reactive oxygen species (ROS) (49). The granules also fuse with the
plasma membrane, releasing antimicrobial peptides into the milieu at the site of
inflammation as well as bringing necessary components of the NADPH oxidase complex
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to produce ROS. This creates an inhospitable environment for the invading pathogen, while
also affecting other cells causing the production of neutrophil and monocyte
chemoattractant and other immune mediators that can enhance the antimicrobial effect of
other immune cells (38, 50-58). Besides killing the pathogen through phagocytosis and the
release of granular content and production of ROS inside the phagosome as well as outside
the plasma membrane, neutrophils are also able to release extracellular traps or NETs, that
are composed of DNA, decondensed chromatin, histones, and granule proteins. These
NETs ensnare the pathogen, preventing it from disseminating, and giving time for other
immune cells to come along and remove it (59, 60). The exact mechanism of NET
formation and whether it is an active form of cell death or something viable neutrophils
can do is not completely understood and is currently an active area of research in our lab
(38, 46, 61-66). ROS and the NADPH oxidase complex are thought to be essential
components of NETosis, though some reports, including ours indicate that it may depend
on the stimulus (61, 65-71). Other processes such as the Raf-MEK-ERK pathway and
autophagy have been implicated in NET formation (65, 66, 72, 73). The studies on
neutrophil functions, including NET formation, have been hampered by the short life span
of these cells and a lack of proper cell lines that faithfully reproduce all neutrophil
functions. Due to these reasons, even though neutrophils were first described in 1846, the
NETs were only discovered in the past two decades, indicating that there is still more to
learn about neutrophil function (59, 74).
Another key aspect of any innate immune response leading to a pro-inflammatory response
is the role of pattern recognition receptors (PRRs) on host immune cells. These receptors
are essential in recognizing pathogen associated molecular patterns (PAMPs) as well as
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damage associated molecular patterns (DAMPs) and initiating an inflammatory response.
There are thought to be five families of PRRs. Those include Toll-like receptors (TLRs),
C-type lectin receptors (CLRs), NOD-like receptors (NLRs), RIG-I-like receptors (RLRs),
and AIM2-like receptors (ALRs). ALRs, NLRs, and RLRs are classified as unbound
intracellular receptors and are found inside the cytoplasm, while TLRs and CLRs are
classified as membrane bound receptors (75-78) (Figure 2). As relevant to my work, I will
only describe TLR and CLR functions and signaling in the sections below.

10
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Figure 2. The Four Major Classes of Pattern-Recognition Receptor and Their Most
Important Ligands.
The four classes are toll-like receptors (TLRs), C-type lectin receptors (CLRs), nucleotidebinding oligomerization domain (NOD) leucine-rich-repeat (LRR)–containing receptors
(NLRs), and retinoic acid–inducible gene I protein (RIG-I) helicase receptors. NLRs, the
central components of the inflammasomes, are complex protein platforms that lead to the
activation of caspase 1 and interleukin-1β processing. The most extensively studied
inflammasomes are as follows: the NOD leucine-rich-repeat and pyrin domain–containing
protein 3 (NLRP3) inflammasome, activated by bacterial and fungal pathogen-associated
molecular patterns; the NLR family caspase recruitment domain–containing protein
(CARD) 4 (NLRC4) inflammasome, activated during intracellular bacterial infections by
flagellin; and the absent in melanoma 2 (AIM2) inflammasome, activated by doublestranded (ds) DNA. ASC denotes apoptosis-associated speck-like protein containing a
CARD, HIN hematopoietic interferon-inducible nuclear protein, IRF3 interferon
regulatory factor 3, LPS lipopolysaccharide, MAL myelin and lymphocyte protein, MDA5
melanoma differentiation-associated protein 5, MR mineralocorticoid receptor, MyD88
myeloid differentiation factor 88, NF-κB nuclear factor-κB, NLRC4 NLR family CARDdomain–containing protein 4 (also known as IPAF), ss single-stranded, SYK spleen
tyrosine kinase, TRAM TRIF-related adaptor molecule, and TRIF toll-like–receptor
adaptor molecule.

Reproduced with permission from the New England Journal of

Medicine, Copyright Massachusetts Medical Society (78).
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TLRs are the most well characterized PRR. There are 10 TLRs expressed in humans and
12 in mice. The localization and signal transduction pathway for each has been elucidated,
while the major ligand for everyone, except TLR 10, is known (33, 76). TLRs signal
through two main signal transduction pathways, the MyD88 dependent pathway and the
TRIF dependent pathway. Only TLRs 3 and 4 signal through the TRIF pathway, but TLR4
is unique in that it can also signal through the MyD88 pathway. Signaling through the
MyD88 dependent pathway begins with MyD88 forming a complex with IRAK4 and
IRAK1. The IRAK complex acts on TRAF6, which in turn polyubiquitinates TAK1 to
activate it. TAK1 activation in turn leads to the activation of two pathways, the IKK
complex NF-κB pathway and the MAPK pathway. Those pathways lead to induction of
pro-inflammatory gene expression and release of pro-inflammatory cytokines. Activation
of the TRIF dependent pathway begins when TRIF interacts with TRAF6 and TRAF3.
TRAF6 then recruits RIP-1 kinase in order to activate TAK1 and the NF-κB and MAPK
pathways. TRAF3 on the other hand interacts with TBK1, IKKi, and NEMO to
phosphorylate IRF3, thereby activating it. Activated IRF3 forms a dimer and induces the
expression of type I INF genes in the nucleus. Activation of either MyD88 or TRIF
pathways leads to the activation of transcription factors AP-1, IRF3, and NF-κB, which
causes the release of pro-inflammatory cytokines such as IL-1β, IL-6, IP-10, INF-γ, and
TNF-α (34, 77-80) (Figure 3).
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Figure 3. Principles in TLR signaling.
TLR4 activates both the MyD88-dependent and MyD88-independent, TRIF-dependent
pathways. The MyD88-dependent pathway is responsible for early-phase NF-κB and
MAPK activation, which control the induction of proinflammatory cytokines.
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Figure 3 cont. Principles in TLR signaling.
The MyD88-independent, TRIF-dependent pathway activates IRF3, which is required for
the induction of IFN-β- and IFN-inducible genes. In addition, this pathway mediates latephase NF-κB as well as MAPK activation, also contributing to inflammatory responses.
Reproduced with permission from the American Society of Microbiology (34).

The other membrane bound PRR, CLRs belong to a broader family of receptors and have
not been as well characterized as TLRs have. There are 17 different groups of CLRs based
on the structure of the carbohydrate recognizing domain (CRD) (81). Given the number of
different groups of CLRs, it is no surprise that the family includes both secreted and
transmembrane proteins. CLRs are most often expressed on myeloid cells and have a wider
range of functions than TLRs. CLRs have been shown to play a role in PAMP recognition,
phagocytosis, cytokine and chemokine production, antigen presentation, and development
of the adaptive immune response (82-85). In addition to pathogen recognition, CLRs have
been shown to be receptors for self-ligands and to play a role in maintaining homeostasis.
For example, Mannose receptor (MR) has been shown to play a role in the clearance of
apoptotic cells via efferocytosis (86, 87). Likewise, soluble CLR, Galectin-3 (Gal3) has
been shown to play a role in the clearance of apoptotic neutrophils via efferocytosis (88).
Work from our lab showed that galectin-3 and -9 can act as DAMPs to increase
inflammatory response during bacterial pneumonia (89, 90). Other CLRs, such as LOX-1,
MGL1, and DEC-205, recognize apoptotic cells, but have not been further implicated in
homeostatic process that is efferocytosis (91-93). Further, soluble lectins such as
Collagenous lectins (Collectins) act as opsonins along with complement proteins in order
15

to opsonize and take up apoptotic cells (94-97). Beyond just apoptotic cell recognition,
CLEC-2, DC-SIGN, and MGL have been implicated in tumor immune surveillance by
binding tumor antigens (98-101). The CLR Mincle (Clec4e), is a sensor for SAP-130, an
alarmin released by necrotic cell bodies (102, 103). We and others have shown its role in
various disease conditions (65, 66, 104-109). Soluble CLRs, Gal3 and Gal9, have both
been characterized as alarmins (89, 90).
Given the numerous ways in which CLRs play a role in inflammation and homeostasis, it
is important to understand what role CLRs play in sepsis development and neutrophil
function. These topics have been researched to some extent with 195 and 430 search results
for sepsis and C-type lectins or neutrophils and C-type lectins respectively in PubMed as
of June 2017. While those search results indicate that research is being done on this topic,
given the sheer number of CLRs it is important to continue to characterize their function
in sepsis development. Doing so will not just increase our understanding on CLRs and their
function, but highlight new therapeutic targets in the treatment of sepsis.

Resolution of Inflammation: Efferocytosis
A vital part of any infection is the clearance of the infiltrating immune cells that fought the
infection in order to achieve a state of homeostasis. Failure to efficiently clear the
infiltrating neutrophils at the site of infection can lead to further inflammation. Apoptotic
neutrophils can undergo secondary necrosis, causing the release of damage associated
molecular patterns (DAMPS) and pathogen associated molecular patterns (PAMPS). The
release of those pro-inflammatory markers will help drive further inflammation,
contributing to the development of sepsis (110-114). The process of efferocytosis involves
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clearing of apoptotic cells by professional phagocytes such as macrophages and immature
dendritic cells. Efferocytosis plays a vital role in controlling inflammation, by clearing
pathogens not destroyed through phagocytosis (115) in addition to preventing the release
of pro-inflammatory mediators from necrotic cells (110). Upon engulfment of dead cells,
the efferocytic phagocytes undergo phenotypic changes that leads to the production of
TGF-beta and IL-10, anti-inflammatory mediators, which are able to shut down the
inflammatory immune response and prevent further cellular influx (112, 116-120). Not
surprisingly, defects in the efferocytic process has been associated with development of a
variety of inflammatory diseases including atherosclerosis, cystic fibrosis, and chronic
obstructive pulmonary disease (COPD) (121). Interestingly, products released by necrotic
neutrophils during infection and inflammation inactivate anticoagulants such as activated
protein C, which can further drive sepsis development by deregulating the coagulation
system, causing vascular injury, and contributing to organ failure and death (122). Given
that sepsis is characterized by massive cell death culminating in organ failure, one might
speculate that a deregulation of efferocytosis causing inefficient neutrophil turnover might
lead to the development of sepsis. A PubMed search for “sepsis and efferocytosis” turned
up only 10 articles as of June 2017. Of those 10 articles, 3 are reviews that only speculate
on the effect efferocytosis has on the development of sepsis. 3 of the other 7 articles deal
directly with the efferocytosis of neutrophils, while the 4 identify different ways to
modulate efferocytosis. This clearly highlighted that this field is highly understudied.
Efferocytosis and the resolution of inflammation is a complex and well-orchestrated
process. The first step in efferocytosis is the recruitment of the phagocytic cells by the
release of "find me" signals by the apoptotic cell, which creates a gradient that leads the
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phagocytic cell to migrate to the apoptotic cell. Once the phagocytic cells are in the vicinity
of the apoptotic cells, they are able to recognize and bind a number of different "eat me"
signals. "Eat me" signal binding to the "eat me" signal receptor activates a signaling
pathway leading to Rac activation, which in turn causes to actin polymerization and
eventual cytoskeletal rearrangement that is required for internalization and clearance (110,
123-125) (Figure 4).
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Figure 4. Immunomodulatory roles of efferocytosis signals.
Depiction of the tree key stages of efferocytosis (dashed boxes) with detailed illustrations
showing some of the known signaling molecules/pathways relevant to immune modulation
for each of the three stages. The lower table indicates some of the key effects of these
efferocytosis signaling mechanisms on the following: immune signaling in phagocytes,
production of immune mediators, and some of the prominent immune outcomes of the
indicated molecules/pathways. Arrows in the table indicate whether signaling via these
pathways generally increases of decreases the effects listed. Please note this diagram
represents only a portion of the efferocytosis signals and their immunoregulatory effects
that have been described. MMP, matrix metalloprotease; PS, phosphatidylserine (PtdSer);
RTK, receptor tyrosine kinase. Reproduced with permission of The American Association
of Immunologist. Copyright 2017. The American Association of Immunologist, Inc. (126).

While the general process of efferocytosis is straight forward, there are numerous factors
that play a role, many of those factors are not fully understood or not even identified yet
(110, 123). There are a few different "find me" signals, lipids such as
lysophosphatidylcholine (LPC), which binds to G-protein-coupled receptor G2A (127) or
S1P that too binds G-protein-coupled receptors (123, 128). Other "find me" signals include
a classical chemokine Fractalkine (CXC3CL1) (129) and nucleotides such as ATP and
UTP that bind the P2Y2 receptor on the phagocytic cell (130). Several "eat me" signals,
including ICAM3 (110, 123, 131), thrombospondin, compliment C1q, Calreticulin (110,
123), changes in glycosylation (132), and the most well characterized one is
phosphatidylserine (PtdSer) (110, 123, 133, 134). Most of the known and characterized
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"eat me" signal receptors, such as TIM1&4, BAI-1, Sabilin-2 bind PdtSer (110, 123, 135140). CD14 binds to the "eat me" signal ICAM3, while CD36 with the help of integrins
binds to thrombospondin (123). The signaling mechanisms activated by "eat me" signal
binding to receptor leading to apoptotic cell internalization are not well known. There are
two semi characterized pathways, both of which lead to the activation of Rac, which is
required for actin polymerization and cytoskeletal rearrangement needed for apoptotic cell
internalization and clearance (110, 123, 124). The CrkII–Dock180–ELMO pathway is the
better characterized pathway of the two. Dock180 and ELMO complex together in order
to form an unconventional guanine nucleotide exchange factor complex, needed to activate
Rac (Figure 5).
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Figure 5. Signaling pathways elicited by three PtdSer recognition receptors.
Binding of the apoptotic cell to the phagocyte triggers signaling pathways. BAI1 is a 7transmembrane receptor that directly binds the PtdSer on the surface of an apoptotic cell,
resulting in the recruitment of the Engulfment and cell motility (ELMO)/Downstream of
Crk (DOCK) complex, which functions as a guanine exchange factor for the small
GTPase Rac. Rac activation promotes actin cytoskeleton remodeling required for the
engulfment of the apoptotic corpse. Integrins αVβ3 or αVβ5 and the Tyro Axl Mer (TAM)
family receptors bind apoptotic cells indirectly, via PtdSer-bound bridging molecules
MFG-E8, Gas6 or ProteinS, resulting in the activation of the focal adhesion kinase (FAK)
and contributing to the activation of Rac. TAM receptors are tyrosine kinases that also
activate cell signaling pathways involving the kinases Src and phosphatidylinositol-3kinase (PI3K) and phospholipase C (PLC). TIM4 functions as a tethering receptor
bringing the apoptotic cell in contact with signaling engulfment receptors, and signal
through co-receptors. The extent of the connection between the signals elicited by
different engulfment receptors awaits further characterization. Reproduced with
permission from Nature Reviews Immunology. Permission # 4126831301692 (141).

In order to activate Rac, Dock180 and ELMO, sometimes CrkII, are recruited to the cell
membrane upon "eat me" signal ligation to the carboxyterminal of the receptor (110, 123,
140, 142). The second pathway recruits the adapter protein GULP, the molecular
components in that pathway are not fully understood (110, 123). Efferocytosis is a complex
process with numerous components that could easily become deregulated and disrupt the
resolution of inflammation and return to homeostasis, which would drive the development
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of chronic inflammation and eventually lead to sepsis. Therefore, it is a promising area of
research in regards to understanding the development of sepsis and how a beneficial host
response aimed at restoring the body to homeostasis could lead to massive inflammation
and tissue destruction if deregulated.

Bacteria Fighting Back
In order to survive inside the host, bacteria have developed numerous ways by which to
evade the host immune response. The host immune response is initiated when the pathogen
is recognized by various pattern recognition receptors (PRRs) on the innate immune cell
as described above. This activates the innate immune response, leading to an inflammatory
response in order to kill the invading pathogen. The pathogen can be killed directly via
phagocytosis and phagolysosomal fusion or indirectly by being trapped via NETosis or
cleared after escaping the phagosome via efferocytosis. Below are just a few cases to
highlight the many ways bacteria are able to evade host recognition, engulfment, and
killing. One of the first steps in fighting of the infection is recognition of the pathogen and
subsequent release of chemokines and cytokines meant to recruit phagocytic cells to the
site of infection. Streptococcal species of bacteria produce streptolysin, which is able to
suppress neutrophil chemotaxis and even kill phagocytes (143). Other bacteria such as
Treponema pallidum, the causative agent of syphilis, cloak themselves in host protein in
order to evade phagocytosis (144, 145). Once the pathogen is recognized and phagocytic
cells recruited to the site of infection the next step in clearing the pathogen is to
phagocytosis. Some bacteria such as Klebsiella pneumoniae produce capsules that prevent
phagocytic engulfment (146-148). While others such as Pseudomonas aeruginosa and
Yersinia enterocolitica utilize type III secretion systems to inject effector molecules into
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the host to prevent phagocytosis (149, 150). If the host is unable to phagocytose and kill
the bacteria, other host defense weapons are deployed. For example, neutrophils have the
ability to produce extracellular traps (NETs) by spewing out their DNA and histones as a
way to trap extracellular pathogens, prevent their dissemination, and allow for them to be
cleared by other means (151). Several pathogens have devised mechanisms to escape
entrapment or killing by NETs. Staphylococcus aureus produces a nuclease which is able
to degrade NETs and allow S. aureus to escape (152). In addition to there, several bacterial
pathogens are able to survive inside the phagocyte upon phagocytosis, whether that be in
the phagosome, the phagolysosome, or in the cytoplasm. Rickettsiae for example, escapes
from the phagosome to survive in the cytoplasm, through the use of bacterial enzyme
phospholipase A (153). Listeria monocytogenes also uses its own hemolysin enzyme
listeriolysin O to escape the phagosome (154). Mycobacterium tuberculosis on the other
hand produces sulfatides that arrest the phagosome and prevent phagosome-lysosome
fusion (155). The bacterium Salmonella typhimurium has the ability to adapt to extremely
low pH values and survive within phagoslysosome (156). Despite the pathogens best
efforts to survive inside the phagocyte, the host is still able to clear the pathogen through
efferocytosis. As mentioned above Mycobacterium tuberculosis is able to arrest the
phagosome, evade the host response, replicate inside the cell, and disseminate when the
cell become necrotic over time. The host can clear the bacteria via the uptake of infected
apoptotic phagocytes by the process of efferocytosis. The M. tuberculosis is already
compartmentalized inside an arrested phagosome and is unable to prevent lysosomal fusion
to the new phagosome, thus killing the bacteria (157). Pseudomonas aeruginosa is also
cleared through efferocytosis. In this case the bacterium binds to apoptotic cells or
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apoptotic bodies and then internalized and killed via efferocytosis (158). Just as with
phagocytosis, bacteria have found a way to hijack efferocytosis. Listeria monocytogenes
can escape the phagosome with its listeriolysin O toxin and then hijack host actin regulation
via its ActA protein. From there it is able to escape the host cell in a membrane-derived
vesicle covered with exofacial phosphatidylserine (PS). That vesicle is recognized by the
PS-binding domain TIM-4 and is then efferocytosed into a new cell, where it can continue
to disseminate from cell to cell (159). S. aureus on the other hand takes a different approach
to exploit efferocytosis. It acts on neutrophils to upregulate the expression of “don’t eat
me” signal CD47 on the cell surface in order to prevent the efferocytosis of the infected
cell as well as driving the cell away from apoptosis and toward necroptosis (160). This
account of host defense strategies and the bacterial evasion mechanisms briefly highlights
the tug of war between the host and the pathogen and describes some of the mechanisms
by which bacteria are able to survive and cause disease. While several advances have been
made on different bacterial strategies used to evade phagocytosis or survive inside the
phagocyte (161-164), the same cannot be said about how bacteria manipulate efferocytosis.
There are only 83 published articles on efferocytosis and bacteria as of June 2017. Of those,
only one study describes the effect bacteria has on neutrophils to inhibit their efferocytosis
(160). Bacterial manipulation of efferocytosis is a promising area of research that is only
just beginning to be explored. This research could identify new targets for antimicrobial
therapies as well as identify novel virulence factors in bacteria. Our work utilizing
Klebsiella pneumoniae (KPn) to induce pneumonic sepsis in mice allows us to not only
look at the role C-type lectin receptors (CLRs) play in pneumonic sepsis; it allows us to
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study the pathogenicity of KPn and the virulence mechanisms that it utilizes to subvert host
defenses in order to become one of the leading causes of sepsis (12, 17, 18).

Animal Model of Sepsis
Three murine models of sepsis have been described to recapitulate the disease development
in humans. The endotoxemia model, uses administration of exogenous toxins such as
bacterial lipopolysaccharide (LPS) to induce sepsis like symptoms in mice. It can only
mimic some of the pathophysiological alterations seen in sepsis patients, but is utilized
owing to its ease and reproducibility. This model shows a rapid increase in systemic
cytokine levels over a period of 8 hours, peaking between 1.5 to 4.5 hours post injection
(165). Unfortunately, this differs from clinical manifestations of sepsis where there is
prolonged systemic cytokine levels that is orders of magnitude lower than what is seen in
the endotoxicosis model. Also, the therapeutic targets identified using this model have
proven ineffective in human clinical trials, strongly suggesting that this model while
convenient and reproducible may not be the most relevant model to use in regards to human
disease (165-172).
The second model is a breach in the endogenous protective barriers, such as cecal ligation
and puncture (CLP) and colon ascendens stent peritonitis (CASP) models. These models
were once considered the “gold standard” of animal sepsis models because they were able
to reproduce a number of key hallmarks of sepsis in mice, such as hyperinflammation,
bacteremia, systemic organ damage, and mortality. However, these models induce
polymicrobial sepsis, while relevant to some forms of sepsis is not relevant to hospitalacquired pneumonias, which are usually caused by a single bacterial species. While these
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models replicate some aspects of sepsis, they do not provide insight into the host pathogen
response mechanisms underlying sepsis (165-173).
The third model is the live bacterial infection model, which includes the pneumosepsis
model. This model focuses on one of the leading causes of sepsis, pneumonia, accounting
for almost 50% of all cases (2, 12). This model is able to reproduce the hallmarks of sepsis
seen in humans such as hyperinflammation, bacteremia, systemic organ damage, and
mortality. Importantly, this model uses only a single pathogen, which is more frequently
the case in human sepsis, unlike the CLP and CASP models that induce polymicrobial
sepsis (12). That allows examination of the host pathogen interaction mechanisms. In our
lab, we utilize the pneumoseptic model of Klebsiella pneumoniae (KPn) infection. This
model focuses on pulmonary bacterial infection, which is a leading cause of sepsis (2, 12,
14, 172). Intranasal delivery of this pathogen in WT (C57/BL6) mice produces major
characteristics of sepsis i.e., hyperinflammation, bacteremia, systemic organ damage, and
mortality.
Klebsiella pneumoniae (KPn), is a Gram-negative, nonmotile, encapsulated, bacterium that
belongs to the Enterobacteriaceae family of bacteria (174-176). Members of that family,
including Klebsiella species and E. coli are the leading cause of sepsis (12, 17, 18). KPn
resides all over the environment and readily colonizes human mucosal surfaces (174, 175).
Pneumonias and Urinary Tract Infections are the primary infections caused by KPn. This
opportunistic pathogen causes both community-acquired pneumonias (CAP) and hospitalacquired pneumonias (HAP), which are the leading cause of mortality among nosocomial
pneumonias

(176-179). Approximately 12% of all HAPs are due to KPn, while

approximately 4% of CAPs are caused by KPn (180-182). Interest in KPn has increased in
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recent years due to the emergence of multidrug resistant and hypervirulent strains. This is
worrisome given the number of HAPs caused by KPn and how it is more likely that the
KPn will be multidrug resistant due to many of those patients having already been treated
with antibiotics (177, 183, 184).
KPn has four well characterized virulence factors, which are capsule, lipopolysaccharide
(LPS), fimbriae, and siderophores. It uses these virulence factors to evade early host
immune responses (176, 185). The capsule is a protective polysaccharide coating that
covers the bacterium and is thought to be necessary for virulence. There are 78 serotypes
of the K antigen that makes up the capsule, of those 25 make up 70% of all isolated strains,
with K1 and K2 being associated with the most virulent strains. K1 and K2 strains are more
virulent due to a lack of mannose in their capsules. The lack of mannose means no mannose
receptor binding, which inhibits efficient phagocytosis and downstream signaling (146148, 186-190). The capsule of KPn prevents opsonization and phagocytosis of the bacteria
by neutrophils and other phagocytic cells (191, 192). The capsule also protects the baterium
from complement mediated killing as well as other antimicrobial peptides. Early
inflammatory response is also suppressed due to the capsule and its ability to inhibit TLR2
and TLR4 signaling. Inhibition of those PRR signaling pathways, removes key aspects of
the innate immune response, thereby reducing the early inflammatory response to the
pathogen when compared to non-capsulated bacteria (146, 192, 193). It is clear from these
examples that the capsule is an essential tool for the bacteria to subvert and suppress the
early host immune response.
KPn is a Gram-negative bacterium and as such the endotoxin LPS is a part of its cell
membrane. LPS is both detrimental and beneficial to KPn virulence. KPn LPS has 9 O
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antigens, with O1 being the most common. Full-length O antigen on LPS prevents
complement mediated killing by hiding complement activators on the bacterial cell surface
(192, 194-196). The lipid A portion of LPS is recognized by the pattern recognition
receptor (PRR) TLR4, which leads to the production of cytokines and chemokines as well
as cellular recruitment (197). Some KPn strains with particular K antigens are able to mask
their LPS inside the capsules, which dampens TLR4 signaling (196). KPn also modulates
its LPS, like other bacteria, such as Yersinia pestis, so that it is no longer recognized by
TLR4 (198, 199). Interestingly, Lipid A along with the core polysaccharide of LPS can
resist phagocytosis in the lungs by alveolar macrophages (200). LPS is an endotoxin and
activates the innate immune system through TLR4 to recruit cells via the release of
chemokines and cytokines. It also plays a protective role on the bacterial surface by
preventing phagocytosis and complement mediated killing.
KPn has both type 1 and type 3 fimbriae as virulence factors. These fimbriae are important
for adhesion and biofilm formation. Type 1 fimbriae are thin, thread like protrusions on the
cell surface and are expressed biased on environment. They are expressed while the
bacteria is in the urinary tract, but not the GI tract or lungs (201, 202). Type 3 fimbriae on
the other hand are helix like filaments, but similar to type 1 fimbriae are not needed for GI
track infection or virulence in the lungs. Type 3 fimbriae can bind tracheal cells and
therefore assist KPn in the colonization of the lungs (203-205).
Siderophores are used to acquire iron from the host and are essential for bacterial survival
and virulence. They are secreted and have a higher affinity for iron than host transport
proteins. KPn has a number of different siderophores, such as enterobactin, yersiniabactin,
salmochelin, and aerobactin. More common KPn strains usually have only enterobactin as
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its siderophore, while more hypervirulent strains also utilize the siderophores
yersiniabactin, salmochelin, and aerobactin (206-210). Other possible virulence factors in
KPn have been identified, but have yet to be fully characterized (176).
KPn virulence factors described above help the bacteria subvert and suppress the early
inflammatory host response, allowing the bacteria to establish an infection and survive.
These virulence factors have been well characterized and the ways in which they aid in
KPn pathogenesis are known. With the emergence of multidrug resistant and hypervirulent
strains of KPn over the past couple of decades, it is essential to identify new virulence
factors and pathogenic mechanisms that can be targeted for new therapies against KPn
infection.

Outline of dissertation
Sepsis is a complex immune disorder, the roles in which CLRs and bacterial pathogenesis
play in the development of sepsis is understudied. The aim of this dissertation is to study
the role two particular CLRs, Macrophage Galactose Type Lectin-1 (MGL1) and Mincle
(Clec4e), play in pneumonic sepsis as well as identity novel pathogenic strategies used by
KPn, a causative agent of pneumonic sepsis, to establish an infection in the host. In the
following chapters, we show that CLRs play an important protective role in KPn induced
pneumonic sepsis by regulating neutrophil turnover and that the pathogen employs a
strategy to help overcome host defense mechanisms to successfully establish infection.
In Chapter 2 the role of MGL1 in pneumonic sepsis will described. MGL1 has not been
characterized in bacterial infections and disease pathogenesis to date. It is known to be
expressed on macrophages and immature dendritic cells and play a role in recognition of
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tumor antigens as well as apoptotic cells (100, 211, 212). Here we show that MGL1 is
protective in KPn induced pneumonic sepsis and that protection is due to its role in
neutrophil migration and turnover. Chapter 3 will focus on the protective role of Mincle
during KPn induced pneumonic sepsis. Mincle is an activating receptor for damageassociated and pathogen-associated molecular patterns, called DAMPs and PAMPs and
can be expressed in neutrophils, macrophages, and dendritic cells. Most of the functional
analysis of the receptor has been done in macrophages. Its role in chronic bacterial
infections has been studied, but how it functions in acute pneumonic infections is not
known (102, 109, 213-215). We show that in pneumonic infections leading to sepsis,
Mincle plays a protective role via bacterial clearance mechanisms phagocytosis and
NETosis in neutrophils.
Chapter 4 transitions from the host response in pneumonic infection to bacterial pathogenic
mechanisms used to establish infection. KPn, a causative agent of sepsis, has virulence
factors that help it evade and suppress early host immune response (146, 191-196). Here
we show a novel mechanism by which KPn modulates the route of cell death in infected
neutrophils to inhibit efferocytosis of those infected cells, indicating another pathogenic
mechanism KPn utilizes to evade the host response. Chapter 5 contains a summary along
with a discussion of these new findings and conclusions in this dissertation.
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MACROPHAGE GALACTOSE-TYPE
LECTIN-1 (MGL1) DEFICIENCT IS
ASSOCIATED WITH INCREASED
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Abstract
C-type lectin receptors (CLRs), the carbohydrate recognizing molecules, orchestrate host
immune response in homeostasis and in inflammation. In the present study we examined
the function of macrophage galactose-type lectin-1 (MGL1), a mammalian CLR, in
pneumonic sepsis, a deadly immune disorder frequently associated with a non-resolving
hyperinflammation. In a murine model of pneumonic sepsis using pulmonary infection
with Klebsiella pneumoniae (KPn), the expression of MGL1 was upregulated in the lungs
of KPn infected mice and the deficiency of this CLR in MGL1-/- mice resulted in
significantly increased mortality to infection than the MGL1-sufficient wild-type mice,
despite a similar bacterial burden. The phagocytic cells from MGL1-/- mice did not exhibit
any defects in bacterial uptake and intracellular killing and were fully competent in
neutrophil extracellular trap formation, a recently identified extracellular killing modality
of neutrophils. Instead, the increased susceptibility of MGL1-/- mice seemed to correlate
with severe lung pathology, indicating that MGL1 is required for resolution of pulmonary
inflammation. Indeed, the MGL1-/- mice exhibited a hyperinflammatory response, massive
pulmonary neutrophilia and increase in neutrophil-associated immune mediators.
Concomitantly, MGL1 deficient neutrophils exhibited an increased influx in pneumonic
lungs of KPn infected mice. Together these results show a previously undetermined role of
MGL1 in controlling neutrophilia during pneumonic infection thus playing an important
role in resolution of inflammation. This is the first report depicting a protective function of
MGL1 in an acute pneumonic bacterial infection.
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Introduction
Pattern recognition receptors (PRRs) activate innate immune responses upon detection of
conserved pathogen motifs as well as self-molecules released during a pathological insult.
Among the PRRs, the Toll-like receptor (TLR) family is the most characterized group of
receptors known to be involved in activation and maturation of innate immune cells such
as dendritic cells and macrophages, among others (216). Another family of PRRs consists
of transmembrane and soluble C-type lectin receptors (CLRs), which have selective
affinity for self and non-self glycan motifs in a Ca2+-dependent manner (217). Due to their
abundant expression on sentinel cells of innate immune system that contribute to
inflammation and maintenance of immune homeostasis, CLRs act as key sensors of tissue
integrity and pathological insult and play a central role in orchestrating immune responses
(218).
Macrophage galactose-type C lectin 1 (MGL1) is a type 2 transmembrane CLR expressed
on macrophages and immature dendritic cells with a binding specificity for galactose
and/or its monosaccharide derivative, that are abundantly expressed on tumor antigen
MUC1 as well as self-antigens such as gangliosides (211). Not surprisingly, MGL1 is
included in the family of scavenger receptors along with macrophage mannose receptor
(212) that plays a role in recognition of tumor antigens and apoptotic cells (93, 100).
Although this CLR can bind antigens from Neisseria gonorrhoeae (219), Campylobacter
jejuni (220) and Bordetella pertussis (221), its role in overall disease pathogenesis is
unknown. An anti-inflammatory function of this CLR in colitis via its interaction with
commensal bacteria has been reported (222). However, the current knowledge of MGL1
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function in infectious diseases, particularly the pathogenesis of pneumonia and sepsis is
virtually non-existent.
Sepsis is a deadly disorder characterized by a systemic hyperinflammation resulting usually
from an infectious insult. An estimated 20-50% of the 750,000 sepsis and severe sepsis
patients die in the US owing to the lack of effective treatment strategies (2). Infections of
the lung and the respiratory tract are the main causes of severe sepsis, and 41% of these
infections are due to Gram-negative bacteria (223-225). Nosocomial infections with
Klebsiella pneumoniae (KPn) account for 5-20% of Gram-negative sepsis cases (223, 225).
KPn-induced lung infection is a clinically relevant animal model of sepsis and a better
understanding of this model may help to increase the knowledge about sepsis
pathophysiology (169). Additionally, emergence of multidrug resistant isolates of KPn in
clinical settings is a serious health concern. In this scenario an understanding of the
functioning of host innate immune components that influence the outcome of KPn
pneumonia might provide targets for modulation of host immune system in a beneficial
manner.
In this study we examined if MGL1 plays a role in orchestrating host defense against KPn
pneumosepsis. Indeed, our results suggest that MGL1-mediated responses are required for
the resolution of pneumonia and an increased susceptibility of MGL1-/- mice correlates with
the increased inflammatory response and with massive accumulation of neutrophils in the
lungs of infected mice, despite similar bacterial burden. These results identify for the first
time, a protective role of MGL1 in regulation of neutrophil influx and inflammatory
response against pneumonic KPn sepsis.
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Materials and Methods
Bacterial strains and Mice
The KPn (ATCC strain 43816) were grown to log phase in LB medium at 37oC. All invivo experiments were performed using 6-8 weeks old female wild-type C57BL/6 (WT) or
MGL1-/- mice on same background obtained from JAX mice (Jackson Laboratory), and
bred in the animal facility of the University of North Dakota. The animals were used
according to institutional and federal guidelines.
Infection of Mice, survival and bacterial burden
Mice were anaesthetized with a mixture of 30mg/ml ketamine and 4 mg/ml xylazine in
PBS and were infected intranasally with 3.0 x 104 CFUs in 20ul of saline, of KPn or with
20 µl of saline alone. Survival of the mice was recorded for up to 2 weeks post-infection
(p.i.). Death was recorded as infection induced mortality. Mice displaying severe signs of
distress (labored breathing, non-responsiveness to cage tapping, failure of grooming and
feeding) were humanely sacrificed and also recorded as infection induced mortality. In
some experiments, the mice were euthanized at indicated times p.i. and blood, lungs and
liver were aseptically homogenized in cold PBS with CompleteTM protease inhibitor
cocktail (Roche Diagnostics, Germany). For the bacterial burden analyses, serially diluted
homogenates and blood were plated on LB agar and incubated at 37oC overnight.
Quantitative real-time PCR
Total RNA from lungs of infected and mock control mice harvested at various times p.i.
was extracted using Trizol reagent (Invitrogen) according to the manufacturers'
instructions. Real-time PCR analysis was performed using SYBR green (Applied
Biosystems, CA, USA) to measure the MGL1-specific mRNA by using specific primers
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(sense)

5'-

5′-TCTCTGAAAGTGGATGTGGAGG-3′

and

(anti-sense)

5′-

CACTACCCAGCTCAAACACAATCC-3′ as described by us (226). The target gene
expression levels were normalized to levels of the house keeping 18S gene in the same
sample. Expression of MGL1 in infected samples was determined as fold change over that
in control samples as calculated by using the formula 2−(ΔΔCt).
Multi-analyte profile analysis
The lung homogenates were prepared as described for the bacterial burden analysis above
and were centrifuged at 2000 x g for 15 min to clear cellular debris. The supernatants were
immediately frozen at -80o C. The biomarker levels in lung homogenates were determined
commercially by Myriad Rules-based Medicine (Austin, TX, USA) utilizing a multiplexed
analysis.
Histological and Immunofluorescence analysis
For histological analysis, frozen lung tissues were processed as previously described (227,
228). Serial horizontal sections (10 µm thick) of frozen lung tissues thus obtained were
stained with hematoxylin and eosin for pathological analysis as previously described (229,
230) . For Immunofluorescence staining, the frozen lung tissue sections were stained for
the detection of MGL1, using an affinity purified anti-mMGL1/CD301 goat IgG (R&D
Systems, Minneapolis, MN) and visualized with Alexa Fluor® 546 donkey anti-goat IgG
(Life Technologies, Grand Island, NY). The images were acquired using a Nikon eclipse
80i upright microscope (Nikon Corporation, Tokyo, Japan) with an attached cooled RTke
Spot 7.3 three spot color camera (Diagnostic Instruments Inc., Sterling Heights, MI). The
images were processed and analyzed using Adobe Photoshop 7.0 software (Adobe,
Mountain View, CA).
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Flow Cytometry
Lungs cells were harvested from mice at 3 days p.i. and processed as previously described
by us (227, 228, 231). Cells types in the lungs were quantified by staining with Pacific
BlueTM anti-mouse CD11b (Clone M1/70), APC-Cy7 anti-mouse CD11c (Clone N418),
FITC anti-mouse CD19 (Clone 6D5), Brilliant Violet 570 anti-mouse CD3 (Clone 17A2),
APC anti-mouse Ly6G (Clone 1A8), PerCP/Cyc5.5 anti-mouse Ly6C (Clone HK1.4), PECy7 anti-mouse F4-80 (Clone BM8) antibodies (Biolegend, San Diego, CA), and PE antimouse TCR β (Clone H57-597) antibody (Becton Dickinson Pharmingen, San Jose, CA).
Enumeration of neutrophils by flow cytometry (using a BD LSR II, Becton Dickinson, San
Jose, CA) was done by quantitating Ly6G+CD11b+ cells stained with Pacific BlueTM antimouse CD11b (Clone M1/70) and APC anti-mouse Ly6G (Clone 1A8) antibodies
(Biolegend, San Diego, CA). FlowJo (Tree Star) software was used to analyze all data.
Bacterial phagocytosis and killing by neutrophils and macrophages
Bacterial phagocytosis of WT and MGL1-/- neutrophils and macrophages was assessed by
plating on LB media, incubating at 37°C overnight, and counting colonies. For this,
peritoneal neutrophils from C57BL/6 and MGL1-/- mice were isolated using an established
method of thioglycollate-induced peritonitis. Sterile 4% thioglycollate was injected in
peritoneal cavity of mice and neutrophils enriched 16-18h following the injection were
isolated. Five x105 Neutrophils were incubated with KPn (MOI 50) for 1 hour to determine
bacteria uptake and 3 hours to determine bacteria killing. After 1h the neutrophils were
washed two times with warm PBS and one time with RPMI before adding 2µg/mL
gentamicin in RPMI (Gibco) with 10% FBS for the remaining 2h (for the 3h samples) and
for 15 minute for the 1h samples. The cells were washed extensively with warm PBS before
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lysing with 0.1% TritonX100. Serial dilutions of the lysates were plated on LB media
overnight at 370C before colonies were counted.
Bone marrow was isolated from wild-type and MGL1-/- mice and the cells were
differentiated to macrophages as previously described (232). On day 6 of culture, 3x105
macrophages were plated in 24-well flat bottom plates and were infected with KPn (MOI
50) for 1 hour to determine bacteria uptake and 3 hours to determine bacteria killing as
described above.
Neutrophil Extracellular Traps
For detection of neutrophil NETs in-vivo, the bronchoalveolar lavage (BAL) was
performed in WT and MGL1-/- mice at 3dp.i. (66). The lavage cells were cytocentrifuged
on glass slides and were stained with Sytox Green (Molecular Probe, Eugene, OR) to
visualize NETs. The percent NET formation was quantitated by dividing the number of
NET-forming neutrophils by total number of cells in 8-10 random microscopic fields and
multiplying the values by 100. The experiment was repeated 3 times.
Neutrophil Adoptive Transfer
Adoptive transfer of bone marrow neutrophils was performed by methods previously
described with modifications (233-235). Briefly, bone marrow neutrophils were isolated
from WT and MGL1-/- mice by gradient separation. Purified neutrophils (~80% purity
determined by flow cytometry) were labeled with CellTracker Orange CMTMR (Life
technologies) or CellTracker Green CMFDA (Life technologies) at 37°C for 10 minutes.
Labeled cells were mixed in 1:1 ratio using 2x106 each group and then injected
intravenously via tail vein into WT and MGL1-/- mice that had been infected with 3.0 x 104
CFUs of KPn intranasally 24h prior. Lungs were harvested 2h after the tail vein injections
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and processed for flow cytometry as described above. Adoptively transferred neutrophils
recruited to the lungs were enumerated using LSR II flow cytometer and analyzed using
FlowJo software (BD Biosciences, San Jose, CA). Relative recruitment of WT and MGL1/-

neutrophils was calculated as the ratio of indicated populations.

In-vivo Efferocytosis
Peritoneal neutrophils from WT and MGL1-/- mice were isolated and labelled with
Carboxyfluorescein succinimidyl ester (CFSE; Cell Trace™ CFSE Cell Proliferation Kit
from Invitrogen) per manufacturer’s instructions. CFSE-labelled WT and MGL1-/neutrophils were suspended in complete RPMI and 35uL/3.5x106 cells were administered
intranasally into mice anaesthetized using a mixture of 30mg/ml ketamine and 4 mg/ml
xylazine in PBS. Lungs were lavaged as described by us (65, 236) 2 hrs after the instillation
and alveolar macrophages analyzed by flow cytometry using PE-Cy7 conjugated antiF4/80 and APC conjugated anti-Ly6G antibodies (BioLegend, San Diego, CA).
Efferocytic uptake by macrophages was quantitated by flow cytometry to enumerate Ly6GF4/80+ CFSE+ cells. All other statistical analyses were performed using the Student t test
(SIGMA PLOT 8.0, Systat Software, San Jose, CA).
Statistical Analysis
Statistical analysis of survival studies was performed by Kaplan Meir log-rank test;
bacterial burdens by non-parametric Mann-Whitney Test. All other statistical analyses
were performed using the Student t test (SIGMA PLOT 8.0, Systat Software, San Jose,
CA).
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Results
MGL1 expression in mouse lungs during pneumonic KPn infection
To examine the role of MGL1 in KPn induced pneumonic sepsis, we first determined its
transcript-level expression by real-time quantitative PCR using RNA from lungs of KPninfected wild-type (WT) mice. The results showed that MGL1 mRNA was maximally
transcribed by 3dp.i. (Fig. 6A), a time when infiltration of immune cells is peaked during
infection (66, 230). To examine the expression of MGL1 at the protein level, in-situ IF
microscopy was performed on lung cryosections of mock control and KPn infected WT
mice at indicated post-infection times. In uninfected mock controls, the expression of
MGL1 was at low basal level (Fig. 6B). Upon infection, this CLR was found to be
abundantly expressed at 3dp.i., consistent with the high transcript level in lungs at that time
(Fig. 6B). Interestingly, in addition to some infiltrating immune cells, MGL1 appeared to
be expressed prominently by endothelial and alveolar epithelial cells in the lungs of these
mice. This infection induced upregulation in the expression of MGL1 in pneumonic lungs
during KPn infection indicated that this CLR likely plays a role in the pathogenesis of KPn
pneumonia.
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Figure 6. MGL1 is upregulated in the lungs of Klebsiella pneumoniae (KPn) infected
pneumonic mice
(A) Total RNA was extracted by Trizol method from the lungs of KPn infected wild-type
(WT) C57/BL6 mice, harvested at indicated times post-infection. The mRNA levels of
MGL1 were analyzed by real-time PCR as described in Methods and are expressed as fold
changes over the levels in mock control mice calculated by using the formula 2−(ΔΔCt). Data
shown are the mean ± SEM of 3-4 mice per time point in two independent experiments.
Significant differences were measured by Student’s t test (p < 0.05) (B) MGL1 expression
was examined by immunofluorescence staining on lung cryosections of mock control and
KPn infected wild-type mice harvested at indicated times post-infection using an affinity
purified anti-mouse MGL1 goat IgG followed by Alexa Fluor® 546 labelled (red) donkey
anti-goat IgG. Nuclei (blue) were stained with 4′,6′-diamidino-2-phenylindole dilactate.
Images shown are representative of 3 independent experiments with 3-4 mice each.

Increased susceptibility of MGL1-/- mice to KPn pneumonia
To examine the role of MGL1 in disease development, overall disease severity and survival
was compared in wild-type (WT) and MGL1-/- mice infected with KPn. As the WT mice
are also susceptible to KPn infection, in order to dissect the role of MGL1, we
experimentally standardized a sublethal dose of KPn at which 60-70% of the WT mice
resolve the infection and display only transient signs of disease (ruffled fur, lethargy) early
during infection. We found that MGL1-/- mice were significantly more susceptible to this
dose and majority of mice succumbed to infection by day 5p.i. (Fig. 7A). These mice
exhibited progressive development of disease and overt signs of infection (weight loss,
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piloerection, hunched gait, lethargy, increased respiratory rate). The increased
susceptibility of MGL1-/- mice clearly indicated a protective role played by this CLR during
pneumonic KPn infection. To examine the impact of MGL1 deficiency on the host
antibacterial defense mechanism, comparison of local and systemic bacterial burden in the
organs of infected WT and MGL1-/- mice was performed. Intriguingly, there were no
statistically significant differences in the bacterial loads in lungs, liver or in blood of WT
and MGL1-/- mice, although the MGL1-/- mice tended to exhibit higher burdens at later
times post-infection (Fig. 7B). Based on this data, the protective function of MGL1 did not
appear to correlate with reduced bacterial burden or systemic dissemination.
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Figure 7. MGL1-/- mice exhibit reduced survival despite similar bacterial burden as
the WT mice
(A) WT and MGL1-/- mice were intranasally infected with 3.0x104 CFUs of KPn in 20µl
of sterile PBS and were assessed daily for disease severity. The survival was monitored for
two weeks. Statistical comparison of susceptibility was done by Kaplan-Meier survival
curve statistical analysis (p=0.0019 **). The data shown is from 3 independent experiments
(n=16). (B) WT and MGL1-/- were intranasally infected with KPn. At indicated times post
infection the mice were sacrificed, systemic organs were isolated, homogenized and plated
as described in Materials and Methods. Bacterial burden was enumerated after incubating
the plates overnight at 37oC. No significant differences in bacterial burden (using nonparametric Mann-Whitney test) in WT and MGL1-/- were found. Each symbol in the scatter
plots represents individual mouse and the data is from 3-4 independent experiments.

Role of MGL1 in phagocyte function

We next examined the direct effect of MGL1 deficiency on the bacterial uptake and killing
capability of phagocytic cells i.e. neutrophils and macrophages. As shown in Fig. 8A and
B, WT and MGL1-/- neutrophils and macrophages were equally competent in phagocytosis
and clearance of KPn. Studies from our and other laboratories have shown that KPn
infection induces Neutrophil Extracellular Trap (NET) formation in-vivo in lungs of mice
and that NETs can effectively inhibit the growth of KPn (66, 237). We thus compared the
extent of NET formation in-vivo in the lungs of KPn infected WT and MGL1-/- mice. As
shown in Fig. 8C, neutrophils isolated from BAL of infected MGL1-/- mice did not exhibit
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any defect in extracellular trap formation. Together with our observation of similar
bacterial burden in WT and MGL1-/- mice in-vivo, these data indicated that protective
function of MGL1 was likely independent of the bacterial clearance mechanisms during
pneumonic KPn infection.
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Figure 8. MGL1 deficiency does not impair bacterial clearance by phagocytes
Bacterial uptake and killing capacity of MGL1-/- and WT neutrophils (A) or bone-marrow
derived macrophages (B) was determined at 1h and 3h by assessing intracellular CFUs in
these cells as described in Methods. Data from a representative of 3 independent
experiments is shown. (C) Neutrophils isolated from bronchoalveolar lavage fluid (BAL)
of WT (upper panel) and MGL1-/- (lower panel) mice infected with KPn, were
cytocentrifuged and stained with Sytox Green to visualize extracellular traps (NETs).
Magnification 200X. Bar graph shows quantitation of NET forming neutrophils in BAL
from KPn infected WT and MGL1-/- mice. Data are mean ± SEM from 8 mice per group
in 3 independent experiments.

MGL1-/- mice exhibit severe lung pathology and hyperinflammatory response

We next compared the gross immunopathological changes and immune cell infiltration in
KPn infected WT and MGL1-/- mice. The mock control mice of both strains displayed
similar normal lung tissue morphology in H&E stained cryosections (Fig. 9a, 9e). A
moderate transient infiltration of immune cells was observed in infected WT mice by day
3p.i. which was reduced substantially by 5dp.i. (Fig. 9b-d). The overall architecture of the
lungs was largely preserved in the WT animals throughout the course of infection. In
MGL1-/- mice on the other hand, an increased immune cell infiltration was evident even at
1dp.i. which progressively increased and resulted in pulmonary inflammation
characterized by highly confluent immune cell infiltrates (Fig. 9f-h). To further examine
the impact of MGL1 deficiency on inflammatory response, levels of multiple inflammatory
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cytokines in lung homogenates were compared between KPn infected WT and MGL1-/mice. While the mock controls displayed low basal levels of these cytokines, KPn infected
WT mice exhibited increased amounts at 3dp.i., a time of peak bacterial burden and cellular
infiltration (Fig. 9B). Infected MGL1-/- mice on the other hand, exhibited significantly
higher levels of inflammatory cytokines at that time compared to the WT mice (Fig. 9B).
The levels of IL-10, an anti-inflammatory cytokine were also significantly higher in MGL1/-

mice, suggesting a condition of “cytokine storm” typical of sepsis, where anti-

inflammatory host mediators are upregulated in an attempt to counter-balance the systemic
inflammatory response (238-240). Together, our results show that MGL1 deficiency did
not render the mice defective in their ability to mount an anti-inflammatory response to
counter the on-going inflammation; instead these mice displayed a hyperinflammatory
phenotype typically associated with sepsis. Our observations thus raised the possibility that
despite a similar bacterial burden, increased lung pathology and hyperinflammatory
response is causing increased susceptibility of MGL1-/- mice to KPn infection.
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Figure 9.

Pneumonic MGL1-/- mice exhibit severe lung pathology and

hyperinflammatory response
(A) Hematoxylin & Eosin staining of lung cryosections from mock control (a and e) and
KPn infected WT (b,c,d) and MGL1-/- (f,g,h) mice isolated at indicated times postinfection. Magnification 200X. (B) The lungs from mock control (WT-M and MGL1-/- M)
and KPn infected WT and MGL1-/- (WT-Inf and MGL1-/- Inf) mice isolated at 3d p.i. were
homogenized in PBS with protease inhibitors and analyzed commercially for host immune
mediators by rodent multi-analyte profile (MyriadTM Rules-Based Medicine, Austin, TX).
Results shown are mean ± SEM of 3-4 each infected and mock control mice from 2-3
independent experiments. Statistical significance are denoted by asterisks (*, p<0.05; **,
p<0.005). CRP; C-reactive protein.

MGL1-/- mice display altered neutrophil accumulation and neutrophilic immune mediators

Pneumonic infection with KPn typically results in immune cell infiltration in lungs. To
examine if there were differences in the immune cell types infiltrating in the lungs of WT
versus MGL1-/- mice, flow cytometry analysis of total lung cells was performed. The
results revealed that the percent as well as absolute numbers of Ly6G+; Ly6C+ and
CD11b+ myeloid cells were significantly higher in the infected MGL1-/- lungs than those
in the WT mice (Fig. 10A and B). We found no significant differences in the numbers of
macrophages (F4/80+), dendritic cells (CD11c+), αβ T cells (TCRβ+) or B cells (CD19+).
Further analysis of the data revealed that the percent as well as total numbers of
Ly6G+CD11b+ neutrophils were increased 2-3 fold in the lungs of MGL1-/- mice upon
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infection, as compared to the WT mice (Fig. 10C). This indicated that MGL1 likely plays
a role in regulating neutrophil infiltration and that increased susceptibility of these mice
may be due to excessive neutrophil accumulation contributing to exacerbated lung
pathology. This was further corroborated with the analysis of neutrophil associated
immune

mediators

which

revealed

significantly higher

levels

of

neutrophil

chemoattractants (CXCL1, CXCL6), neutrophil survival mediator (GM-CSF) and
neutrophil activation markers (MMP9, MPO) in lung homogenates of MGL1 -/- mice, as
compared to their WT counterparts (Fig. 11). Together our data suggested a neutrophiliapromoting effect of MGL1 deficiency in KPn pneumosepsis, which results in severe
pathology and hyperinflammatory response contributing to the increased susceptibility of
MGL1-/- mice to KPn pneumonia.
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Figure 10. Pneumonic MGL1/-/- mice exhibit increased neutrophil accumulation in
their lungs
(A) Flow cytometry analysis of total lung cells from mock and KPn infected WT and
MGL1-/- at 3dp.i. Total lungs cells were isolated from mice by collagenase treatment
followed by staining with antibodies against indicated cell markers as described in
methods. Each bar represents percent cells positive for individual markers in lungs of
indicated experimental mice. (B) Shows total number of cells positive for indicated cell
markers. Data shown are the mean ± SEM of 5-6 mice from 3-4 independent experiments.
Statistical significance are denoted by asterisks (*, p<0.05). (C) Ly6G+CD11b+
neutrophils in lungs of KPn infected WT and MGL1-/- mice at 3dp.i. The cells were doublestained with anti-Ly6G-APC and anti-CD11b-Pacific Blue antibodies as markers for
neutrophils. The bar graph shows mean ± SEM of total number of neutrophils in lungs of
3-4 mock control and 4-5 KPn infected WT and MGL1-/- mice each from 3 independent
experiments. Contour plots shown on the right are from one representative experiment.
Statistical significance are denoted by asterisks (*, p<0.05).
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Figure 11. Pneumonic MGL1/-/- mice exhibit increased levels of neutrophil associated
immune mediators
The lungs from mock control and KPn infected WT and MGL1-/- mice were harvested at
3dp.i. and analyzed commercially for host immune mediators by rodent multi-analyte
profile (MyriadTM Rules-Based Medicine, Austin, TX). Levels of neutrophil
chemoattractants and growth factor (CXCL1, CXCL6, GM-CSF) and activation markers
(matrix metalloproteinase-9, MMP-9 and myeloperoxidase, MPO) are shown. Results
shown are mean ± SEM of 3-4 each infected and mock control mice from 2-3 independent
experiments. Statistical significance are denoted by asterisks (*, p<0.05; **, p<0.005).
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MGL-1 deficiency causes increased neutrophil influx into the lungs during KPn pneumonia

In order to gain mechanistic insights into the role of MGL1 in neutrophil accumulation, we
performed neutrophil adoptive transfer using WT and MGL1-/- neutrophils labelled with
two different intracellular dyes. Injecting a mix of the two types of neutrophils and
calculating the ratio of MGL1-/- neutrophils to WT neutrophils and vice versa, allowed us
to assess the relative migration efficiency of WT and MGL1-/- neutrophils in the exact
same microenvironment (Fig. 12A). Consistent with our pathological and flow cytometry
findings, we observed that MGL1-/- neutrophils were recruited at a higher rate than their
WT counterparts in pneumonic lungs of recipient WT as well as MGL1-/- mice (Fig.12B).
Deficiency of MGL1 on endothelial and possibly other resident cells did not appear to
affect neutrophil recruitment, as evidenced by similar migration of WT neutrophils in
MGL1-/- and WT mice (Fig. 12B black bar). These results further solidified the fact that
MGL1-/- neutrophils exhibit an increased capacity to infiltrate the lungs during KPn
pneumonia indicating a previously undetermined role of MGL1 in controlling neutrophilia
during pneumonic infection.
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Figure 12. MGL1 deficiency causes increased neutrophil influx in the pneumonic
lungs
(A) Schematic representation of the adoptive transfer experiment as described in the
Methods. Purified bone marrow neutrophils from WT mice were labelled with CellTracker
Orange CMTMR and those from MGL1-/- mice labeled with CellTracker Green CMFDA,
mixed in 1:1 ratio and injected intravenously (i.v.) into WT or MGL1-/- recipient mice
infected intranasally with KPn 24h prior to injection. Lungs were harvested 2 hrs after the
adoptive transfer and processed for flow cytometry. (B) Relative recruitment of MGL1-/and WT neutrophils in each mouse strain is depicted as the ratio of indicated populations
in the KPn infected lungs. Data shown are mean ± SEM form 9 mice per group in 3
independent experiments. Statistical significance are denoted by asterisks (**, p<0.005).
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Discussion
Gram-negative pneumonic sepsis remains a serious healthcare challenge despite effective
antibiotic treatments. This underscores that erratic host response to the infectious insult is
an important element in determining the outcome of the disease. Here we report that
MGL1, a host CLR, impacts the outcome of Klebsiella induced pneumosepsis as evidenced
by a reduced survival, severe neutrophilic lung pathology and hyperinflammation of
MGL1-/- mice. While the antimicrobial functions of neutrophils and macrophages remain
unaffected by MGL1 deficiency, the mechanistic basis for the observed differences
between the WT and MGL1-/- mice appeared to be de-regulated neutrophil influx and
excessive, non-resolving inflammation. Our study shows, for the first time, a protective
role of MGL1 in Gram-negative pneumonic sepsis by controlling neutrophil influx into the
lungs.
CLRs, by way of their abundant expression on phagocytic cells, can mediate pathogen
uptake and antigen presentation (241-243). MGL1 has been shown to mediate the
attachment and entry of influenza A virus (244) and recombinant MGL1 can bind intestinal
commensal bacteria (222). We examined if this CLR plays any role in KPn uptake and
clearance by phagocytic cells which may explain the increased susceptibility of MGL1 -/mice to this infection. Strikingly, we observed no difference in the phagocytic and bacterial
killing capacity of neutrophils and macrophages, two cells types involved in KPn
phagocytosis and clearance. Neutrophils can also kill pathogens by the release of NETs
composed of chromatin decorated with neutrophil derived proteins (245). The NETs have
been demonstrated to play a role in controlling KPn growth (59, 66, 237). However, similar
to the phagocytosis and intracellular killing, we did not find any defect in NETs formation
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in MGL1-/- neutrophils in-vivo. Together, these observations correlated with similar local
and systemic bacterial burden in WT and MGL-1-/- mice and led to the possibility that the
poor disease outcome in the absence of MGL1 is due to its impact on host immune
responses other than those directly affecting antibacterial mechanisms.
Unlike humans, who express only one form of MGL, mice have two orthologues of this
CLR: MGL1 and MGL2 (211). MGL1 and MGL2 have been suggested to perform nonredundant functions with MGL1 being most widely studied for its role in inflammatory and
infectious disease conditions (211). To the best of our knowledge, there are no reports to
suggest that MGL2 expression is modulated due to a deficiency of MGL1 in MGL1-/- mice.
While this will require detailed structural and functional studies utilizing MGL2-/- mice,
our data presented in this manuscript shows a clear phenotype of increased susceptibility
and poor disease outcome in the absence of MGL1 in MGL1-/- mice. Moreover, unlike
MGL1, KPn infection did not cause any increase in expression of MGL2 at the transcript
level in infected mouse lungs as compared to the uninfected control mice (data not shown).
Whether or not MGL2 is involved synergistically, directly or indirectly; could be a topic
of future investigation.
Despite a similar bacterial burden, MGL1 deficiency resulted in more severe lung
pathology

and

heightened

inflammatory

response.

These

mice

displayed

hyperinflammation and a lack of resolution in their lungs, suggesting a protective, proresolving role of MGL1 in pneumosepsis. Both anti- as well as pro-inflammatory functions
of MGL1 have been described in distinct pathological conditions. Increased susceptibility
of MGL1-/- mice to helminth parasitic infection with Taenia crassiceps was shown to
correlate with reduction in the levels of proinflammtory cytokines (246). An MGL59

dependent induction of pro-inflammatory cytokines, TNF-α, IL-6 and IFN-ɣ in Bordetella
pertussis stimulated mast cells was reported (221), however, the relevance of these findings
to overall disease outcome was not examined. In contrast to these studies, an antiinflammatory role of MGL1 was described in experimental colitis, where the protective
function of MGL1 was attributed to induction of IL-10 by colonic lamina propria
macrophages in response to commensal bacteria (222).

We observed an excessive

upregulation of both pro- as well as anti-inflammatory cytokines in MGL1-/- mice
undergoing KPn pneumoseptic infection. It is likely that the presence of multiple PAMPs
and alarmins released due to bacterial growth and/or inflammation contributes to the effect
of MGL1 deficiency and causes stimulation of multiple PRRs on immune cells resulting in
a mixed pro-and anti-inflammatory hyper response reminiscent of characteristic cytokine
storm. Indeed, a cross-talk between CLRs and Toll-like receptors (TLR)-induced immune
responses has been reported where CLR mediated uptake of Schistosoma antigens
suppresses TLR-mediated dendritic cell maturation (247). Whether an inverse relationship
between MGL1 and TLR signaling exists or if MGL1 negatively regulates TLR stimulation
in KPn pneumonia remains to be determined. Nonetheless, the fact that a
hypeinflammation and more severe pathological changes were observed in MGL1 -/- mice
despite a similar bacterial burden indicate that MGL1 negatively regulates the
inflammation and a perpetuation of inflammation rather than the bacterial growth
contributes to lethality of MGL1-/- mice.
We found that KPn infected MGL1-/- mice exhibited significantly increased neutrophil
accumulation in their lungs. Neutrophil mediated responses are essential for combating
pneumonic bacterial infection and their protective role in sepsis and KPn infection in
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particular has been described elegantly (248, 249). However, persistent accumulation of
neutrophils can lead to bystander tissue destruction, owing to their tissue destructive cargo.
Accumulation of large numbers of neutrophils in the lungs of MGL1-/- mice and higher
amounts of their associated inflammatory mediators suggested that there is a defect in
neutrophil turnover in these mice. This could either be due to increased influx of
neutrophils into the lungs; due to a defect in their clearance by efferocytosis; or a
combination of both. While we are currently investigating the role of MGL1 in
efferocytosis, our adoptive transfer experiment showed that MGL1 deficiency on
neutrophils significantly increases their capacity to infiltrate the lungs of pneumonic mice.
This suggested a novel role of MGL1 as a negative regulator of neutrophil influx, although
previous studies have implicated this CLR in trafficking of other myeloid cell types.
Relevant to our study, mouse MGL has been reported to impede migration of immature
dendritic cells (DCs) via its interaction with its glycan ligands on endothelium, and
blockage of MGL results in an enhanced random mobility of these cells (250). Mature DCs
lose MGL expression (251), thus enabling these cells to overcome the negative effect of
MGL and egress. Similar mechanisms could be at play in our model where MGL1
negatively regulates epithelium-neutrophil interactions thereby impeding neutrophil
infiltration into the intrapulmonary space and retaining them into circulation, and only after
MGL1 expression is lost, are these neutrophils able to infiltrate into the lungs. This could
also explain why we could not detect MGL1 expression on neutrophils infiltrating the lungs
of KPn infected WT mice (data not shown). Curiously, while MGL1 was expressed on
bronchial epithelial and endothelial cells in lungs, we did not see a significant effect of
endothelial cell expressed MGL1 on neutrophil influx (evidenced by similar infiltration of
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labelled WT neutrophils in MGL1-/- and WT mice). While the role of MGL1 expressed on
other resident cells cannot be ruled out at this time, the significance of this endothelial
expression pattern remains to be experimentally determined.
In the absence of MGL1 we also observed significantly higher induction of neutrophil
chemoattractants (CXCL1 and CXCL6), neutrophil survival mediator (GM-CSF) and
neutrophil activation markers (MMP9, MPO) in MGL1-/- mice, as compared to their WT
counterparts. These results further support the notion that MGL1 is likely involved in
neutrophil turnover and the absence of MGL1 results in greater and prolonged
accumulation of neutrophils in lungs of mice. This leads to a greater neutrophil-mediated
inflammation and lung pathology observed in MGL1-/- mice as compared to their WT
counterparts where the neutrophils infiltrate transiently and are cleared off as the infection
resolves. These observations clearly suggest that while deficiency of MGL1 does not
impair bacterial phagocytosis and activation of neutrophils, this CLR is required for
regulating neutrophil trafficking.
In summary, this study shows that MGL1 plays an important role in mitigating the
inflammation during a pneumonic infection, by negatively regulating the neutrophil influx.
This study opens up new avenues of research on the role of MGL1 in neutrophil trafficking.
This can have major implications in the therapeutic measurements of inflammation
associated disorders.
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Current Work
I am currently working to understand the mechanistic underpinnings of massive neutrophil
accumulation in the lungs of MGL1-/- mice. We hypothesized that the accumulation of
neutrophils in the lungs of MGL1-/- mice could be due to either an increase in influx into
the lungs or a defect in their ability to be cleared via efferocytosis; or a combination of
both. I tested both possibilities and found that:
MGL1 deficiency leads to an increase in neutrophil mobilizing factors during KPn induced
pneumonia
The adoptive transfer experiment described above indicated that MGL1 plays a role in
negatively regulating neutrophil influx. In order to gain mechanistic insight into this, we
analyzed the levels of neutrophil mobilizing factors Granulocyte Chemotactic Protein-2
(GCP-2) and Granulocyte-Colony Stimulating Factor (G-CSF) levels in the lung
homogenates of uninfected mock control and KPn infected WT and MGL1-/- mice at 3dp.i.
The basal levels of these mediators in the lung homogenate of uninfected WT and MGL1/-

uninfected mice was similar. However, by 3dp.i. MGL1-/- mice had significantly elevated

levels of both neutrophil mobilizing factors in their lungs compared to WT mice (Fig 13).
Elevated G-CSF levels are known to cause emergency granulopoiesis (252-261) which is,
a form of hematopoiesis for granulocytes and occurs constantly to maintain a steady state
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of mature granulocytes in the blood. In the case of severe systemic infection a demandadapted granulopoietic response (emergency granulopoiesis) kicks in to drastically
increase the number of neutrophils to meet the current situation (252). We next analyzed
granulopoiesis in WT and MGL1-/- mice upon KPn infection.

Figure 13. Pneumonic MGL1−/− mice exhibit increased neutrophil mobilizing factors
in their lungs
Lung homogenate from K. pneumoniae–infected WT and MGL1−/− mice at 3 d p.i. were
analyzed for a number of chemokines, cytokines, and growth factors. Data represented
above shows Granulocyte Chemotactic Protein-2 (GCP-2) and Granulocyte-Colony
Stimulating Factor (G-CSF). (n = 3) *p < 0.05, **p < 0.005.
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Pneumonic MGL1-/- mice display an increase in mature neutrophil mobilization from
reserves in the bone marrow
We analyzed the process of granulopoiesis in WT and MGL1-/- mice over a 3-day time
course beginning at 6 hours post KPn infection via flow cytometry. Using the
hematopoietic stem cell marker c-Kit, granulocyte marker Ly6G, and gating on different
subpopulations; we quantitated the number of progenitor cells (c-Kit++ Ly6G-), early
granulocytes (c-Kit_Low Ly6G_Low), and mature neutrophils (c-Kit- Ly6G+) in the bone
marrow and blood of WT and MGL1-/- mice. As shown in Figure 14, there was no
difference in the numbers of progenitor cells, early granulocytes, or mature neutrophils in
bone marrow or blood of uninfected mock as well as at 6hr p.i. and 1dp.i. in WT and MGL1/-

mice. However, by 3dp.i. MGL1-/- mice had increase numbers of progenitor cells, early

granulocytes, and mature neutrophils in the blood compared to the infected WT mice.
These results suggested that in the absence of MGL1, increase in neutrophil mobilizing
factors in the lungs, there is increased mobilization of mature neutrophils from the bone
marrow.
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Figure 14. Pneumonic MGL1-/- mice showed an increased mobilization of neutrophil
reserves from bone marrow
WT and MGL1-/- mice were infected with K. pneumoniae and the generation and
mobilization of hematopoietic progenitor cells to mature neutrophils via the process of
granulopoiesis was checked at the indicated time points in the blood and bone marrow. (n
= 6). Data was analyzed as shown above, using cKit to identify hematopoietic stem cells
and Ly6G to identify neutrophils. cKit+ Ly6G- cells are progenitors, cKit_Low
Ly6G_Low cells are early granulocytes, and CD11b+ Ly6G+ cells are mature
neutrophils. *p < 0.05, **p < 0.005.

Absence of MGL1 on neutrophils negatively impacts the uptake of neutrophils by alveolar
macrophages
Previous reports have shown that the efferocytosis of apoptotic neutrophils is able to
regulates granulopoiesis by reducing the production of granulopoietic stimulating factors
such as G-CSF (262). To examine this we performed an in-vivo efferocytosis experiment
by administering CFSE labelled WT or MGL1-/- neutrophils intranasally into WT mice
followed by isolation of alveolar macrophages by lung lavage. The macrophages were then
analyzed by flow cytometry to quantitate Ly6G-F4/80+CFSE+ efferocytic cells. As shown
in Figure 15, MGL1-/- neutrophils were efferocytosed less than WT neutrophils by WT
alveolar macrophages, indicating a defect in the clearance of neutrophils in the absence of
MGL1 expression on their surface.
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Figure 15. MGL1-/- neutrophils are efferocytosed less by alveolar macrophages invivo compared to WT neutrophils
CFSE labelled WT or MGL1-/- neutrophils were instilled intranasally in anaesthetized mice
(3.5 million cells in 35 µl PBS). Two hours later lungs were lavaged as described in
methods and cells were stained with PE-Cy7 conjugated anti-F4/80 and APC conjugated
anti-Ly6G antibodies for flow cytometry.
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Figure 15 cont. MGL1-/- neutrophils are efferocytosed less by alveolar macrophages
in-vivo compared to WT neutrophils
Percentage of efferocytic uptake by macrophages was quantitated by enumeration of
Ly6G- F4/80+ CFSE+ cells. Data are from 4 mice per group in 2 independent experiments
(**, p<0.005).
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Abstract
Background: Nosocomial infections with Klebsiella pneumoniae (KPn) are a frequent
cause of Gram-negative sepsis. To understand the functioning of host innate immune
components in this disorder, we examined a previously uninvestigated role of C-type lectin
receptor Mincle, in pneumonic sepsis caused by KPn.
Methods: Disease progression in wild-type and Mincle-/- mice undergoing pulmonary
infection with KPn was compared.
Results: While the wild-type mice infected with a sublethal dose of bacteria could resolve
the infection with bacterial clearance and regulated host response, the Mincle-/- mice were
highly susceptible with a progressive increase in bacterial burden despite their ability to
mount an inflammatory response which turned to an exaggerated hyperinflammation with
the onset of severe pneumonia. This correlated with severe lung pathology with a massive
accumulation of neutrophils in their lungs. Importantly, Mincle-/- neutrophils displayed a
defective ability to phagocytize non-opsonic bacteria and an impaired ability to form
extracellular traps (NETs), an important neutrophil function against invading pathogens,
including KPn.
Conclusion: Our results demonstrate protective role of Mincle in host defense against KPn
pneumonia by coordinating bacterial clearance mechanisms of neutrophils. A novel role
for Mincle in regulation of NETosis may have implications in chronic disease conditions
characterized by deregulated NET formation.

Key words: Mincle, Clec4e, Klebsiella, pneumonia, sepsis, neutrophils, NETs,
phagocytosis
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Introduction
Lower respiratory tract infection with bacteria can lead to sepsis development, which is a
complex immune disorder characterized by a systemic hyperinflammation. There are
currently no effective therapies for sepsis that results in 750,000 hospitalizations annually
in the United States with a mortality rate of 20-50% (2, 224). Nosocomial infections with
opportunistic pathogen Klebsiella pneumoniae (KPn) account for 5-20% of Gram-negative
sepsis cases (223, 225, 263). Additionally, emergence of multidrug resistant isolates of
KPn in clinical settings is a serious health concern. As innate mucosal immunity plays a
direct role in bacterial killing and immunomodulation in this acute infection (237, 248,
264-266), an understanding of functioning of host innate immune components might
provide targets for modulation of host immune system in a beneficial manner.
Mincle is a C-type lectin receptor (CLR) belonging to the Dectin-2 subfamily of innate
immune receptors that can function as an activating receptor for host- as well as pathogenassociated molecular patterns, termed alarmins and PAMPs respectively (reviewed in (213,
214). It is an inducible receptor, expressed mainly by myeloid cells such as macrophages,
neutrophils, myeloid dendritic cells as well as some B-cell subsets (213, 215, 267).
Functional analysis of this receptor in macrophages has received the most attention, where
its association with FcRγ activates downstream signaling cascades involving Syk kinases
resulting in induction of protective inflammatory response (84, 109, 268). While the
function of Mincle in chronic bacterial infections such as tuberculosis and fungal infections
was examined in these studies, its role in acute pneumonic infections leading to sepsis
development has not been explored. Furthermore, its functions other than as an
inflammatory PRR (Pattern Recognition Receptor) have received little, if any, attention.
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Neutrophil mediated responses are essential for combating pneumonic bacterial infection
and their protective role in sepsis and KPn infection in particular has been described (249,
269). The professional antimicrobial program of neutrophils mainly constitutes
phagocytosis of infectious agents followed by production of noxious agents such as
reactive oxygen species which kill the internalized microbes. Another recently established
mechanism of microbial killing by neutrophils is by formation of extracellular traps
(termed neutrophil extracellular traps or NETs) which are DNA fibrils expelled by these
cells that are decorated with granular contents such as various proteases and can ensnare
and kill the microbes without phagocytosis (59, 270, 271). Mincle has been shown to be
expressed by neutrophils and while shown to play a role in neutrophil mediated protective
responses against Candida and mycobacteria (105, 107), its direct role in bacterial
phagocytosis and NET formation is not known. Since neutrophils are a key cell type in
controlling KPn infection, Mincle signaling in neutrophils may be a key event in control
of KPn infection and sepsis.
In this study, we examined the role of Mincle in acute KPn infection causing pneumonic
sepsis. Our results suggest novel protective function of Mincle as non-opsonic phagocytic
receptor for the bacteria and in regulation of neutrophil NET formation indicating the
importance of this CLR in neutrophil-specific bacterial clearance mechanisms in
pneumonic infections.

73

Materials and Methods
Bacterial strains and Mice
The KPn (ATCC strain 43826) were grown to log phase in LB medium at 37oC. All invivo experiments were performed using 6-8 weeks old female wild-type C57BL/6 or
Mincle-/- mice on same background obtained from the Consortium of Functional Genomics,
Scripps, La Jolla and bred in the animal facility of the University of North Dakota. The
animals were used according to institutional and federal guidelines.
Infection of Mice, survival and bacterial burden
Mice were anaesthetized with a mixture of 30mg/ml ketamine and 4 mg/ml xylazine in
PBS and were infected intranasally with sublethal dose (2.5 x 104 bacteria in 20ul of saline,
determined experimentally) of KPn or with 20 µl of saline alone. Survival of the mice was
recorded for up to 2 weeks post-infection (p.i.). In some experiments, the mice were
euthanized at indicated times p.i. and blood, lungs and liver were aseptically homogenized
in cold PBS with CompleteTM protease inhibitor cocktail (Roche Diagnostics, Germany).
For the bacterial burden analyses, serially diluted homogenates and blood were plated on
LB agar and incubated at 37oC overnight.
Quantitative real-time PCR
Total RNA from lungs of infected and mock control mice harvested at various times p.i.
was extracted using Trizol reagent (Invitrogen) according to the manufacturers'
instructions. Real-time PCR analysis was performed using SYBR green (Applied
Biosystems, CA, USA) to measure the expression levels of Mincle-specific mRNA by
using specific primers (sense) 5'- ACC AAA TCG CCT GCA TCC -3' and (anti-sense) 5'CAC TTG GGA GTT TTT GAA GCA TC -3' (as described by us in (89). The target gene
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expression levels were normalized to levels of the house keeping 18S gene in the same
sample. Expression of Mincle in infected samples was determined as fold change over that
in control samples as calculated by using the formula 2−(ΔΔCt).
Multi-analyte profile analysis
The lung homogenates were prepared as described for the bacterial burden analysis above
and were centrifuged at 2000 x g for 15 min to clear cellular debris. The supernatants were
immediately frozen at -80o C. The biomarker levels in lung homogenates were determined
commercially by Myriad Rules-based Medicine (Austin, TX, USA) utilizing a multiplexed
analysis.
Histological analysis
For histological analysis, frozen lung tissues were processed as previously described (227,
228). Serial horizontal sections (10 µm thick) of frozen lung tissues thus obtained were
stained with hematoxylin and eosin for pathological analysis as previously described (229,
230) .
Flow Cytometry
Lungs or BAL cells were harvested from mice at 3 days p.i. and processed as previously
described by us (227, 228, 231). Enumeration of neutrophils by flow cytometry (using a
BD LSR II, Becton Dickinson, San Jose, CA) was done by quantitating Ly6G+CD11b+
cells stained with Pacific BlueTM anti-mouse CD11b and APC anti-mouse Ly6G (Clone
1A8) antibodies (Biolegend, San Diego, CA). Mincle expression was examined by using a
rat anti-mouse Mincle monoclonal antibody (Clone 6G5, InvivoGen, CA) followed by goat
anti-rat Alexa-488 secondary antibody (InvitroGen, OR). FlowJo (Tree Star) software was
used to analyze all data.
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Bacterial phagocytosis by neutrophils
Bacterial phagocytosis of WT and Mincle-/- neutrophils was assessed by flow cytometry.
For this, peritoneal neutrophils were isolated using an established model of thioglycollateinduced peritonitis. Sterile 4% thioglycollate was injected in peritoneal cavity of mice and
neutrophils enriched 8-12h following the injection were isolated (95-99% pure as assessed
by flow cytometry using GR1 and CD11b antibodies). Neutrophils were incubated with
GFP-labeled KPn (kindly provided by Dr. Steven Clegg, University of Iowa) for 1 hour
and washed three times with ice-cold FACS-buffer (PBS+10% fetal bovine serum).
Fluorescence of the attached but non-internalized bacteria was quenched by treating the
cells with 0.04% Trypan Blue. The % positive cells containing fluorescent bacteria were
determined by flow-cytometry using uninfected neutrophils as control.
Neutrophil NETs
For detection of neutrophil NETs in-vivo, the bronchoalveolar lavage (BAL) was
performed in WT and Mincle-/- mice at 3dp.i.. The lavage cells were cytocentrifuged on
glass slides and were co-stained with Sytox Green (Molecular Probe, Eugene, OR) and
rabbit anti-neutrophil elastase (NE) polyclonal antibody (Abcam) followed by goat antirabbit Alexa546 antibody. The percent NET formation was quantitated by dividing the
number of NET-forming neutrophils by total number of cells in 8-10 random microscopic
fields and multiplying the values by 100.
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Statistical Analysis
Statistical analysis of survival studies was performed by Kaplan Meir log-rank test;
bacterial burdens by non-parametric Mann-Whitney Test. All other statistical analyses
were performed using the Student t test (SIGMA PLOT 8.0, Systat Software, San Jose,
CA).
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RESULTS
Mincle is highly expressed in lungs during pneumonic KPn infection.
To examine the role of innate immune receptors in pathogenesis of KPn induced
pneumonic sepsis, we initially screened a panel of 52 membrane-bound and soluble CLRs
by Taqman Low-density arrays which showed an upregulated expression of Dectin-2
family CLR, Clec4e (also called Mincle), among others in the lungs of mice undergoing
respiratory KPn infection. To further confirm the Mincle expression, real-time quantitative
PCR was performed using RNA from lungs of KPn infected wild-type mice. The results
showed a progressive increase in the transcript level of Mincle mRNA which was
maximally transcribed by 3dp.i. and remained at high level throughout the course of
infection (Figure 16A). Flow cytometry analysis further confirmed the increased numbers
of Mincle-positive cells, majority of which were CD11b+Ly6G+ neutrophils, in the lungs
of KPN-infected mice (Figure 16B). This indicated that Mincle was highly expressed on
neutrophils and played a role in pathogenesis of KPn pneumonia.
Mincle deficient mice are highly susceptible to KPn pneumonia.
To examine the role of Mincle in disease development, overall disease severity and survival
was compared in wild-type and Mincle-/- mice infected with a sub-lethal dose of KPn. This
dose was experimentally determined at which the WT mice displayed minimal morbidity
and mortality (230). As shown in Figure 16C, 76% of WT mice infected with 2.5x104 CFUs
of KPn survived the infection with transient signs of disease (ruffled fur, lethargy) early
during infection and appeared healthy later. The Mincle-/- mice, in contrast, were extremely
susceptible to this dose and all mice succumbed to infection by day 6p.i. While majority of
the infected WT mice cleared the infection by day 5 p.i., Mincle-/- mice exhibited
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progressive development of disease and overt signs of infection (weight loss, piloerection,
hunched gait, lethargy, increased respiratory rate). The increased susceptibility of Mincle/- mice clearly indicated a protective role played by this CLR during pneumonic KPn
infection.

Figure 16. Mincle is highly induced in the lungs of KPn infected pneumonic mice and
Mincle deficiency increases susceptibility to the infection
A. Total RNA was extracted by Trizol method from the lungs of KPn infected wild-type
C57/BL6 mice, harvested at indicated time post-infection. The mRNA levels of Mincle
were analyzed by real-time PCR as described in Methods and are expressed as fold changes
over the levels in mock control mice calculated by using the formula 2−(ΔΔCt). Data shown
are the averages of 6-8 mice per group in two independent experiments.
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Figure 16 cont. Mincle is highly induced in the lungs of KPn infected pneumonic mice
and Mincle deficiency increases susceptibility to the infection
B. Mincle expression was examined on infiltrating lung cells from KPn infected wild-type
C57/BL6 mice harvested at 3dp.i. by flow cytometry using a rat anti-mouse Mincle
antibody followed by goat anti-rat secondary antibody labeled with Alexa-488. Mincle
positive cells were gated and further analyzed for expression of CD11b and Ly6G as
mentioned in the Methods section. The dot plots shown are representative of 3 independent
experiments with 3 mice each. C. Fifteen each WT and Mincle-/- mice were intranasally
infected with 2.5X104 CFUs of Klebsiella pneumonia (KPn) in 20µl of sterile PBS and
were assessed daily for disease severity. The survival was monitored for two week.
Statistical comparison of susceptibility was done by Kaplan-Meier survival curve statistical
analysis (p<0.001).

Mincle deficiency results in increased bacterial burden and systemic dissemination
In order to examine if increased susceptibility of Mincle-/- mice to KPn infection correlated
with inefficiency to clear bacteria, homogenized lungs, liver and blood from infected
Mincle-/- and WT mice collected at various times post infection were plated on LB agar.
Up to 2dp.i., Mincle-/- and WT animals displayed similar bacterial burdens in their lungs
(Figure 17A). By 3dp.i., however, lungs of Mincle-/- mice exhibited significantly higher
bacterial counts as compared to their WT counterparts. The bacterial burden in these mice
remained high at 5dp.i., the time when majority of mice had become moribund. In contrast,
the WT mice displayed 3-5 logs lower bacterial burden at 3dp.i. and the counts continued
to drop through 5dp.i., indicating clearance of bacteria and resolution of the infection in
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these mice. The Mincle-/- mice also displayed a higher systemic dissemination of bacteria
as depicted by significantly higher bacterial load in liver (Figure 17B) and a more severe
bacteremia (Figure 17C). In contrast, no viable bacteria were detected in the blood of WT
mice by 5dp.i. These data indicated that Mincle mediated responses directly or indirectly
influenced bacterial clearance in pneumonic infection with KPn.

81

Figure 17. Mincle-/- mice display increased bacterial burden and systemic
dissemination during pneumonic KPn infection
WT and Mincle-/- were intranasally infected with 2.5X104 CFUs of KPn. At indicated times
post infection the mice were sacrificed, systemic organs were isolated, homogenized and
plated as described in Materials and Methods. Bacterial burden was enumerated after
incubating the plates overnight at 37oC. The data shown is from three independent
experiments with 3-5 mice at each time point per experiment. Significant differences in
bacterial burden (using non-parametric Mann-Whitney test) in WT and Mincle-/- are
denoted by asterisks (*, p<0.05; **, p<0.005, ***p<0.001).

Mincle-/- mice exhibit hyperinflammatory response
We next examined if the inability of Mincle-/- mice to clear the bacteria was due to a defect
in mounting inflammatory response. In both WT and Mincle-/- strains, mock infected
mouse lungs displayed similar low basal levels of inflammatory cytokines tested (Figure
18). Upon KPn infection, WT mice exhibited increased levels of these cytokines at 1dp.i.,
which started to drop by 3dp.i. and were reduced to minimal levels by 5dp.i. (Figure 18).
This was consistent with the reduced bacterial burden in these mice at these times p.i.. In
contrast, infection of Mincle-/- mice resulted in a progressive increase in levels of these
cytokines through the course of infection, which remained high till the mice became
moribund. These mice in fact exhibited an overwhelming inflammatory response at 3d and
5dp.i. (Figure 18). The levels of inflammatory cytokines and chemokines tested in lungs of
these mice were significantly higher than WT mice at these time points. The levels of IL82

10, an anti-inflammatory cytokine were also significantly higher in Mincle-/- mice,
suggesting a condition of “cytokine storm” typical of sepsis, where anti-inflammatory host
mediators are upregulated in an attempt to counter-balance the systemic inflammatory
response (238-240). These results show that Mincle deficiency did not render the mice
defective in their ability to mount an inflammatory response but these mice rather displayed
a hyperinflammatory phenotype typically associated with sepsis. Our observations thus
raised the possibility that Mincle likely plays a direct role in bacterial clearance and the
hyperinflammation resulted due to activation of other PRRs and inflammatory receptors in
response to persistent overwhelming bacterial burden in Mincle-/- mice undergoing
pneumonic KPn infection.
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Figure 18. Pneumonic Mincle-/- mice exhibit hyperinflammatory response
The lungs from mock control and KPn infected WT and Mincle-/- mice were harvested at
indicated time points post-infection, homogenized in PBS with protease inhibitors and
analyzed commercially for host immune mediators by rodent multi-analyte profile
(MyriadTM Rules-Based Medicine, Austin, TX). Results shown are average of 3-4 each
infected and mock control mice from 3 independent experiments. Amounts of mediators
shown were significantly higher (***p<0.001) in KPn infected Mincle-/- mice at 3dp.i. and
5dp.i. in comparison with their levels in the infected WT mice at those time points tested.

Effect of Mincle deficiency on neutrophil infiltration and overall lung pathology

Since neutrophils are a key cell type involved in bacterial clearance and initiation of
protective immune response during KPn pneumonia, we next compared neutrophil
infiltration and gross immunopathological changes in KPn infected WT and Mincle-/- mice.
The mock control mice of both strains displayed similar normal lung tissue morphology in
H&E stained sections (Figure 19). A moderate transient infiltration of immune cells was
observed in infected WT mice by day 3p.i. which was reduced substantially by 5dp.i. The
overall architecture of the lungs was largely preserved in the WT animals throughout the
infection. The Mincle-/- mice, on the other hand, displayed a progressive increase in
immune cell infiltration, which were mainly neutrophils, based on characteristic multilobed nuclei (Figure 19 inset). By day 3 p.i. substantially increased influx of cells was
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observed in large lesions and by 5 p.i., extensive foci of consolidation were visible with
massive accumulation of neutrophils around alveolar spaces (Figure 19).
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Figure 19. Pneumonic Mincle-/- mice exhibit severe lung pathology characterized by
massive neutrophil accumulation
Hematoxylin & Eosin staining of lung cryosections from mock control and KPn infected
WT and Mincle-/- mice isolated at indicated times post-infection. Magnification 100X.
Inset shows a highly magnified area (1000X) of a lesion in infected Mincle-/- lung depicting
neutrophils as indicated by characteristic multilobed nuclear morphology.

Flow cytometry analysis of infiltrating cells in lungs confirmed that the majority of these
cells were Ly6G+CD11b+ neutrophils (Figure 20A). The numbers of these cells were
significantly higher in the infected Mincle-/- lungs than those in the WT mice (Fig. 20A,
bar graph). This correlated with significantly higher levels of neutrophil chemoattractants
(CXCL1, CXCL6), neutrophil survival mediator (GM-CSF) and neutrophil activation
markers (MMP9, MPO) in these mice, as compared to their WT counterparts (Figure 20B).
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Figure 20. Increased neutrophil accumulation coincides with elevated expression of
neutrophil chemoattractant and activation markers in lungs of KPn infected Mincle /-

mice A. Flow cytometry analysis of Ly6G+CD11b+ neutrophils in mock control (WT-

M and Mincle-/--M) and KPn infected (WT-Inf and Mincle-/--Inf) WT and Mincle-/- mice.
Total lungs cells were isolated from mice by collagenase treatment at 3dp.i.. The cells were
stained with anti-Ly6G-APC and anti-CD11b-Pacific Blue antibodies as markers for
neutrophils. The bar graph shows average of total number of neutrophils in lungs of 2-3
mock control and 3-4 KPn infected WT and Mincle-/- mice each from 3 independent
experiments. Dot plots shown on the right are from one representative experiment.
Statistical significance are denoted by asterisks (***, p<0.001). B. The lungs from mock
control and KPn infected WT and Mincle-/- mice were harvested at indicated time points
post-infection and analyzed commercially for host immune mediators by rodent multianalyte profile (MyriadTM Rules-Based Medicine, Austin, TX). Levels of neutrophil
chemoattractants (CXCL2, CXCL6, GM-CSF) and activation markers (matrix
metalloproteinase 9, MMP-9 and myeloperoxidase, MPO) shown are average of 3-4 each
infected and mock control mice from 3 independent experiments. Amounts of mediators
shown were significantly higher (***p<0.001) in Mincle-/- mice at 3dp.i. and 5dp.i. in
comparison with their levels in the WT mice at those time points tested.

Mincle-/- neutrophils are defective in KPn phagocytosis
We next examined the bacterial uptake by Mincle-/- neutrophils, in light of an increased
bacterial burden in Mincle-/- mice. For this, phagocytosis of GFP-labeled KPn was
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compared between WT and Mincle-/- neutrophils by flow cytometry. As shown in Figure
21, Mincle deficiency resulted in significantly reduced phagocytosis of non-opsonized
bacteria by neutrophils. The uptake of opsonized bacteria was also reduced in Mincle-/neutrophils as compared to the Mincle-sufficient WT cells, however the differences were
not statistically significant. These results indicate that Mincle is likely a novel non-opsonic
phagocytic receptor for KPn and plays an important role in bacterial uptake by neutrophils.
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Figure 21. Mincle deficiency impairs neutrophil phagocytosis of non-opsonized
bacteria Peritoneal neutrophils from WT and Mincle-/- mice were incubated with GFP
(Green Fluorescent Protein)-labeled KPn with (opsonized) or without (non-opsonized)
10% normal mouse serum for 1 hour followed by quantitation of phagocytosis by flow
cytometry. The results are expressed as % cells positive for fluorescent bacteria.
Significant differences are denoted by asterisks (**, p<0.005).

Mincle-/- neutrophils are defective in NET formation

Extracellular trap formation is an important mechanism by which neutrophils clear
extracellular bacteria. Since Neutrophil NET mediated killing has been shown to play a
role in KPn clearance (237, 272), we saught to determine if Mincle deficiency resulted in
a defect in NET formation. In order to minimize the tissue processing to avoid degradation
of NETs, neutrophils isolated from BAL were used. Flow cytometry analysis showed that
neutrophils were a predominant cell-type in the BAL of infected WT and Mincle-/- mice
(Figure 22A). A quantitative comparison of BAL neutrophils showed that significantly
higher numbers Mincle sufficient WT neutrophils produced NETs (Figure 22B) which
stained positive for neutrophil-specific enzyme neutrophil elastase (Figure 22C), showing
that these fibrillar structures originated mainly from neutrophils. Furthermore, the NETs
observed in Mincle-/- neutrophils appeared dwarfed and lacked the web-like appearance as
observed in the WT mice. This observation, together with reduced phagocytic ability of
Mincle-/- neutrophils shows that Mincle deficiency severely impairs neutrophil mediated
bacterial uptake and clearance mechanisms in lungs during pneumonic KPn infection.
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Figure 22. Mincle deficiency causes a defect in formation of neutrophil extracellular
traps (NETs) in the lungs of mice upon pneumonic KPn infection
A. Enumeration of CD11b+Ly6G+ neutrophils by flow cytometry in BAL isolated from
KPn infected WT and Mincle-/- mice. B. Quantitation of neutrophils showing NETs in BAL
isolated from WT and Mincle-/- mice infected with KPn. (***p<0.001). C. Representative
fluorescence images of the neutrophils isolated from BAL fluid of WT (upper panel) and
Mincle-/- (lower panel) mice infected with KPn, and stained with Sytox Green to label DNA
(green) and a rabbit anti-neutrophil elastase (NE) polyclonal antibody followed by goat
anti-rabbit Alexa546 (red). The neutrophils from WT mice showed web-like structures that
stained positive for NE and Sytox green (white arrow), while the Mincle-/- neutrophils
appeared inactive and displayed occasional small DNA fibers that lacked the typical weblike appearance of NETs (blue arrow). The experiment was repeated 3 times with 3-4 mice
in each group. Magnification 400X.
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DISCUSSION
Pneumonic sepsis is a major health care burden worldwide and K. pneumoniae (KPn) is
the most frequent Gram-negative sepsis-associated opportunistic pathogen (224). An
imbalance of innate immune responses resulting in deleterious and prolonged inflammation
and impairment of protective functions of first responder cells such as neutrophils have
been directly correlated with sepsis-associated mortality (23, 273, 274). This warrants an
improved understanding of functioning of innate immune components in this deadly
disease. In this study, we sought to determine the role of Mincle, an innate immune C-type
lectin receptor in KPn pneumonia. Here we report several novel findings: 1) We show, for
the first time, a clear phenotype in terms of a severely reduced survival rate of Mincle-/mice upon pneumonic KPn infection; 2) the reduced survival is not due to a defect in ability
to mount an inflammatory response in absence of Mincle; 3) Mincle acts as a non-opsonic
phagocytic receptor mediating uptake of KPn by neutrophils; and 4) Mincle deficiency
results in a defect in neutrophil NET formation upon KPn infection. Our results thus show
that Mincle is required for defense against KPn induced pneumonic sepsis and that lack of
Mincle causes a defect in neutrophil mediated bacterial clearance mechanisms such as
phagocytosis and NET formation.

Mincle has been previously shown to play a role in eliciting inflammatory responses
against Mycobacterium, Candida albicans and skin fungal pathogens, Malassezia and
Fonsecaea (104, 108, 109, 275). In these infections, Mincle expressed on macrophages,
upon recognition of its ligands triggers FcRγ-Syk-Card9 pathway to induce production of
protective Th1/Th17 responses as well as chemokines required for recruitment of
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inflammatory cell types (85, 268, 275). The increased susceptibility to these infections in
the absence of Mincle was measured in terms of increased bacterial and fungal burden
which was attributed to reduced inflammatory response and defective pathogen clearance
in these studies. However, overall survival of the experimental animals was not affected
by Mincle deficiency. Our study for the first time, reports a clear outcome where Mincle
seems to play a non-redundant role in survival of KPn infected pneumonic mice. Moreover,
the reduced survival of Mincle-/- mice is not due to their inability to mount an inflammatory
response. These mice, instead exhibit hyperinflammation in their lungs suggesting that the
protective ability of Mincle was independent of its role in eliciting inflammatory response.
It is likely that the redundant function of other PRRs, upon recognition of bacterial PAMPs
and endogenous alarmins generated from increased bacterial growth and accumulation of
dead cells over time, is sufficient to induce inflammation in the absence of Mincle. Indeed,
Mincle-/- mice in our studies, exhibited overwhelming local as well as systemic bacterial
burdens.
Concomitant to increased bacterial burden, Mincle-/- mice exhibited extensive neutrophil
accumulation, the primary cell type shown to play an important role in mediating protective
immune response against Kpn infection (248, 263, 269, 276). We thus examined if Mincle/-

neutrophils were defective in performing cellular functions such as internalization of

bacteria via phagocytosis which would explain increased bacterial burden in Mincle-/- mice
despite a heightened inflammation. Indeed, Mincle-/- neutrophils showed a mitigated
phagocytosis of non-opsonized, but not opsonized KPn, suggesting a non-redundant and
direct role of Mincle for internalization of non-opsonized bacteria. To the best of our
knowledge, this is the first study reporting Mincle as a non-opsonic phagocytic receptor.
94

Ongoing studies in our lab are currently investigating Mincle specific ligand of KPn, nature
of this interaction and production of specific antibodies that can inhibit this interaction.
Lectinophagocytosis or lectin-mediated uptake by macrophages has been reported
previously for several pathogens (reviewed in (148). However, the receptors or
mechanisms of non-opsonized phagocytosis of bacteria by neutrophils are poorly
understood. Non-opsonic phagocytosis by receptors like Mincle may be important during
early stages of infection before the onset of humoral immunity to generate opsonins, and
in complement deficient or immunosuppressed patients. This mode of phagocytosis is
particularly significant for inhaled bacteria as serum and complement components are as
such limited in the alveolar space (277). Although appearance of serum components in
alveolar space is common during severe KPn pneumonia, owing to high binding capacity
of Mincle to mannose and N-acetyleglucosamine (278), uptake by Mincle of KPn with
mannan-rich capsule in lungs could be a major mechanism of bacterial clearance in lungs.
Absence of Mincle and a resulting defect in initial phagocytic uptake of KPn, as observed
in our studies likely contributes to the increased bacterial burden and subsequent
inflammation via activation of other PRRs such as TLRs.

One of the more recently defined mechanisms of antimicrobial activity of neutrophils is
extrusion of fibrous mesh of chromatin that entraps extracellular pathogens (59). These
structures, termed NETs, are decorated with antimicrobial factors normally contained
within neutrophil granules and represent an important strategy of neutrophils to immobilize
and kill pathogens. Our observation reported in this study that Mincle-/- neutrophils are
defective in NET formation in-vivo during KPn infection coincides with overwhelming
bacterial burdens in these mice. These results are in line with previous reports indicating
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that NET mediated killing is an important mechanism of bacterial clearance and protection
against KPn induced pneumonia (237, 272). How Mincle regulates NET formation is
currently under investigation in our laboratory and is expected to provide novel insights
into mechanism of NETosis. This will have important implications in chronic disease
conditions where deregulated NET formation is associated with the pathophysiology.

Taken together, our results show that Mincle plays a protective role in KPn induced
pneumonic sepsis by regulating neutrophil phagocytosis and NET formation, two
important mechanisms of antimicrobial activity of neutrophils. Particularly, the novel
observation of Mincle as a potential new component of NETosis pathway implicates this
CLR in a much wider range of biological functions that initially surmised.
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Abstract

A profound neutrophilia and neutrophilic inflammation is characteristic of pneumoseptic
infections with bacterial pathogens including Klebsiella pneumoniae (KPn). In homeostatic
conditions, macrophages clear neutrophils by efferocytosis, via recognition of “eat me”
signal phosphatidylserine (PS) exposed exofacially on these cells. We demonstrate here
that infection with live, but not heat-killed KPn inhibits the efferocytic uptake of
neutrophils in-vitro and in-vivo by macrophages. This infection-induced inhibition of
efferocytosis correlated with a drastic decrease in surface exposed PS as well as induction
of nonapoptotic cell death by necroptosis in KPn infected neutrophils. Concomitantly,
treatment with sulfhydryl agent N-ethylmaleimide (NEM), which enhances PS
externalization on plasma membrane, as well as necrostatin-1, a necroptosis inhibitor
rescued the infected neutrophils from KPn mediated inhibition of efferocytic clearance. To
our knowledge, this is the first report of inhibition of efferocytosis by KPn by PS
redistribution and necroptosis, which likely promotes neutrophilia and persistent
neutrophilic inflammation in this infection.

Keywords: Efferocytosis; Klebsiella pneumonia; neutrophil turnover; phosphatidylserine;
necroptosis, pneumonia, sepsis, neutrophilia
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Introduction
Sepsis is one of the oldest and most elusive syndromes and despite extensive efforts to
better understand and treat sepsis, it is still a major challenge in medicine (279). With no
effective therapies there are over 750,000 cases of sepsis each year in the United States
alone, which accounts for 10% of all ICU patients, leading to a mortality rate between 2050% depending on certain risk factors (2). Pneumonia is the most frequent cause of sepsis
(223-225). In particular Klebsiella pneumoniae (KPn), an opportunistic pathogen, accounts
for 5-20% of all Gram-negative sepsis cases (223, 225). A notable emergence of antibiotic
resistant strains of KPn in clinical settings has caused concerns over an already dwindling
armamentarium of antibiotics. In this scenario, elucidation of protective host immune
responses and pathogen-mediated manipulation thereof will likely provide novel
therapeutic targets.

Neutrophils are the first cell types to infiltrate the site of infection and contribute to initial
protective response. Indeed, in murine models of KPn infection, neutrophil-mediated
responses are shown to be essential for initial control of the infection (248, 249). However,
persistent accumulation of neutrophils and their over activation later causes neutrophildependent inflammatory diseases in the lungs, including bacterial pneumonia and sepsis
(114, 280). A profound neutrophilia and the role of released alarmins in perpetuation of
inflammation in septic bacterial infections has been shown by us recently (65, 66, 89, 90,
236). In Klebsiella infection, neutrophils have been reported to constitute a reservoir for
this pathogen and aide in systemic dissemination of this infection (281). This underscores
the importance of neutrophil turnover and resolution of neutrophil associated responses in
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KPn pneumonia and sepsis. In this regard, clearance of neutrophils by phagocytic cells,
mainly macrophages, occurs via efferocytosis which is a highly regulated receptordependent process (282, 283). Recognition of surface exposed “eat-me” signal
phosphatidylserine (PS), which replaces the native “don’t eat me” signals on apoptotic
cells, by macrophage cell surface receptors initiates engulfment and engulfment-associated
downstream signaling events that induce a pro-resolving macrophage phenotype (284286). Concomitantly, efferocytosis has been documented to play a vital role in controlling
inflammation, by preventing the release of pro-inflammatory mediators from dead cells as
well as by clearing pathogens not destroyed through phagocytosis (114, 157). While there
is considerable research done on the efferocytosis pathways and its effect on disease
development, studies on pathogen subversion of this important protective host response
and the underlying mechanisms are extremely limited. Whether KPn can directly
manipulate efferocytosis to promote disease is completely unknown.

In this study we determined if KPn infection of neutrophils modulates their clearance via
efferocytosis by macrophages. Our results presented in this manuscript show that KPn
inhibits efferocytic clearance of neutrophils by causing a live infection- and timedependent decrease in the surface exposure of “eat-me” signal PS on the infected
neutrophils as well as by driving the cell death away from immunologically silent apoptosis
to a more inflammatory necroptosis pathway. Concomitantly, restoration of PS on KPn
infected neutrophils as well as inhibition of necroptosis rescued the efferocytic uptake of
these cells. Our studies present evidence for novel virulence mechanisms of KPn causing
neutrophil turnover deficit which likely contributes to the genesis of KPn dissemination
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and neutrophilic inflammation. PS and necroptosis targeted therapies may be useful to treat
KPn infections in the face of constant emergence of antibiotic resistant strains of this
bacterium.
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Materials and Methods
Bacterial strains and Mice
The KPn (ATCC strain 43816) were grown to log phase in LB medium at 37oC. For
isolation of cells and in-vivo experiments 6-8 weeks old wild-type C57BL/6 bred in the
animal facility of the University of North Dakota were used. The animals were handled
according to the institutional and federal guidelines.
Flow cytometry analysis of “Eat-me and “Don’t eat me” signals
Peritoneal neutrophils isolated from mice 12-16 hrs after intraperitoneal injection with
sterile 4% thioglycollate (BD Biosciences, San Jose, CA) as described by us previously
(65, 236). Purity was ensured by quantitating Ly6G+CD11b+ cells by flow cytometry (8590 % neutrophils). Isolated neutrophils were left uninfected or infected with 10 MOI of
KPn. Cells were stained with PerCP-Cy5.5 labelled anti-CD31 (Biolegend, San Diego,
CA) or FITC abelled anti-CD47 (Biolegend, San Diego, CA) antibodies to detect “Don’t
eat-me” signals by flow cytometry as described by us (65, 236). A FITC Annexin V
Apoptosis Detection Kit (BD Biosciences, San Jose, CA) was used according to
manufacturer’s instructions followed by flow cytometry analysis at indicated times to
enumerate percentage of PI- Annexin V+ cells with surface exposed “Eat-me” signal PS
using BD LSR II flow cytometer (Becton Dickinson, San Jose, CA). FlowJo (Tree Star)
software was used to analyze the data.
In-vivo Efferocytosis
Peritoneal neutrophils were infected with KPn (MOI 10) for 2 hours before killing of
extracellular,

non-internalized

bacteria

with

antibiotics,

then

labelled

with

Carboxyfluorescein succinimidyl ester (CFSE; Cell Trace™ CFSE Cell Proliferation Kit
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from Invitrogen) per manufacturer’s instructions. CFSE-labelled infected or uninfected
neutrophils were suspended in complete RPMI and 35uL/3.5x106 cells were administered
intranasally into mice anaesthetized using a mixture of 30mg/ml ketamine and 4 mg/ml
xylazine in PBS. Lungs were lavaged as described by us (65, 236) 2 hrs after the instillation
and alveolar macrophages analyzed by flow cytometry using PE-Cy7 conjugated antiF4/80 and APC conjugated anti-Ly6G antibodies (BioLegend, San Diego, CA).
Efferocytic uptake by macrophages was quantitated by flow cytometry to enumerate Ly6GF4/80+ CFSE+ cells. Efferocytic index was calculated as the percent difference between
uninfected and KPn infected neutrophils. All other statistical analyses were performed
using the Student t test (SIGMA PLOT 8.0, Systat Software, San Jose, CA).
In-vitro Efferocytosis
Peritoneal neutrophils and macrophages were isolated 12-16hr and 5 days respectively after
intraperitoneal injection of sterile 4% thioglycollate. Macrophages were seeded on 6 well
plates at a density of 0.5x106 cell/ml for 1-2 hr before adding CFSE-labelled uninfected or
KPn infected neutrophils (prepared as described above) at a ratio of 5:1. After 2 hrs cells
were thoroughly washed, scraped and stained with PE-Cy7 conjugated anti-F4/80 and APC
conjugated anti-Ly6G antibodies for flow cytometry. For some experiments, uninfected
and infected neutrophils were treated with 5 mM of N-ethylmaleimide (NEM) or
neutralizing antibodies against CD31 and CD47 (BioLegend, San Diego, CA), or with
necroptosis inhibitors necrostatin-1 (100 µM) or GSK’872 (3 µM) (Millipore Sigma, St.
Louis, MO) before incubating with macrophages. Efferocytic index was calculated as
described above.
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Western blot Analysis
For detection of necroptosis markers, peritoneal neutrophils uninfected or infected with 10
MOI KPn for 3 hours were lysed with RIPA buffer and probed with anti-mouse Caspase
8, RIPK1 antibodies (Cell Signaling Technology, Danvers, MA) and pRIP3 S232 & T231,
pMLKL S345 antibodies (Abcam, Cambridge, MA) by immunoblot analysis.
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as loading control.
Peritoneal neutrophils treated with 1 μM Smac mimetic AT‐406 and 20 μM Q‐VD for 30
min prior to stimulating with 100 ng/mL mouse TNF‐α were used as positive control for
necroptosis induction (287).

Statistical analyses
Statistical analyses were performed using the Student t test (SIGMA PLOT 8.0, Systat
Software, San Jose, CA). A p value of ≤ 0.05 was considered statistically significant.
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Results
KPn infection inhibits efferocytosis of neutrophils
In order to determine the effect of KPn infection on efferocytosis of neutrophils, we
compared the uptake of CFSE labelled uninfected or KPn infected neutrophils by
macrophages using flow cytometry. As shown in Figure 23A, after 3 hrs of incubation with
CFSE labelled neutrophils, 32.7% ± 5.4% macrophages stained positive for uptake of
uninfected neutrophils. On the other hand, only 13.9% ± 1.6% macrophages had
efferocytosed KPn infected neutrophils which was significantly lower than their uninfected
counterparts. This indicated that infection of neutrophils with KPn caused a significant
reduction in their efferocytic uptake by macrophages. Importantly, this infection-induced
inhibition was largely dependent on live bacteria and/or active bacterial replication because
heat-killed KPn were significantly less potent in inhibiting efferocytosis of neutrophils
causing a reduction only by 29.1% ± 2.3% of the uninfected neutrophils, compared to live
bacteria which inhibited the efferocytosis by 57.2% ± 1.4% (Figure 23B).

We next investigated if KPn infection can inhibit efferocytic clearance of neutrophils invivo in lungs by alveolar macrophages. For this, CFSE labelled uninfected or KPn infected
neutrophils were inoculated intranasally into anesthetized mice followed by isolation and
flow cytometry analysis of alveolar macrophages as described in methods. Consistent with
our in-vitro results, KPn infection of neutrophils reduced their efferocytic uptake by 45.1%
± 1.6% compared to the uninfected cells (Figure 23C). Together, these data strongly
suggested that KPn infection inhibits the efferocytic clearance of neutrophils by
macrophages in-vitro and in-vivo.
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Figure 23. Live KPn infection inhibits efferocytosis of neutrophils
Neutrophils left uninfected or infected with live (A) or heat-killed (B) KPn at MOI 10 for
2 hours were labelled with CFSE and incubated with macrophages at 5:1 ratio for 2 hours.
The cells were washed thoroughly and the macrophages were processed for flow-cytometry
by staining with anti-F4/80 and anti- Ly6G antibodies. The percent of Ly6G-F4/80+CFSE+
cells indicating macrophages that have internalized CFSE labelled neutrophils calculated
from 5 independent experiments is shown in the representative density plots. The
efferocytic index was calculated as the percent difference between uninfected and KPn
infected neutrophils, (**, p<0.005; ***, p<0.001).
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Figure 23 cont. Live KPn infection inhibits efferocytosis of neutrophils
(C). CFSE labelled uninfected or KPn infected neutrophils were instilled intranasally in
anaesthetized mice (3.5 million cells in 35 µl PBS). Two hours later lungs were lavaged as
described in methods and cells were stained with PE-Cy7 conjugated anti-F4/80 and APC
conjugated anti-Ly6G antibodies for flow cytometry. Efferocytic uptake by macrophages
was quantitated by enumeration of Ly6G- F4/80+ CFSE+ cells. Efferocytosis of uninfected
neutrophils was taken as 100% and efferocytic index was calculated as the percent
difference between uninfected and KPn infected neutrophils. Data are from 3 mice per
group in 3 independent experiments (**, p<0.005).

Effect of KPn infection on “don’t eat me” signals expressed by neutrophils
Expression of specific cell surface molecules called the “don’t eat me” signals on healthy
cells prevents their efferocytosis by phagocytes (288). We determined if impaired
efferocytosis of KPn infected neutrophils could be attributed to these negative regulatory
signals. Flow cytometry analysis showed that KPn infected neutrophils exhibited
significantly increased surface expression of CD47 and CD31, two well-defined “don’t eat
me” signals, as compared to the uninfected neutrophils (Figure 24A). However,
upregulation of these signals on KPn infected neutrophils did not appear to contribute to
the inhibition of their efferocytic uptake since the inhibitory effect of KPn infection
remained intact even after blocking neutralization of CD47 and CD31 individually or in
combination (Figure 24B). This indicated to us that “don’t eat me” signals do not play any
significant role in KPn mediated inhibition of neutrophil efferocytosis.
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Figure 24. “Don’t eat me” signals do not play any role in efferocytic inhibition of KPn
infected neutrophils
(A). Neutrophils were left uninfected or infected with KPn (MOI 10) for 3 hrs. Cells were
then co-stained with antibodies against neutrophil marker Ly6G and the “don’t eat me”
signals CD31 and anti-CD47. Each bar represents percent of Ly6G positive neutrophils
expressing CD31 or CD47. Data are mean ± SEM from 4 independent experiments (*,
p<0.05). (B). CFSE labelled neutrophils uninfected or infected with KPn were incubated
with 5µg/mL anti-CD47 or anti-CD31 blocking antibodies individually or in combination
30 min. prior to incubating with macrophages for 2 hrs.

Efferocytic uptake by

macrophages was quantitated by flow cytometry using neutrophil specific anti-Ly6G and
macrophage specific anti-F4/80 antibodies to enumerate percent of efferocytic cells.
Numbers on the representative density plots show percent of Ly6G- F4-80+ CFSE+ cells
from 3 independent experiments.
108

KPn infection of neutrophils causes reduced exposure of “eat me” signal
phosphatidylserine
We next examined if modulation of “eat-me” signal on neutrophils played any role in KPn
mediated inhibition of efferocytosis. Phosphatidylserine (PS) is externalized to the plasma
membrane of apoptotic cells, and has been classically characterized as an “eat me” signal
essential for the recognition and efferocytosis by phagocytes (288). We thus compared the
kinetics of PS externalization in uninfected and KPn infected neutrophils by flow
cytometry using Annexin V which binds to PS. Propidium iodide was used to exclude
necrotic cells from analysis. As shown in Figure 25A, uninfected neutrophils exhibited
surface exposure of PS after 30 min. of culture, which gradually increased over a period of
5 hrs. The KPn infected neutrophils, on the other hand, showed similar levels of PS
exposure as their uninfected counterparts for the initial two hours (19.7% ± 3.3% in KPn
infected and 19.3% ± 4.6% in uninfected neutrophils). By 3 hrs post-infection, however, a
drastic reduction in PS exposure was observed in KPn infected neutrophils (9.7% ± 1.9%
in KPn infected compared to 21.8% ± 6.5% in uninfected neutrophils) which remained
significantly lower than that in the uninfected cells up to 5 hrs (2.5% ± 0.3% in KPn
infected compared to 33% ± 7.1% in uninfected neutrophils), the time at which the
experiment was terminated. Importantly, this sharp decrease in the PS exposure in KPn
infected neutrophils at 3 hrs coincided with the time by which these neutrophils were
incubated with macrophages for efferocytic uptake, indicating that this phenomenon is
likely responsible for the reduced uptake of KPn infected neutrophils by macrophages. This
reduced PS exposure was not due to necrosis as the number of PI positive cells did not
increase over time (data not shown).
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KPn infection activates necroptosis in neutrophils
As PS exposure is regarded a measure of apoptotic cell death, given the reduced PS
exposure we examined if KPn infection modulates the cell death mechanism of neutrophils.
In this regard, Caspase 8 is centrally positioned to control the extrinsic pathway of
apoptosis as well as necroptosis by activating caspase 3 and 7 and by degradation of RIPK1,
which is required for recruitment of RIPK3, eventuating in phosphorylated mixed lineage
kinase domain-like protein (MLKL)-dependent necroptosis. Western blot analysis of
Caspase 8 and RIPK1 in uninfected and KPn infected neutrophils showed reduced
processing of procaspase 8 into active Caspase 8 (Figure 25B). This coincided with the
reduced degradation of RIPK1 in these cells, indicating inhibition of apoptosis and
activation of necroptosis. Indeed, phosphorylation of RIPK3 and MLKL was increased in
KPn infected neutrophils confirming the activation of necroptosis in these cells upon
infection (Figure 25B). As a positive control neutrophils treated with TNF-alpha in
combination with caspase inhibitor Q-VAD were analyzed for necroptosis activation in the
absence of caspase-8 activity, which showed a similar inhibition of caspase 8 processing
and RIPK1 cleavage and increased phosphorylation of RIPK3 and MLKL (Figure 25B first
lane). Taken together these data strongly suggested that KPn infection inhibits apoptosis,
a cell death favorable for efferocytic clearance and instead activates pro-inflammatory
necroptosis of neutrophils.
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Figure 25 KPn infection decreases the level of surface exposed “eat me” signal
phosphatidylserine (PS) on infected neutrophils and induces necroptosis
(A). Neutrophils were left uninfected or were infected with KPn (MOI 10). The level of
“eat me” signal PS was monitored by over time by Annexin V staining using a Annexin V
Apoptosis Detection followed by flow cytometry analysis. Propidium iodide (PI) was used
to exclude necrotic cells. Percent of Annexin V+ PI- cells at indicated times is shown (mean
± SEM from 5 independent experiments; *, p<0.05; p**<0.005).
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Figure 25 cont. KPn infection decreases the level of surface exposed “eat me” signal
phosphatidylserine (PS) on infected neutrophils and induces necroptosis
(B). Immunoblots for caspase-8, RIPK1, pRIPK3 and pMLKL in whole cell lysates from
uninfected and KPn infected neutrophils are shown. Lysate from primary neutrophils
treated with TNF-α with pan-caspase inhibitor Q‐VD and Smac mimetic was used as
positive control for necroptosis activation. GAPDH was used as loading control.

Restoration of PS exposure and inhibition of necroptosis rescues the efferocytic uptake of
KPn infected neutrophils
Given our data showing KPn-infection induced necroptosis and reduced externalization of
PS, we determined if restoration of PS and necroptosis inhibition will rescue the efferocytic
uptake of KPn infected neutrophils. In this regard, treatment with a sulphydryl modifying
agent N-ethylmaleimide (NEM) triggers flipping of PS to outer plasma membrane of cells
(289-291). As shown in Figure 26A, NEM treatment of KPn infected neutrophils reversed
the PS exposure on their surface as 52.1% ± 7.7% cells stained positive for Annexin V
staining by flow cytometry at 3 hrs as compared to the untreated KPn infected neutrophils
on which the PS exposure remained low (9.9% ± 2.1%). Having established that NEM
treatment could reverse KPn infection-induced reduction of PS surface exposure, we next
tested if efferocytic uptake of KPn infected neutrophils was improved following NEM
treatment. Indeed, reversal of PS externalization upon NEM treatment restored the
efferocytic uptake of KPn infected neutrophils to the levels of uninfected neutrophils which
was significantly higher than the untreated KPn infected cells (26.5% ± 1.7% NEM treated
KPn infected Vs 10.1% ± 1.8% of untreated KPn infected) (Figure 26B).
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To establish the role of KPn induced necroptosis in efferocytosis inhibition, we similarly
treated KPn infected neutrophils with necrostatin-1, a RIPK1 inhibitor which suppresses
necroptosis (292). As shown in Figures 26 C and D, treatment with necrostatin-1 reversed
the inhibitory effect of KPn infection on efferocytic uptake of neutrophils by restoring it to
the levels similar to uninfected cells. Necrostatin-1 treatment itself did not affect the
efferocytosis of uninfected cells. Because necroptosis-independent functions of RIPK1
have been reported (293), we also tested the effect of RIPK3 inhibitor GSK’872 to further
confirm the role of necroptosis in inhibition of efferocytosis of KPn infected neutrophils.
Indeed, GSK’872 treatment of KPn infected neutrophils increased their efferocytic uptake
by macrophages to 80% (Figure 26 E and F). This strongly implicated the activation of
necroptosis as an important mechanism underlying impaired effrocytosis of KPn infected
neutrophils.

Interestingly, RIPK1 or RIPK3 inhibition did not affect the level of

externalized PS in the infected neutrophils (data not shown), indicating that necroptosis
induction and PS exposure are, likely two independent mechanisms which KPn employs
to inhibit the efferocytosis of neutrophils. Taken together, these data showed that KPn
infection inhibits the efferocytic clearance of neutrophils by reducing the surface exposure
of PS, a classical “eat-me” signal as well as by driving the cells to necroptosis.
Consequently, restoration of exofacial PS as well as suppression of necroptosis pathway
reverses this inhibitory effect of KPn infection.
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Figure 26. Restoration of PS exposure and inhibition of necroptosis rescues the
efferocytic uptake of KPn infected neutrophils
(A). Treatment with N-ethylmaleimide (NEM) rescues surface exposed “eat me” signal PS
in KPn infected cells and restores efferocytosis. The level of surface exposed PS in
uninfected or KPn infected neutrophils with or without NEM treatment (5mM for 30 min)
was measured by Annexin V staining followed by flow cytometry. Percent of Annexin V+
PI- cells at 3hrs post-infection is shown (mean ± SEM from 3 independent experiments,
**p<0.005; ***, p<0.001). (B) Uninfected and KPn infected neutrophils were treated or
left untreated with NEM. The efferocytosis of these cells by macrophages was performed
followed by flow cytometry as described above. Numbers on the representative density
plots show percent of Ly6G- F4/80+ CFSE+ efferocytic cells (mean ± SEM) from 3
independent experiments. (C&E) Efferocytic index and (D&F) percent of Ly6G- F4/80+
CFSE+ cells efferocytosing uninfected and KPn infected neutrophils with and without
treatment with RIPK-1 inhibitor Necrostatin-1 (C&D) or RIPK3 inhibitor GSK’872
(E&F). Data is presented as (mean ± SEM) from 3 independent experiments.
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Discussion
During an acute injury neutrophils are promptly recruited to the site which, upon the
resolution of insult, are cleared by efferocytosis to maintain homeostasis (114). Given its
host protective consequences, subversion of efferocytosis may be advantageous for
pathogens to establish infection. Here we report that Klebsiella pneumoniae, an
opportunistic pathogen causing pneumonic sepsis characterized by neutrophilia and
hyperinflammation, prevents efferocytic clearance of neutrophils. We show that a down
modulation of cell surface exposure of PS, an “eat-me” signal recognized by the
phagocytes for efferocytic internalization of neutrophils, and modulation of cell death
mode toward necroptosis are the underlying mechanisms by which KPn subverts
efferocytosis. Our study provides important insights into pathogenic mechanisms that can
be targeted for future antimicrobial therapies for this infection.

KPn has recently gained attention as a “successful” pathogen owing to an emergence of
hypervirulent strains as well as antibiotic resistance (294). The wide range of infections
caused by this pathogen in immunocompromised and immune-competent individuals have
become increasingly difficult to treat owing partly to the arsenal of virulence factors
exhibited by this pathogen that it utilizes to protect itself from host immune response (295).
Based on these virulence factors KPn has been categorized as an “evader” rather than an
“offender” pathogen. For example, a polysaccharide capsule, lipopolysaccharide, Type 1
and 3 fimbrae and outer membrane proteins have been identified and characterized as
factors required for survival and growth of the pathogen within the host (176). Our results
presented in this manuscript, show for the first time, strategies employed by this pathogen
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to actively suppress an important host defense i.e. efferocytic clearance of neutrophils by
modulation of cell death pathway and PS externalization. Our data showing
downregulation of PS exposure, reduced activation of apoptosis executioner Caspase 8 and
activation of necroptosis in neutrophils infected with KPn highlight strategies employed
by this pathogen to impair efferocytic clearance of these cells by macrophages. In this
regard it is important to note that a recent report showed neutrophils as vehicles for KPn
for its dissemination to establish liver abscess, a severe clinical complication of KPn
infection (281). Efferocytic clearance of KPn-infected neutrophils thus may aid in
circumventing these distant metastatic complications, as has been shown in case of
mycobacterial infection (157). These findings open new avenues to treat and prevent the
systemic spread of this infection.

Efferocytic clearance of apoptotic cells is a highly orchestrated event involving specific
receptors on phagocytic cells that discriminate live cells from dead/dying cells by
recognizing “don’t eat-me” and “eat me” signals respectively (288). Phosphatidyleserine
(PS) is considered the most well-characterized “eat-me” signal recognized by the
phagocytes via receptors such as Bai1 and Tim4 for removal of apoptotic cells (296).
Owing to an efficient and immunologically silent nature of this event, many viruses and
parasites have been reported to use PS mimicry by concentrating PS on their surface and
hijack efferocytic machinery of host cells to promote their internalization and cell-to-cell
spread (159, 297, 298). In contrast to this, pathogen -mediated skewing of efferocytic
clearance of immune cells via PS recognition is much less studied. Staphylococcus aureus
is shown to inhibit efferocytic clearance of neutrophils via upregulation of CD47, a “don’t
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eat me” signal and necroptosis (160). In our study “don’t eat me” signals, although
upregulated on neutrophils upon infection, did not appear to play any significant role in
inhibition of efferocytosis. Instead, KPn infected neutrophils showed a drastic down
modulation in the externalization of “eat-me” signal PS. PS distribution on the lipid bilayer
in biological membranes is controlled by the activity of ATP-dependent flippases and
scramblases (299). Flippases contribute to PS maintenance in the inner leaflet via ATP
dependent transport of phospholipid from the outer to inner membrane. Scramblases on the
other hand, transport PS to the outer leaflet. Whether the decreased PS exposure on the
outer membrane of KPn infected neutrophils is due to KPn mediated modulation of
flippases and scramblases, is an exciting area of mechanistic research which we are
currently pursuing. Notwithstanding the molecular mechanism, the relevance of this event
was confirmed by reversal of PS exposure on KPn infected neutrophils by NEM treatment
which rescued their efferocytic clearance. To the best of our knowledge, this is the first
report of pathogen mediated inhibition of PS exposure on neutrophils to avoid their
efferocytic clearance. PS-dependent clearance of immune cells results in the release of antiinflammatory and pro-resolving factors which downregulate the inflammation (300). In
addition, recent studies have shown that efferocytic uptake of apoptotic neutrophils
regulates granulopoiesis and peripheral neutrophilia via an IL-23/IL-17/G-CSF axis (262).
KPn mediated inhibition of neutrophil clearance may result in the loss of this negative
regulatory axis thus promoting the neutrophilia and inflammation characteristic of this
infection. In addition, maintenance of neutrophilic niche may help disseminate the
infection to systemic sites.
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Necroptosis is defined as a caspase-independent non-apoptotic form of regulated cell death
which requires RIPK1 and RIPK3-mediated activation of pseudokinase, mixed lineage
kinase-like protein (MLKL) (301). Extrinsic pathway of apoptosis activated by death
ligands such as FasL or TLR ligands promotes processing of caspase-8 which degrades
RIPK1 and drives apoptotic cell death (302). Conversely, inhibition of caspase 8 spares
RIPK1 to promote RIPK3 autophosphorylation and recruitment of MLKL to form a
necroptosome complex (303). Phosphorylation of the C-terminal pseudokinase domain of
MLKL by RIPK3 promotes MLKL translocation to plasma membrane which then disrupts
the membrane integrity (304). Our results showed reduced processing of caspase 8 in KPn
infected neutrophils indicating the inhibition of apoptosis in these cells. This coincided
with increased RIPK1 levels, RIPK3 phosphorylation and MLKL phosphorylation strongly
suggesting the activation of necroptosis pathway in KPN infected neutrophils. This
supports the notion that KPn drives the cell death away from immunologically silent
apoptosis which favors efferocytosis, toward necroptosis which lacks “eat-me” signals and
promotes inflammation (305). While inhibition of apoptosis by KPn has recently been
reported (306), our studies present physiological consequence of this phenomenon
eventuating in reduced PS externalization and modulation of cell death pathway relevant
to KPn infection induced inhibition of efferocytosis. This is supported by increased
efferocytic uptake of infected neutrophils upon treatment with NEM to increase PS
exposure as well as with necrostatin-1 and GSK’872, which are inhibitors of necroptosis.
It is noteworthy here that necroptotic fibroblasts and monocytic cell lines were recently
reported to expose PS on their surface in pMLKL-dependent fashion (307, 308). While
these findings indicate a novel function of necroptosis pathway in PS exposure in these
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cells, the inhibition of PS exposure and induction of necroptosis in KPn infected primary
neutrophils in our studies appears to be via two independent pathways since inhibition of
necroptosis did not affect the levels of PS on KPn infected neutrophils (data not shown).
In light of our results showing the rescue of efferocytosis upon increased PS exposure by
NEM treatment as well as upon inhibition of necroptosis it is highly likely that KPn utilizes
two independent strategies to inhibit the clearance of neutrophils and to drive the
neutrophilia and inflammation characteristic of pneumonic infection. As the antibiotic
resistance is a serious problem associated with Klebsiella infections, elucidation of
mechanism by which this pathogen manipulates efferocytosis, as reported here, might
provide novel therapeutic targets.
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CHAPTER 5
DISCUSSION
General Discussion
As described in the Introduction section, sepsis continues to be a major healthcare burden.
Despite decades of dedicated research efforts, occurrence of sepsis and septic shock is
rising and the mortality rate has not changed over the past three decades (309, 310). A
likely reason as to why it has been so difficult to find effective treatment for sepsis is that
immune regulatory processes that respond to sepsis are not completely understood (273,
311). An overwhelming inflammatory response, termed “cytokine storm” or
hypercytokinemia resulting from stimulation with pathogen-derived (PAMPs) or hostderived factors (alarmins) is thought to be responsible for shock, multiple-organ failure and
eventual death in septic patients (23). However, anti-inflammatory interventions have not
been a successful treatment option for sepsis. This highlights the need to take into account,
not only the initiation of inflammation, but also the resolution thereof, which favors tissue
repair. In this regard, neutrophil mediated responses are essential for combating pneumonic
bacterial infection and their protective role in sepsis has been described (248, 249).
However, persistent accumulation of neutrophils can lead to bystander tissue destruction,
owing to their tissue destructive cargo. Neutrophil turnover and resolution of neutrophil
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associated responses is thus, an integral part of a resolving inflammatory response to an
infectious insult such as pneumonic infection. My dissertation revolves around the
hypothesis that a failure of this process likely contributes to the acceleration of
inflammation resulting in the development of sepsis. This is a highly understudied area of
research. The studies described here provide an understanding of the host factors regulating
neutrophil mediated responses and their perturbations by pathogen in a setting of
pneumonic sepsis, which will likely provide new targets for therapeutic intervention of this
deadly immune disorder.
In chapter 1 I presented an overview of the disease burden, inflammatory immune
responses, clearance of dead cells via efferocytosis, mechanisms by which bacteria subvert
host immune response to establish infection, and animal models used to study sepsis.
Chapters 2 and 3 elucidated the protective roles of the CLRs, MGL1 and Mincle, in
pneumonic sepsis. In chapter 4, a novel mechanism by which the pathogen KPn, modulates
the host response in order to prevent its clearance via efferocytosis was presented. The
remainder of chapter 5 will summarize and discuss the new findings from this work.

Protective role of CLRs during inflammation and sepsis
C-type lectin receptors (CLRs) are considered pattern recognition receptors (PRRs) and
have been shown to play a role in numerous inflammatory and homeostatic host functions
(82). Surprisingly, little is known about the role of CLRs in the development of pneumonic
sepsis. We set out to characterize the function of CLRs in pneumonic sepsis using our KPn
infection model. Initial transcript level screening of more than 60 CLRs showed several
CLRs upregulated at in the lungs of these pneumonic septic mice. I focused on two of those
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CLRs namely Macrophage Galactose Type Lectin 1 (MGL1) and Mincle (Clec4e). We
found that in the absence of either of these CLRs, mice were highly susceptible to KPn
infection compared to WT mice and most mice succumbed to infection by 5 days post
infection. This data suggested that both MGL1 and Mincle play a protective role in
pneumonic sepsis. In both MGL1-/- and Mincle-/- mice infected with KPn we observed
severe lung pathology along with a hyperinflammatory response with massive increases in
pro- and anti-inflammatory cytokines when compared to infected WT mice 3 days post
infection. There was also a massive accumulation of neutrophils in the lungs of both
infected CLR knockout mice compared to infected WT mice. However, a kinetic analysis
of bacterial burden in these knockout mice showed disparate phenotypes. Whereas MGL1/-

mice showed no difference in bacterial burden when compared to WT mice, Mincle-/-

mice displayed increased systemic and local bacterial burden compared to WT mice. This
indicated distinct roles of these two CLRs in KPn infection induced pneumonic sepsis.
Considering a massive neutrophil influx in the absence of both MGL1 and Mincle, and the
fact that both CLRs are expressed mainly by myeloid cells, we further analyzed the
function of neutrophils in MGL1-/- and Mincle-/- mice. We found that while MGL1-/neutrophils were fully competent in bacterial clearance mechanism (bacterial uptake by
phagocytosis as well as NET formation), Mincle-/- neutrophils were defective in these
functions. No functional defect seen in MGL1-/- neutrophils, but a massive influx of
neutrophils into the lungs of infected MGL1-/- mice, indicated to us two possible scenarios.
One possibility is that MGL1 plays a role in neutrophil influx and in the absence of MGL1
the neutrophils infiltrate the lungs in increased numbers. The other possibility is a defect
in the ability of MGL1-/- mice to clear apoptotic cells via efferocytosis thus causing their
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increased accumulation in their lungs. To this end, we began by looking at the role of
MGL1 in neutrophil influx by adoptive transfer experiments of WT and MGL1 -/neutrophils. Those experiments showed that the absence of MGL1 on neutrophils and not
endothelial cells, led to the increased neutrophil influx as seen in MGL1-/- mice. Additional
experiments looking into neutrophil mobilization markers, showed that by 3 days post
infection MGL1-/- had significantly higher levels of GCP-2 and G-CSF, when compared to
WT mice. The massive increase of G-CSF in the lungs of KPn infected MGL1-/- mice,
suggested that emergency granulopoiesis could be occurring (252-261). We therefore
examined the process of granulopoiesis in WT and MGL1-/- mice over a 3-day time course.
The results of the experiments showed that by 3 days post infection, MGL1-/- mice exhibit
an increase in mature neutrophil mobilization from the bone marrow to the blood when
compared with WT mice. This could possibly be due to the increased levels of G-CSF
observed in the lungs of KPn infected MGL1-/- mice. It has been shown that defects in
efficient clearance of apoptotic neutrophils via efferocytosis leads to an increase in G-CSF
production (262). It is possible then that a defect in MGL1-/- mice ability to clear apoptotic
neutrophils drives the increased levels of G-CSF in MGL1-/- mice. In-vivo efferocytosis
experiments to determine if MGL1-/- neutrophils are cleared as efficiently as WT
neutrophils showed that indeed in the absence of MGL1, neutrophils were cleared less
efficiently than the WT neutrophils. This result indicated to us that a defect in the clearance
of apoptotic neutrophils in MGL1-/- mice during KPn infection, lead to increased
production of G-CSF, and ultimately increased neutrophil influx into the lungs. Combined
with the results of the adoptive transfer experiment it is possible that MGL1 negatively
regulates neutrophil influx as well as aids in efficient clearance of apoptotic neutrophils via
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efferocytosis. Future studies in the lab will determine the mechanisms by which MGL1
plays a role in these processes. This study identified a novel role of MGL1 in pneumonic
sepsis by regulating neutrophil influx through either the negative regulation of neutrophil
influx, clearance of apoptotic neutrophils, or a combination of both.

Our findings show that both MGL1 and Mincle play a protective role during KPn induced
pneumonic sepsis and inflammation. MGL1 by regulating neutrophil influx into the lungs
and Mincle by regulating bacterial clearance mechanisms through neutrophil phagocytosis
and NET formation. These discoveries help identify novel mechanisms to be used in the
development of treatments and therapies for sepsis.

KPn’s modulatory effect on neutrophils and impact on efferocytosis
Klebsiella pneumoniae (KPn) is an opportunistic pathogen known for causing hospital
acquired pneumonic sepsis. It has become a pathogen of interest recently due to the
emergence of multidrug resistant strains, which are even resistance to colistin, an antibiotic
considered a last line of defense (177, 183, 184). Given that, it is critical that we understand
the virulence factors, which aid in the ability of this pathogen to infect and survive in the
host tissue. KPn has four well characterized virulence factors; capsule, lipopolysaccharide
(LPS), fimbriae, and siderophores. KPn utilizes these virulence factors to evade rather than
subvert an early host immune response. With our studies described in Chapter 4, we have
identified a novel virulence mechanism by which KPN subverts a protective host response
i.e. efferocytosis of neutrophils thereby maintaining a replicative niche (281). Our results
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showed that KPn infected neutrophils were cleared less efficiently via efferocytosis than
uninfected neutrophils. The mechanism underlying this inhibition appears to be different
from what has been reported in case of Staphylococcus aureus where the pathogen inhibits
the efferocytic uptake of infected cells by upregulating the surface expression of the “don’t
eat me” signal CD47, while also inducing necroptosis (160). Our results instead showed
that while KPn does increase the expression of two “don’t eat me” signals in CD31 and
CD47, neutralization of these signals has no effect on KPn induced inhibition of
efferocytosis of infected neutrophils. Instead, KPn infection drastically reduced the surface
exposure of the most well characterized “eat me” signal, phosphatidyleserine (PS). This
decrease in cell surface PS exposure in KPn infected neutrophils coincided with the timing
of our efferocytosis assay and suggested to us that KPn modulation of cell surface PS
exposure was leads to the KPn mediated inhibition of efferocytosis of infected neutrophils.
Indeed, reversal of PS exposure by treatment with NEM rescued the efferocytic uptake of
infected cells. In this regard a recent report showed that KPn infection delays apoptosis in
human neutrophils (306). AS PS exposure is a characteristic measure of apoptotic cell
death, our studies present the first evidence of physiological relevance of this phenomenon
in KPn infection.
We next determined if KPn could induce alternative routes of cell death Western blot
analysis of caspase 8 and RIP1 via Western blot analysis in uninfected and KPn infected
neutrophils showed that KPn infection inhibited caspase 8 activation, which in turn
prevented RIP1 inactivation through cleavage. That indicated an activation of necroptosis
in KPn infected neutrophils. An increased phosphorylation of downstream kinases RIPK3
and MLKL confirmed this notion. Concomitantly, inhibition of necroptosis with
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necrostatin-1 (RIPK1 inhibitor) as well as GSK’872 (RIPK3 inhibitor), rescued the defect
in the efferocytosis of KPn infected neutrophils. The results of this study indicate that KPn
infection inhibits apoptosis resulting in reduced PS exposure, while inducing an alternative
cell death by necroptosis in neutrophils in order to inhibit their efferocytic clearance. The
inhibition of efferocytosis through these mechanisms likely contributes to the development
of a pro-inflammatory environment, which allows the pathogen to establish an infection,
thus driving the development of sepsis. To our knowledge this is the first instance of a
pathogen modulating PS exposure mechanisms in conjunction with induction of
necroptosis to avoid efferocytic clearance. Understanding the mechanisms behind KPn
modulation of PS exposure and induction of necroptosis could lead to novel therapeutic
targets against KPn, which given the rise of antibiotic resistant strains is essential. Work is
underway in the lab to determine the mechanisms leading to the molecular pathway
underlying these aspects of KPn mediated inhibition of efferocytosis.

127

REFERENCES
1.
2.

3.

4.

5.
6.

7.
8.
9.
10.

11.
12.

13.
14.
15.

16.

17.
18.

Angus DC, van der Poll T. 2013. Severe sepsis and septic shock. N Engl J Med 369: 840-51
Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. 2001.
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and
associated costs of care. Crit Care Med 29: 1303-10
Fleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P, Angus DC,
Reinhart K. 2016. Assessment of Global Incidence and Mortality of Hospital-treated
Sepsis. Current Estimates and Limitations. Am J Respir Crit Care Med 193: 259-72
Lagu T, Rothberg MB, Shieh MS, Pekow PS, Steingrub JS, Lindenauer PK. 2012.
Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007.
Crit Care Med 40: 754-61
Wang Z, Su F, Rogiers P, Vincent JL. 2007. Beneficial effects of recombinant human
activated protein C in a ewe model of septic shock. Crit Care Med 35: 2594-600
Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. 2007. Rapid increase in hospitalization
and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to
2003. Crit Care Med 35: 1244-50
Martin GS, Mannino DM, Eaton S, Moss M. 2003. The epidemiology of sepsis in the
United States from 1979 through 2000. N Engl J Med 348: 1546-54
Abad CL, Kumar A, Safdar N. 2011. Antimicrobial therapy of sepsis and septic shock-when are two drugs better than one? Crit Care Clin 27: e1-27
Kochanek KD, Xu J, Murphy SL, Minino AM, Kung HC. 2011. Deaths: preliminary data for
2009. Natl Vital Stat Rep 59: 1-51
Stevenson EK, Rubenstein AR, Radin GT, Wiener RS, Walkey AJ. 2014. Two decades of
mortality trends among patients with severe sepsis: a comparative meta-analysis*. Crit
Care Med 42: 625-31
Mayr FB, Yende S, Angus DC. 2014. Epidemiology of severe sepsis. Virulence 5: 4-11
Alberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman S, Artigas A, Sicignano A,
Palazzo M, Moreno R, Boulme R, Lepage E, Le Gall R. 2002. Epidemiology of sepsis and
infection in ICU patients from an international multicentre cohort study. Intensive Care
Med 28: 108-21
Annane D, Aegerter P, Jars-Guincestre MC, Guidet B. 2003. Current epidemiology of
septic shock: the CUB-Rea Network. Am J Respir Crit Care Med 168: 165-72
Annane D, Bellissant E, Cavaillon J-M. 2005. Septic shock. The Lancet 365: 63-78
Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J,
Gomersall C, Sakr Y, Reinhart K. 2009. International study of the prevalence and
outcomes of infection in intensive care units. Jama 302: 2323-9
Phua J, Ngerng W, See K, Tay C, Kiong T, Lim H, Chew M, Yip H, Tan A, Khalizah H,
Capistrano R, Lee K, Mukhopadhyay A. 2013. Characteristics and outcomes of culturenegative versus culture-positive severe sepsis. Crit Care 17: R202
Tsiotou AG, Sakorafas GH, Anagnostopoulos G, Bramis J. 2005. Septic shock; current
pathogenetic concepts from a clinical perspective. Med Sci Monit 11: Ra76-85
Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, Finfer S, Gardlund B,
Marshall JC, Rhodes A, Artigas A, Payen D, Tenhunen J, Al-Khalidi HR, Thompson V, Janes
J, Macias WL, Vangerow B, Williams MD. 2012. Drotrecogin alfa (activated) in adults
with septic shock. N Engl J Med 366: 2055-64

128

19.
20.
21.

22.

23.
24.

25.

26.
27.
28.

29.

30.
31.

32.
33.
34.
35.
36.

Minasyan H. 2017. Sepsis and septic shock: Pathogenesis and treatment perspectives. J
Crit Care 40: 229-42
Gaieski DF, Edwards JM, Kallan MJ, Carr BG. 2013. Benchmarking the incidence and
mortality of severe sepsis in the United States. Crit Care Med 41: 1167-74
Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ.
1992. Definitions for sepsis and organ failure and guidelines for the use of innovative
therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American
College of Chest Physicians/Society of Critical Care Medicine. Chest 101: 1644-55
Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent
JL, Ramsay G. 2003. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions
Conference. Crit Care Med 31: 1250-6
Rittirsch D, Flierl MA, Ward PA. 2008. Harmful molecular mechanisms in sepsis. Nat Rev
Immunol 8: 776-87
Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D,
Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M. 2006. Duration of hypotension before
initiation of effective antimicrobial therapy is the critical determinant of survival in
human septic shock. Crit Care Med 34: 1589-96
Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung
CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell
RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent
JL, Moreno R, Surviving Sepsis Campaign Guidelines Committee including the Pediatric S.
2013. Surviving sepsis campaign: international guidelines for management of severe
sepsis and septic shock: 2012. Crit Care Med 41: 580-637
Ward PA, Bosmann M. 2012. A Historical Perspective on Sepsis. The American Journal of
Pathology 181: 2-7
Marshall JC. 2014. Why have clinical trials in sepsis failed? Trends in Molecular Medicine
20: 195-203
Cohen J, Vincent JL, Adhikari NK, Machado FR, Angus DC, Calandra T, Jaton K, Giulieri S,
Delaloye J, Opal S, Tracey K, van der Poll T, Pelfrene E. 2015. Sepsis: a roadmap for
future research. Lancet Infect Dis 15: 581-614
Namas R, Zamora R, Namas R, An G, Doyle J, Dick TE, Jacono FJ, Androulakis IP, Nieman
GF, Chang S, Billiar TR, Kellum JA, Angus DC, Vodovotz Y. 2012. Sepsis: Something old,
something new, and a systems view. J Crit Care 27: 314.e1-11
Reinhart K, Karzai W. 2001. Anti-tumor necrosis factor therapy in sepsis: update on
clinical trials and lessons learned. Crit Care Med 29: S121-5
Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub
JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ, Jr. 2001. Efficacy and safety of
recombinant human activated protein C for severe sepsis. N Engl J Med 344: 699-709
Basset C, Holton J, O'Mahony R, Roitt I. 2003. Innate immunity and pathogen-host
interaction. Vaccine 21 Suppl 2: S12-23
Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell
124: 783-801
Mogensen TH. 2009. Pathogen recognition and inflammatory signaling in innate
immune defenses. Clin Microbiol Rev 22: 240-73, Table of Contents
Borregaard N. 2010. Neutrophils, from marrow to microbes. Immunity 33: 657-70
Finger EB, Puri KD, Alon R, Lawrence MB, von Andrian UH, Springer TA. 1996. Adhesion
through L-selectin requires a threshold hydrodynamic shear. Nature 379: 266-9

129

37.
38.
39.
40.

41.
42.
43.
44.

45.

46.

47.
48.
49.

50.
51.
52.

53.

54.
55.

Lawrence MB, Kansas GS, Kunkel EJ, Ley K. 1997. Threshold levels of fluid shear promote
leukocyte adhesion through selectins (CD62L,P,E). J Cell Biol 136: 717-27
Amulic B, Cazalet C, Hayes GL, Metzler KD, Zychlinsky A. 2012. Neutrophil function: from
mechanisms to disease. Annu Rev Immunol 30: 459-89
Zarbock A, Ley K. 2008. Mechanisms and consequences of neutrophil interaction with
the endothelium. Am J Pathol 172: 1-7
Chen Y, Yao Y, Sumi Y, Li A, To UK, Elkhal A, Inoue Y, Woehrle T, Zhang Q, Hauser C,
Junger WG. 2010. Purinergic signaling: a fundamental mechanism in neutrophil
activation. Sci Signal 3: ra45
Sabroe I, Dower SK, Whyte MK. 2005. The role of Toll-like receptors in the regulation of
neutrophil migration, activation, and apoptosis. Clin Infect Dis 41 Suppl 7: S421-6
Parker LC, Whyte MK, Dower SK, Sabroe I. 2005. The expression and roles of Toll-like
receptors in the biology of the human neutrophil. J Leukoc Biol 77: 886-92
Ley K. 2002. Integration of inflammatory signals by rolling neutrophils. Immunol Rev
186: 8-18
Guthrie LA, McPhail LC, Henson PM, Johnston RB, Jr. 1984. Priming of neutrophils for
enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for
increased activity of the superoxide-producing enzyme. J Exp Med 160: 1656-71
El-Benna J, Dang PM, Gougerot-Pocidalo MA. 2008. Priming of the neutrophil NADPH
oxidase activation: role of p47phox phosphorylation and NOX2 mobilization to the
plasma membrane. Semin Immunopathol 30: 279-89
Kruger P, Saffarzadeh M, Weber AN, Rieber N, Radsak M, von Bernuth H, Benarafa C,
Roos D, Skokowa J, Hartl D. 2015. Neutrophils: Between host defence, immune
modulation, and tissue injury. PLoS Pathog 11: e1004651
Underhill DM, Ozinsky A. 2002. Phagocytosis of microbes: complexity in action. Annu
Rev Immunol 20: 825-52
Borregaard N, Cowland JB. 1997. Granules of the human neutrophilic
polymorphonuclear leukocyte. Blood 89: 3503-21
Jesaitis AJ, Buescher ES, Harrison D, Quinn MT, Parkos CA, Livesey S, Linner J. 1990.
Ultrastructural localization of cytochrome b in the membranes of resting and
phagocytosing human granulocytes. J Clin Invest 85: 821-35
Soehnlein O, Zernecke A, Weber C. 2009. Neutrophils launch monocyte extravasation by
release of granule proteins. Thromb Haemost 102: 198-205
Scapini P, Lapinet-Vera JA, Gasperini S, Calzetti F, Bazzoni F, Cassatella MA. 2000. The
neutrophil as a cellular source of chemokines. Immunol Rev 177: 195-203
Sica A, Matsushima K, Van Damme J, Wang JM, Polentarutti N, Dejana E, Colotta F,
Mantovani A. 1990. IL-1 transcriptionally activates the neutrophil chemotactic factor/IL8 gene in endothelial cells. Immunology 69: 548-53
Kasama T, Miwa Y, Isozaki T, Odai T, Adachi M, Kunkel SL. 2005. Neutrophil-derived
cytokines: potential therapeutic targets in inflammation. Curr Drug Targets Inflamm
Allergy 4: 273-9
Yang D, de la Rosa G, Tewary P, Oppenheim JJ. 2009. Alarmins link neutrophils and
dendritic cells. Trends Immunol 30: 531-7
Serhan CN. 2007. Resolution phase of inflammation: novel endogenous antiinflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol 25:
101-37

130

56.

57.
58.

59.
60.

61.

62.

63.

64.

65.
66.

67.

68.

69.

70.

Schmielau J, Finn OJ. 2001. Activated granulocytes and granulocyte-derived hydrogen
peroxide are the underlying mechanism of suppression of t-cell function in advanced
cancer patients. Cancer Res 61: 4756-60
Soehnlein O, Weber C, Lindbom L. 2009. Neutrophil granule proteins tune monocytic
cell function. Trends Immunol 30: 538-46
Soehnlein O, Kai-Larsen Y, Frithiof R, Sorensen OE, Kenne E, Scharffetter-Kochanek K,
Eriksson EE, Herwald H, Agerberth B, Lindbom L. 2008. Neutrophil primary granule
proteins HBP and HNP1-3 boost bacterial phagocytosis by human and murine
macrophages. J Clin Invest 118: 3491-502
Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y,
Zychlinsky A. 2004. Neutrophil extracellular traps kill bacteria. Science 303: 1532-5
Urban CF, Ermert D, Schmid M, Abu-Abed U, Goosmann C, Nacken W, Brinkmann V,
Jungblut PR, Zychlinsky A. 2009. Neutrophil extracellular traps contain calprotectin, a
cytosolic protein complex involved in host defense against Candida albicans. PLoS
Pathog 5: e1000639
Fuchs TA, Abed U, Goosmann C, Hurwitz R, Schulze I, Wahn V, Weinrauch Y, Brinkmann
V, Zychlinsky A. 2007. Novel cell death program leads to neutrophil extracellular traps. J
Cell Biol 176: 231-41
Papayannopoulos V, Metzler KD, Hakkim A, Zychlinsky A. 2010. Neutrophil elastase and
myeloperoxidase regulate the formation of neutrophil extracellular traps. J Cell Biol 191:
677-91
Yipp BG, Petri B, Salina D, Jenne CN, Scott BN, Zbytnuik LD, Pittman K, Asaduzzaman M,
Wu K, Meijndert HC, Malawista SE, de Boisfleury Chevance A, Zhang K, Conly J, Kubes P.
2012. Infection-induced NETosis is a dynamic process involving neutrophil multitasking
in vivo. Nat Med 18: 1386-93
Yousefi S, Mihalache C, Kozlowski E, Schmid I, Simon HU. 2009. Viable neutrophils
release mitochondrial DNA to form neutrophil extracellular traps. Cell Death Differ 16:
1438-44
Sharma A, Simonson TJ, Jondle CN, Mishra BB, Sharma J. 2017. Mincle regulates
autophagy to control neutrophil extracellular trap formation. J Infect Dis
Sharma A, Steichen AL, Jondle CN, Mishra BB, Sharma J. 2014. Protective role of mincle
in bacterial pneumonia by regulation of neutrophil mediated phagocytosis and
extracellular trap formation. J Infect Dis 209: 1837-46
Patel S, Kumar S, Jyoti A, Srinag BS, Keshari RS, Saluja R, Verma A, Mitra K, Barthwal MK,
Krishnamurthy H, Bajpai VK, Dikshit M. 2010. Nitric oxide donors release extracellular
traps from human neutrophils by augmenting free radical generation. Nitric Oxide 22:
226-34
Metzler KD, Fuchs TA, Nauseef WM, Reumaux D, Roesler J, Schulze I, Wahn V,
Papayannopoulos V, Zychlinsky A. 2011. Myeloperoxidase is required for neutrophil
extracellular trap formation: implications for innate immunity. Blood 117: 953-9
Pilsczek FH, Salina D, Poon KK, Fahey C, Yipp BG, Sibley CD, Robbins SM, Green FH,
Surette MG, Sugai M, Bowden MG, Hussain M, Zhang K, Kubes P. 2010. A novel
mechanism of rapid nuclear neutrophil extracellular trap formation in response to
Staphylococcus aureus. J Immunol 185: 7413-25
Parker H, Dragunow M, Hampton MB, Kettle AJ, Winterbourn CC. 2012. Requirements
for NADPH oxidase and myeloperoxidase in neutrophil extracellular trap formation
differ depending on the stimulus. J Leukoc Biol 92: 841-9

131

71.

72.

73.

74.
75.
76.
77.
78.
79.
80.
81.
82.
83.
84.
85.

86.

87.

88.

89.

Arai Y, Nishinaka Y, Arai T, Morita M, Mizugishi K, Adachi S, Takaori-Kondo A, Watanabe
T, Yamashita K. 2014. Uric acid induces NADPH oxidase-independent neutrophil
extracellular trap formation. Biochem Biophys Res Commun 443: 556-61
Hakkim A, Fuchs TA, Martinez NE, Hess S, Prinz H, Zychlinsky A, Waldmann H. 2011.
Activation of the Raf-MEK-ERK pathway is required for neutrophil extracellular trap
formation. Nat Chem Biol 7: 75-7
Remijsen Q, Vanden Berghe T, Wirawan E, Asselbergh B, Parthoens E, De Rycke R,
Noppen S, Delforge M, Willems J, Vandenabeele P. 2011. Neutrophil extracellular trap
cell death requires both autophagy and superoxide generation. Cell Res 21: 290-304
Waller. 1846. Microscopic observation on the perforation of capillaries by the
corpuscles of blood and the origin of mucus and pus globules.
Kumar H, Kawai T, Akira S. 2011. Pathogen recognition by the innate immune system. Int
Rev Immunol 30: 16-34
Takeuchi O, Akira S. 2010. Pattern recognition receptors and inflammation. Cell 140:
805-20
Brubaker SW, Bonham KS, Zanoni I, Kagan JC. 2015. Innate immune pattern recognition:
a cell biological perspective. Annu Rev Immunol 33: 257-90
Netea MG, van der Meer JW. 2011. Immunodeficiency and genetic defects of patternrecognition receptors. N Engl J Med 364: 60-70
Kawasaki T, Kawai T. 2014. Toll-like receptor signaling pathways. Front Immunol 5: 461
Piras V, Selvarajoo K. 2014. Beyond MyD88 and TRIF Pathways in Toll-Like Receptor
Signaling. Front Immunol 5: 70
Zelensky AN, Gready JE. 2005. The C-type lectin-like domain superfamily. Febs j 272:
6179-217
Sancho D, Reis e Sousa C. 2012. Signaling by myeloid C-type lectin receptors in immunity
and homeostasis. Annu Rev Immunol 30: 491-529
Kerrigan AM, Brown GD. 2011. Syk-coupled C-type lectins in immunity. Trends Immunol
32: 151-6
Drummond RA, Saijo S, Iwakura Y, Brown GD. 2011. The role of Syk/CARD9 coupled Ctype lectins in antifungal immunity. Eur J Immunol 41: 276-81
Strasser D, Neumann K, Bergmann H, Marakalala MJ, Guler R, Rojowska A, Hopfner KP,
Brombacher F, Urlaub H, Baier G, Brown GD, Leitges M, Ruland J. 2012. Syk kinasecoupled C-type lectin receptors engage protein kinase C-sigma to elicit Card9 adaptormediated innate immunity. Immunity 36: 32-42
Ezekowitz RA, Sastry K, Bailly P, Warner A. 1990. Molecular characterization of the
human macrophage mannose receptor: demonstration of multiple carbohydrate
recognition-like domains and phagocytosis of yeasts in Cos-1 cells. J Exp Med 172: 178594
Hodge S, Dean M, Hodge G, Holmes M, Reynolds PN. 2011. Decreased efferocytosis and
mannose binding lectin in the airway in bronchiolitis obliterans syndrome. J Heart Lung
Transplant 30: 589-95
Wright RD, Souza PR, Flak MB, Thedchanamoorthy P, Norling LV, Cooper D. 2017.
Galectin-3-null mice display defective neutrophil clearance during acute inflammation. J
Leukoc Biol 101: 717-26
Mishra BB, Li Q, Steichen AL, Binstock BJ, Metzger DW, Teale JM, Sharma J. 2013.
Galectin-3 functions as an alarmin: pathogenic role for sepsis development in murine
respiratory tularemia. PLoS One 8: e59616

132

90.
91.

92.
93.

94.
95.
96.

97.

98.

99.

100.

101.
102.
103.

104.

105.

Steichen AL, Simonson TJ, Salmon SL, Metzger DW, Mishra BB, Sharma J. 2015. Alarmin
function of galectin-9 in murine respiratory tularemia. PLoS One 10: e0123573
Xie J, Zhu H, Guo L, Ruan Y, Wang L, Sun L, Zhou L, Wu W, Yun X, Shen A, Gu J. 2010.
Lectin-like oxidized low-density lipoprotein receptor-1 delivers heat shock protein 60fused antigen into the MHC class I presentation pathway. J Immunol 185: 2306-13
Shrimpton RE, Butler M, Morel AS, Eren E, Hue SS, Ritter MA. 2009. CD205 (DEC-205): a
recognition receptor for apoptotic and necrotic self. Mol Immunol 46: 1229-39
Yuita H, Tsuiji M, Tajika Y, Matsumoto Y, Hirano K, Suzuki N, Irimura T. 2005. Retardation
of removal of radiation-induced apoptotic cells in developing neural tubes in
macrophage galactose-type C-type lectin-1-deficient mouse embryos. Glycobiology 15:
1368-75
Stuart LM, Henson PM, Vandivier RW. 2006. Collectins: opsonins for apoptotic cells and
regulators of inflammation. Curr Dir Autoimmun 9: 143-61
Schagat TL, Wofford JA, Wright JR. 2001. Surfactant protein A enhances alveolar
macrophage phagocytosis of apoptotic neutrophils. J Immunol 166: 2727-33
Vandivier RW, Ogden CA, Fadok VA, Hoffmann PR, Brown KK, Botto M, Walport MJ,
Fisher JH, Henson PM, Greene KE. 2002. Role of surfactant proteins A, D, and C1q in the
clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common
collectin receptor complex. J Immunol 169: 3978-86
Litvack ML, Palaniyar N. 2010. Review: Soluble innate immune pattern-recognition
proteins for clearing dying cells and cellular components: implications on exacerbating
or resolving inflammation. Innate Immun 16: 191-200
van Gisbergen KP, Aarnoudse CA, Meijer GA, Geijtenbeek TB, van Kooyk Y. 2005.
Dendritic cells recognize tumor-specific glycosylation of carcinoembryonic antigen on
colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3grabbing nonintegrin. Cancer Res 65: 5935-44
Breiteneder-Geleff S, Soleiman A, Kowalski H, Horvat R, Amann G, Kriehuber E, Diem K,
Weninger W, Tschachler E, Alitalo K, Kerjaschki D. 1999. Angiosarcomas express mixed
endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific
marker for lymphatic endothelium. Am J Pathol 154: 385-94
van Vliet SJ, van Liempt E, Saeland E, Aarnoudse CA, Appelmelk B, Irimura T, Geijtenbeek
TB, Blixt O, Alvarez R, van Die I, van Kooyk Y. 2005. Carbohydrate profiling reveals a
distinctive role for the C-type lectin MGL in the recognition of helminth parasites and
tumor antigens by dendritic cells. Int Immunol 17: 661-9
Aarnoudse CA, Garcia Vallejo JJ, Saeland E, van Kooyk Y. 2006. Recognition of tumor
glycans by antigen-presenting cells. Curr Opin Immunol 18: 105-11
Yamasaki S, Ishikawa E, Sakuma M, Hara H, Ogata K, Saito T. 2008. Mincle is an ITAMcoupled activating receptor that senses damaged cells. Nat Immunol 9: 1179-88
Suzuki Y, Nakano Y, Mishiro K, Takagi T, Tsuruma K, Nakamura M, Yoshimura S,
Shimazawa M, Hara H. 2013. Involvement of Mincle and Syk in the changes to innate
immunity after ischemic stroke. Sci Rep 3: 3177
Behler F, Steinwede K, Balboa L, Ueberberg B, Maus R, Kirchhof G, Yamasaki S, Welte T,
Maus UA. 2012. Role of Mincle in Alveolar Macrophage-Dependent Innate Immunity
against Mycobacterial Infections in Mice. J Immunol 189: 3121-9
Lee WB, Kang JS, Yan JJ, Lee MS, Jeon BY, Cho SN, Kim YJ. 2012. Neutrophils Promote
Mycobacterial Trehalose Dimycolate-Induced Lung Inflammation via the Mincle
Pathway. PLoS Pathog 8: e1002614

133

106.

107.
108.

109.

110.
111.
112.

113.
114.
115.
116.

117.
118.
119.

120.
121.
122.
123.
124.

Lobato-Pascual A, Saether PC, Fossum S, Dissen E, Daws MR. 2013. Mincle, the receptor
for mycobacterial cord factor, forms a functional receptor complex with MCL and
FcepsilonRI-gamma. Eur J Immunol 43: 3167-74
Vijayan D, Radford KJ, Beckhouse AG, Ashman RB, Wells CA. 2012. Mincle polarizes
human monocyte and neutrophil responses to Candida albicans. Immunol Cell Biol
Wells CA, Salvage-Jones JA, Li X, Hitchens K, Butcher S, Murray RZ, Beckhouse AG, Lo YL,
Manzanero S, Cobbold C, Schroder K, Ma B, Orr S, Stewart L, Lebus D, Sobieszczuk P,
Hume DA, Stow J, Blanchard H, Ashman RB. 2008. The macrophage-inducible C-type
lectin, mincle, is an essential component of the innate immune response to Candida
albicans. J Immunol 180: 7404-13
Yamasaki S, Matsumoto M, Takeuchi O, Matsuzawa T, Ishikawa E, Sakuma M, Tateno H,
Uno J, Hirabayashi J, Mikami Y, Takeda K, Akira S, Saito T. 2009. C-type lectin Mincle is
an activating receptor for pathogenic fungus, Malassezia. Proc Natl Acad Sci U S A 106:
1897-902
Szondy Z, Garabuczi E, Joos G, Tsay GJ, Sarang Z. 2014. Impaired clearance of apoptotic
cells in chronic inflammatory diseases: therapeutic implications. Front Immunol 5: 354
Headland SE, Norling LV. 2015. The resolution of inflammation: Principles and
challenges. Semin Immunol 27: 149-60
Kimani SG, Geng K, Kasikara C, Kumar S, Sriram G, Wu Y, Birge RB. 2014. Contribution of
Defective PS Recognition and Efferocytosis to Chronic Inflammation and Autoimmunity.
Front Immunol 5: 566
Schmidt EP, Tuder RM. 2010. Role of Apoptosis in Amplifying Inflammatory Responses in
Lung Diseases. J Cell Death 2010: 41-53
Greenlee-Wacker MC. 2016. Clearance of apoptotic neutrophils and resolution of
inflammation. Immunol Rev 273: 357-70
Martin CJ, Peters KN, Behar SM. 2014. Macrophages clean up: efferocytosis and
microbial control. Curr Opin Microbiol 17: 17-23
Ferracini M, Rios FJ, Pecenin M, Jancar S. 2013. Clearance of apoptotic cells by
macrophages induces regulatory phenotype and involves stimulation of CD36 and
platelet-activating factor receptor. Mediators Inflamm 2013: 950273
Fullerton JN, O'Brien AJ, Gilroy DW. 2013. Pathways mediating resolution of
inflammation: when enough is too much. J Pathol 231: 8-20
Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I. 1997.
Immunosuppressive effects of apoptotic cells. Nature 390: 350-1
Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. 1998.
Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory
cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2,
and PAF. J Clin Invest 101: 890-8
Korns D, Frasch SC, Fernandez-Boyanapalli R, Henson PM, Bratton DL. 2011. Modulation
of macrophage efferocytosis in inflammation. Front Immunol 2: 57
Henson PM, Tuder RM. 2008. Apoptosis in the lung: induction, clearance and detection.
Am J Physiol Lung Cell Mol Physiol 294: L601-11
Iba T, Hashiguchi N, Nagaoka I, Tabe Y, Murai M. 2013. Neutrophil cell death in response
to infection and its relation to coagulation. J Intensive Care 1: 13
Hochreiter-Hufford A, Ravichandran KS. 2013. Clearing the dead: apoptotic cell sensing,
recognition, engulfment, and digestion. Cold Spring Harb Perspect Biol 5: a008748
Castellano F, Montcourrier P, Chavrier P. 2000. Membrane recruitment of Rac1 triggers
phagocytosis. J Cell Sci 113 ( Pt 17): 2955-61

134

125.
126.
127.

128.

129.
130.

131.

132.

133.

134.

135.

136.
137.

138.

139.
140.

141.

Serhan CN, Chiang N, Dalli J. 2015. The resolution code of acute inflammation: Novel
pro-resolving lipid mediators in resolution. Semin Immunol 27: 200-15
Elliott MR, Koster KM, Murphy PS. 2017. Efferocytosis Signaling in the Regulation of
Macrophage Inflammatory Responses. J Immunol 198: 1387-94
Peter C, Waibel M, Radu CG, Yang LV, Witte ON, Schulze-Osthoff K, Wesselborg S,
Lauber K. 2008. Migration to apoptotic "find-me" signals is mediated via the phagocyte
receptor G2A. J Biol Chem 283: 5296-305
Gude DR, Alvarez SE, Paugh SW, Mitra P, Yu J, Griffiths R, Barbour SE, Milstien S, Spiegel
S. 2008. Apoptosis induces expression of sphingosine kinase 1 to release sphingosine-1phosphate as a "come-and-get-me" signal. FASEB J 22: 2629-38
Peter C, Wesselborg S, Herrmann M, Lauber K. 2010. Dangerous attraction: phagocyte
recruitment and danger signals of apoptotic and necrotic cells. Apoptosis 15: 1007-28
Elliott MR, Chekeni FB, Trampont PC, Lazarowski ER, Kadl A, Walk SF, Park D, Woodson
RI, Ostankovich M, Sharma P, Lysiak JJ, Harden TK, Leitinger N, Ravichandran KS. 2009.
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic
clearance. Nature 461: 282-6
Kristof E, Zahuczky G, Katona K, Doro Z, Nagy E, Fesus L. 2013. Novel role of ICAM3 and
LFA-1 in the clearance of apoptotic neutrophils by human macrophages. Apoptosis 18:
1235-51
Franz S, Frey B, Sheriff A, Gaipl US, Beer A, Voll RE, Kalden JR, Herrmann M. 2006.
Lectins detect changes of the glycosylation status of plasma membrane constituents
during late apoptosis. Cytometry A 69: 230-9
Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. 1992. Exposure
of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific
recognition and removal by macrophages. J Immunol 148: 2207-16
Krahling S, Callahan MK, Williamson P, Schlegel RA. 1999. Exposure of
phosphatidylserine is a general feature in the phagocytosis of apoptotic lymphocytes by
macrophages. Cell Death Differ 6: 183-9
Kobayashi N, Karisola P, Pena-Cruz V, Dorfman DM, Jinushi M, Umetsu SE, Butte MJ,
Nagumo H, Chernova I, Zhu B, Sharpe AH, Ito S, Dranoff G, Kaplan GG, Casasnovas JM,
Umetsu DT, Dekruyff RH, Freeman GJ. 2007. TIM-1 and TIM-4 glycoproteins bind
phosphatidylserine and mediate uptake of apoptotic cells. Immunity 27: 927-40
Park D, Hochreiter-Hufford A, Ravichandran KS. 2009. The phosphatidylserine receptor
TIM-4 does not mediate direct signaling. Curr Biol 19: 346-51
Park SY, Jung MY, Kim HJ, Lee SJ, Kim SY, Lee BH, Kwon TH, Park RW, Kim IS. 2008. Rapid
cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor. Cell Death
Differ 15: 192-201
Park SY, Kim SY, Jung MY, Bae DJ, Kim IS. 2008. Epidermal growth factor-like domain
repeat of stabilin-2 recognizes phosphatidylserine during cell corpse clearance. Mol Cell
Biol 28: 5288-98
Miyanishi M, Tada K, Koike M, Uchiyama Y, Kitamura T, Nagata S. 2007. Identification of
Tim4 as a phosphatidylserine receptor. Nature 450: 435-9
Park D, Tosello-Trampont AC, Elliott MR, Lu M, Haney LB, Ma Z, Klibanov AL, Mandell
JW, Ravichandran KS. 2007. BAI1 is an engulfment receptor for apoptotic cells upstream
of the ELMO/Dock180/Rac module. Nature 450: 430-4
Arandjelovic S, Ravichandran KS. 2015. Phagocytosis of apoptotic cells in homeostasis.
Nat Immunol 16: 907-17

135

142.

143.
144.
145.

146.
147.

148.
149.

150.

151.
152.

153.

154.

155.

156.

157.

158.

Brugnera E, Haney L, Grimsley C, Lu M, Walk SF, Tosello-Trampont AC, Macara IG,
Madhani H, Fink GR, Ravichandran KS. 2002. Unconventional Rac-GEF activity is
mediated through the Dock180-ELMO complex. Nat Cell Biol 4: 574-82
Van Epps DE, Andersen BR. 1974. Streptolysin O inhibition of neutrophil chemotaxis and
mobility: nonimmune phenomenon with species specificity. Infect Immun 9: 27-33
Cameron CE, Brown EL, Kuroiwa JM, Schnapp LM, Brouwer NL. 2004. Treponema
pallidum fibronectin-binding proteins. J Bacteriol 186: 7019-22
Brinkman MB, McGill MA, Pettersson J, Rogers A, Matejkova P, Smajs D, Weinstock GM,
Norris SJ, Palzkill T. 2008. A novel Treponema pallidum antigen, TP0136, is an outer
membrane protein that binds human fibronectin. Infect Immun 76: 1848-57
Lawlor MS, Handley SA, Miller VL. 2006. Comparison of the host responses to wild-type
and cpsB mutant Klebsiella pneumoniae infections. Infect Immun 74: 5402-7
Pan YJ, Fang HC, Yang HC, Lin TL, Hsieh PF, Tsai FC, Keynan Y, Wang JT. 2008. Capsular
polysaccharide synthesis regions in Klebsiella pneumoniae serotype K57 and a new
capsular serotype. J Clin Microbiol 46: 2231-40
Ofek I, Goldhar J, Keisari Y, Sharon N. 1995. Nonopsonic phagocytosis of
microorganisms. Annu Rev Microbiol 49: 239-76
Grosdent N, Maridonneau-Parini I, Sory MP, Cornelis GR. 2002. Role of Yops and
adhesins in resistance of Yersinia enterocolitica to phagocytosis. Infect Immun 70: 416576
Garrity-Ryan L, Kazmierczak B, Kowal R, Comolli J, Hauser A, Engel JN. 2000. The arginine
finger domain of ExoT contributes to actin cytoskeleton disruption and inhibition of
internalization of Pseudomonas aeruginosa by epithelial cells and macrophages. Infect
Immun 68: 7100-13
Papayannopoulos V, Zychlinsky A. 2009. NETs: a new strategy for using old weapons.
Trends Immunol 30: 513-21
Berends ET, Horswill AR, Haste NM, Monestier M, Nizet V, von Kockritz-Blickwede M.
2010. Nuclease expression by Staphylococcus aureus facilitates escape from neutrophil
extracellular traps. J Innate Immun 2: 576-86
Walker DH, Feng HM, Popov VL. 2001. Rickettsial phospholipase A2 as a pathogenic
mechanism in a model of cell injury by typhus and spotted fever group rickettsiae. Am J
Trop Med Hyg 65: 936-42
Geoffroy C, Gaillard JL, Alouf JE, Berche P. 1987. Purification, characterization, and
toxicity of the sulfhydryl-activated hemolysin listeriolysin O from Listeria
monocytogenes. Infect Immun 55: 1641-6
Goren MB, D'Arcy Hart P, Young MR, Armstrong JA. 1976. Prevention of phagosomelysosome fusion in cultured macrophages by sulfatides of Mycobacterium tuberculosis.
Proc Natl Acad Sci U S A 73: 2510-4
Park YK, Bearson B, Bang SH, Bang IS, Foster JW. 1996. Internal pH crisis, lysine
decarboxylase and the acid tolerance response of Salmonella typhimurium. Mol
Microbiol 20: 605-11
Martin CJ, Booty MG, Rosebrock TR, Nunes-Alves C, Desjardins DM, Keren I, Fortune SM,
Remold HG, Behar SM. 2012. Efferocytosis is an innate antibacterial mechanism. Cell
Host Microbe 12: 289-300
Capasso D, Pepe MV, Rossello J, Lepanto P, Arias P, Salzman V, Kierbel A. 2016.
Elimination of Pseudomonas aeruginosa through Efferocytosis upon Binding to
Apoptotic Cells. PLoS Pathog 12: e1006068

136

159.

160.

161.
162.
163.
164.
165.

166.
167.

168.
169.

170.
171.
172.

173.

174.
175.

176.
177.

Czuczman MA, Fattouh R, van Rijn JM, Canadien V, Osborne S, Muise AM, Kuchroo VK,
Higgins DE, Brumell JH. 2014. Listeria monocytogenes exploits efferocytosis to promote
cell-to-cell spread. Nature 509: 230-4
Greenlee-Wacker MC, Rigby KM, Kobayashi SD, Porter AR, DeLeo FR, Nauseef WM.
2014. Phagocytosis of Staphylococcus aureus by human neutrophils prevents
macrophage efferocytosis and induces programmed necrosis. J Immunol 192: 4709-17
Flannagan RS, Cosio G, Grinstein S. 2009. Antimicrobial mechanisms of phagocytes and
bacterial evasion strategies. Nat Rev Microbiol 7: 355-66
Hornef MW, Wick MJ, Rhen M, Normark S. 2002. Bacterial strategies for overcoming
host innate and adaptive immune responses. Nat Immunol 3: 1033-40
do Vale A, Cabanes D, Sousa S. 2016. Bacterial Toxins as Pathogen Weapons Against
Phagocytes. Front Microbiol 7: 42
Celli J, Finlay BB. 2002. Bacterial avoidance of phagocytosis. Trends Microbiol 10: 232-7
Remick DG, Newcomb DE, Bolgos GL, Call DR. 2000. Comparison of the mortality and
inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and
puncture. Shock 13: 110-6
Fink MP. 2014. Animal models of sepsis. Virulence 5: 143-53
Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonaldSmith GP, Gao H, Hennessy L, Finnerty CC, Lopez CM, Honari S, Moore EE, Minei JP,
Cuschieri J, Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West MA, Jeschke
MG, Klein MB, Gamelli RL, Gibran NS, Brownstein BH, Miller-Graziano C, Calvano SE,
Mason PH, Cobb JP, Rahme LG, Lowry SF, Maier RV, Moldawer LL, Herndon DN, Davis
RW, Xiao W, Tompkins RG. 2013. Genomic responses in mouse models poorly mimic
human inflammatory diseases. Proc Natl Acad Sci U S A 110: 3507-12
Buras JA, Holzmann B, Sitkovsky M. 2005. Animal models of sepsis: setting the stage.
Nat Rev Drug Discov 4: 854-65
Sordi R, Menezes-de-Lima O, Della-Justina AM, Rezende E, Assreuy J. 2013. Pneumoniainduced sepsis in mice: temporal study of inflammatory and cardiovascular parameters.
Int J Exp Pathol 94: 144-55
Deitch EA. 1998. Animal models of sepsis and shock: a review and lessons learned. Shock
9: 1-11
Copeland S, Warren HS, Lowry SF, Calvano SE, Remick D. 2005. Acute inflammatory
response to endotoxin in mice and humans. Clin Diagn Lab Immunol 12: 60-7
Cohen J, Guyatt G, Bernard GR, Calandra T, Cook D, Elbourne D, Marshall J, Nunn A, Opal
S. 2001. New strategies for clinical trials in patients with sepsis and septic shock. Crit
Care Med 29: 880-6
Zantl N, Uebe A, Neumann B, Wagner H, Siewert JR, Holzmann B, Heidecke CD, Pfeffer K.
1998. Essential role of gamma interferon in survival of colon ascendens stent peritonitis,
a novel murine model of abdominal sepsis. Infect Immun 66: 2300-9
Bagley ST. 1985. Habitat association of Klebsiella species. Infect Control 6: 52-8
Rock C, Thom KA, Masnick M, Johnson JK, Harris AD, Morgan DJ. 2014. Frequency of
Klebsiella pneumoniae carbapenemase (KPC)-producing and non-KPC-producing
Klebsiella species contamination of healthcare workers and the environment. Infect
Control Hosp Epidemiol 35: 426-9
Paczosa MK, Mecsas J. 2016. Klebsiella pneumoniae: Going on the Offense with a Strong
Defense. Microbiol Mol Biol Rev 80: 629-61
Kang CI, Kim SH, Bang JW, Kim HB, Kim NJ, Kim EC, Oh MD, Choe KW. 2006. Communityacquired versus nosocomial Klebsiella pneumoniae bacteremia: clinical features,

137

178.

179.

180.

181.

182.

183.

184.
185.

186.
187.

188.

189.

190.

treatment outcomes, and clinical implication of antimicrobial resistance. J Korean Med
Sci 21: 816-22
Qureshi ZA, Paterson DL, Potoski BA, Kilayko MC, Sandovsky G, Sordillo E, Polsky B,
Adams-Haduch JM, Doi Y. 2012. Treatment outcome of bacteremia due to KPCproducing Klebsiella pneumoniae: superiority of combination antimicrobial regimens.
Antimicrob Agents Chemother 56: 2108-13
Zarkotou O, Pournaras S, Tselioti P, Dragoumanos V, Pitiriga V, Ranellou K, Prekates A,
Themeli-Digalaki K, Tsakris A. 2011. Predictors of mortality in patients with bloodstream
infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate
antimicrobial treatment. Clin Microbiol Infect 17: 1798-803
Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, Lynfield R,
Maloney M, McAllister-Hollod L, Nadle J, Ray SM, Thompson DL, Wilson LE, Fridkin SK.
2014. Multistate point-prevalence survey of health care-associated infections. N Engl J
Med 370: 1198-208
Tsay RW, Siu LK, Fung CP, Chang FY. 2002. Characteristics of bacteremia between
community-acquired and nosocomial Klebsiella pneumoniae infection: risk factor for
mortality and the impact of capsular serotypes as a herald for community-acquired
infection. Arch Intern Med 162: 1021-7
Ko WC, Paterson DL, Sagnimeni AJ, Hansen DS, Von Gottberg A, Mohapatra S, Casellas
JM, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP, McCormack JG, Yu VL. 2002.
Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical
patterns. Emerg Infect Dis 8: 160-6
Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg
B, Bartlett J. 2009. Bad bugs, no drugs: no ESKAPE! An update from the Infectious
Diseases Society of America. Clin Infect Dis 48: 1-12
Kuehn BM. 2013. "Nightmare" bacteria on the rise in US hospitals, long-term care
facilities. Jama 309: 1573-4
Cortes G, Borrell N, de Astorza B, Gomez C, Sauleda J, Alberti S. 2002. Molecular analysis
of the contribution of the capsular polysaccharide and the lipopolysaccharide O side
chain to the virulence of Klebsiella pneumoniae in a murine model of pneumonia. Infect
Immun 70: 2583-90
Podschun R, Ullmann U. 1998. Klebsiella spp. as nosocomial pathogens: epidemiology,
taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 11: 589-603
Cryz SJ, Jr., Mortimer PM, Mansfield V, Germanier R. 1986. Seroepidemiology of
Klebsiella bacteremic isolates and implications for vaccine development. J Clin Microbiol
23: 687-90
Mizuta K, Ohta M, Mori M, Hasegawa T, Nakashima I, Kato N. 1983. Virulence for mice
of Klebsiella strains belonging to the O1 group: relationship to their capsular (K) types.
Infect Immun 40: 56-61
Yu WL, Ko WC, Cheng KC, Lee CC, Lai CC, Chuang YC. 2008. Comparison of prevalence of
virulence factors for Klebsiella pneumoniae liver abscesses between isolates with
capsular K1/K2 and non-K1/K2 serotypes. Diagn Microbiol Infect Dis 62: 1-6
Athamna A, Ofek I, Keisari Y, Markowitz S, Dutton GG, Sharon N. 1991.
Lectinophagocytosis of encapsulated Klebsiella pneumoniae mediated by surface lectins
of guinea pig alveolar macrophages and human monocyte-derived macrophages. Infect
Immun 59: 1673-82

138

191.

192.
193.

194.

195.

196.
197.

198.

199.

200.

201.

202.
203.

204.

205.
206.

Pan YJ, Lin TL, Hsu CR, Wang JT. 2011. Use of a Dictyostelium model for isolation of
genetic loci associated with phagocytosis and virulence in Klebsiella pneumoniae. Infect
Immun 79: 997-1006
Li B, Zhao Y, Liu C, Chen Z, Zhou D. 2014. Molecular pathogenesis of Klebsiella
pneumoniae. Future Microbiol 9: 1071-81
Regueiro V, Campos MA, Pons J, Alberti S, Bengoechea JA. 2006. The uptake of a
Klebsiella pneumoniae capsule polysaccharide mutant triggers an inflammatory
response by human airway epithelial cells. Microbiology 152: 555-66
Hsieh PF, Lin TL, Yang FL, Wu MC, Pan YJ, Wu SH, Wang JT. 2012. Lipopolysaccharide O1
antigen contributes to the virulence in Klebsiella pneumoniae causing pyogenic liver
abscess. PLoS One 7: e33155
Merino S, Altarriba M, Izquierdo L, Nogueras MM, Regue M, Tomas JM. 2000. Cloning
and sequencing of the Klebsiella pneumoniae O5 wb gene cluster and its role in
pathogenesis. Infect Immun 68: 2435-40
Merino S, Camprubi S, Alberti S, Benedi VJ, Tomas JM. 1992. Mechanisms of Klebsiella
pneumoniae resistance to complement-mediated killing. Infect Immun 60: 2529-35
Branger J, Knapp S, Weijer S, Leemans JC, Pater JM, Speelman P, Florquin S, van der Poll
T. 2004. Role of Toll-like receptor 4 in gram-positive and gram-negative pneumonia in
mice. Infect Immun 72: 788-94
Montminy SW, Khan N, McGrath S, Walkowicz MJ, Sharp F, Conlon JE, Fukase K,
Kusumoto S, Sweet C, Miyake K, Akira S, Cotter RJ, Goguen JD, Lien E. 2006. Virulence
factors of Yersinia pestis are overcome by a strong lipopolysaccharide response. Nat
Immunol 7: 1066-73
Llobet E, Martinez-Moliner V, Moranta D, Dahlstrom KM, Regueiro V, Tomas A, Cano V,
Perez-Gutierrez C, Frank CG, Fernandez-Carrasco H, Insua JL, Salminen TA, Garmendia J,
Bengoechea JA. 2015. Deciphering tissue-induced Klebsiella pneumoniae lipid A
structure. Proc Natl Acad Sci U S A 112: E6369-78
March C, Cano V, Moranta D, Llobet E, Perez-Gutierrez C, Tomas JM, Suarez T,
Garmendia J, Bengoechea JA. 2013. Role of bacterial surface structures on the
interaction of Klebsiella pneumoniae with phagocytes. PLoS One 8: e56847
Stahlhut SG, Tchesnokova V, Struve C, Weissman SJ, Chattopadhyay S, Yakovenko O,
Aprikian P, Sokurenko EV, Krogfelt KA. 2009. Comparative structure-function analysis of
mannose-specific FimH adhesins from Klebsiella pneumoniae and Escherichia coli. J
Bacteriol 191: 6592-601
Klemm P, Schembri MA. 2000. Fimbrial surface display systems in bacteria: from
vaccines to random libraries. Microbiology 146 Pt 12: 3025-32
Tarkkanen AM, Westerlund-Wikstrom B, Erkkila L, Korhonen TK. 1998.
Immunohistological localization of the MrkD adhesin in the type 3 fimbriae of Klebsiella
pneumoniae. Infect Immun 66: 2356-61
Struve C, Bojer M, Krogfelt KA. 2009. Identification of a conserved chromosomal region
encoding Klebsiella pneumoniae type 1 and type 3 fimbriae and assessment of the role
of fimbriae in pathogenicity. Infect Immun 77: 5016-24
Jagnow J, Clegg S. 2003. Klebsiella pneumoniae MrkD-mediated biofilm formation on
extracellular matrix- and collagen-coated surfaces. Microbiology 149: 2397-405
Miethke M, Marahiel MA. 2007. Siderophore-based iron acquisition and pathogen
control. Microbiol Mol Biol Rev 71: 413-51

139

207.

208.

209.

210.

211.

212.
213.
214.
215.

216.
217.
218.
219.

220.

221.

222.
223.

Bachman MA, Lenio S, Schmidt L, Oyler JE, Weiser JN. 2012. Interaction of lipocalin 2,
transferrin, and siderophores determines the replicative niche of Klebsiella pneumoniae
during pneumonia. MBio 3
Brock JH, Williams PH, Liceaga J, Wooldridge KG. 1991. Relative availability of
transferrin-bound iron and cell-derived iron to aerobactin-producing and enterochelinproducing strains of Escherichia coli and to other microorganisms. Infect Immun 59:
3185-90
Bachman MA, Oyler JE, Burns SH, Caza M, Lepine F, Dozois CM, Weiser JN. 2011.
Klebsiella pneumoniae yersiniabactin promotes respiratory tract infection through
evasion of lipocalin 2. Infect Immun 79: 3309-16
Russo TA, Shon AS, Beanan JM, Olson R, MacDonald U, Pomakov AO, Visitacion MP.
2011. Hypervirulent K. pneumoniae secretes more and more active iron-acquisition
molecules than "classical" K. pneumoniae thereby enhancing its virulence. PLoS One 6:
e26734
van Kooyk Y, Ilarregui JM, van Vliet SJ. 2015. Novel insights into the immunomodulatory
role of the dendritic cell and macrophage-expressed C-type lectin MGL. Immunobiology
220: 185-92
van Vliet SJ, Saeland E, van Kooyk Y. 2008. Sweet preferences of MGL: carbohydrate
specificity and function. Trends Immunol 29: 83-90
Kerscher B, Willment JA, Brown GD. 2013. The Dectin-2 family of C-type lectin-like
receptors: an update. Int Immunol 25: 271-7
Miyake Y, Ishikawa E, Ishikawa T, Yamasaki S. 2010. Self and nonself recognition through
C-type lectin receptor, Mincle. Self Nonself 1: 310-3
Matsumoto M, Tanaka T, Kaisho T, Sanjo H, Copeland NG, Gilbert DJ, Jenkins NA, Akira S.
1999. A novel LPS-inducible C-type lectin is a transcriptional target of NF-IL6 in
macrophages. J Immunol 163: 5039-48
Kumagai Y, Takeuchi O, Akira S. 2008. Pathogen recognition by innate receptors. J Infect
Chemother 14: 86-92
Rabinovich GA, van Kooyk Y, Cobb BA. 2012. Glycobiology of immune responses. Ann N
Y Acad Sci 1253: 1-15
Dambuza IM, Brown GD. 2015. C-type lectins in immunity: recent developments. Curr
Opin Immunol 32: 21-7
van Vliet SJ, Steeghs L, Bruijns SC, Vaezirad MM, Snijders Blok C, Arenas Busto JA, Deken
M, van Putten JP, van Kooyk Y. 2009. Variation of Neisseria gonorrhoeae
lipooligosaccharide directs dendritic cell-induced T helper responses. PLoS Pathog 5:
e1000625
van Sorge NM, Bleumink NM, van Vliet SJ, Saeland E, van der Pol WL, van Kooyk Y, van
Putten JP. 2009. N-glycosylated proteins and distinct lipooligosaccharide glycoforms of
Campylobacter jejuni target the human C-type lectin receptor MGL. Cell Microbiol 11:
1768-81
Vukman KV, Ravida A, Aldridge AM, O'Neill SM. 2013. Mannose receptor and
macrophage galactose-type lectin are involved in Bordetella pertussis mast cell
interaction. J Leukoc Biol 94: 439-48
Saba K, Denda-Nagai K, Irimura T. 2009. A C-type lectin MGL1/CD301a plays an antiinflammatory role in murine experimental colitis. Am J Pathol 174: 144-52
Eddens T, Kolls JK. 2012. Host defenses against bacterial lower respiratory tract
infection. Curr Opin Immunol 24: 424-30

140

224.

225.
226.

227.

228.
229.

230.
231.

232.
233.

234.

235.
236.

237.

238.

239.

Kang CI, Song JH, Chung DR, Peck KR, Ko KS, Yeom JS, Ki HK, Son JS, Lee SS, Kim YS, Jung
SI, Kim SW, Chang HH, Ryu SY, Kwon KT, Lee H, Moon C, Korean Network for Study of
Infectious D. 2011. Risk factors and pathogenic significance of severe sepsis and septic
shock in 2286 patients with gram-negative bacteremia. J Infect 62: 26-33
Nordmann P, Cuzon G, Naas T. 2009. The real threat of Klebsiella pneumoniae
carbapenemase-producing bacteria. Lancet Infect Dis 9: 228-36
Mishra BB, Gundra UM, Teale JM. 2011. STAT6(-)/(-) mice exhibit decreased cells with
alternatively activated macrophage phenotypes and enhanced disease severity in
murine neurocysticercosis. J Neuroimmunol 232: 26-34
Mares CA, Ojeda SS, Morris EG, Li Q, Teale JM. 2008. Initial delay in the immune
response to Francisella tularensis is followed by hypercytokinemia characteristic of
severe sepsis and correlating with upregulation and release of damage-associated
molecular patterns. Infect Immun 76: 3001-10
Sharma J, Li Q, Mishra BB, Pena C, Teale JM. 2009. Lethal pulmonary infection with
Francisella novicida is associated with severe sepsis. J Leukoc Biol 86: 491-504
Gundra UM, Mishra BB, Wong K, Teale JM. 2011. Increased disease severity of parasiteinfected TLR2-/- mice is correlated with decreased central nervous system inflammation
and reduced numbers of cells with alternatively activated macrophage phenotypes in a
murine model of neurocysticercosis. Infect Immun 79: 2586-96
Steichen AL, Binstock BJ, Mishra BB, Sharma J. 2013. C-type lectin receptor Clec4d plays
a protective role in resolution of Gram-negative pneumonia. J Leukoc Biol 94: 393-8
Sharma J, Li Q, Mishra BB, Georges MJ, Teale JM. 2009. Vaccination with an attenuated
strain of Francisella novicida prevents T-cell depletion and protects mice infected with
the wild-type strain from severe sepsis. Infect Immun 77: 4314-26
Mariathasan S, Weiss DS, Dixit VM, Monack DM. 2005. Innate immunity against
Francisella tularensis is dependent on the ASC/caspase-1 axis. J Exp Med 202: 1043-9
Sakai J, Li J, Subramanian KK, Mondal S, Bajrami B, Hattori H, Jia Y, Dickinson BC, Zhong
J, Ye K, Chang CJ, Ho YS, Zhou J, Luo HR. 2012. Reactive oxygen species-induced actin
glutathionylation controls actin dynamics in neutrophils. Immunity 37: 1037-49
Swamydas M, Lionakis MS. 2013. Isolation, purification and labeling of mouse bone
marrow neutrophils for functional studies and adoptive transfer experiments. J Vis Exp:
e50586
Swamydas M, Luo Y, Dorf ME, Lionakis MS. 2015. Isolation of Mouse Neutrophils. Curr
Protoc Immunol 110: 3 20 1-3 15
Jondle CN, Sharma A, Simonson TJ, Larson B, Mishra BB, Sharma J. 2016. Macrophage
Galactose-Type Lectin-1 Deficiency Is Associated with Increased Neutrophilia and
Hyperinflammation in Gram-Negative Pneumonia. J Immunol 196: 3088-96
Achouiti A, Vogl T, Urban CF, Rohm M, Hommes TJ, van Zoelen MA, Florquin S, Roth J,
van 't Veer C, de Vos AF, van der Poll T. 2012. Myeloid-related protein-14 contributes to
protective immunity in gram-negative pneumonia derived sepsis. PLoS Pathog 8:
e1002987
Matera G, Puccio R, Giancotti A, Quirino A, Pulicari MC, Zicca E, Caroleo S, Renzulli A,
Liberto MC, Foca A. 2013. Impact of interleukin-10, soluble CD25 and interferon-gamma
on the prognosis and early diagnosis of bacteremic systemic inflammatory response
syndrome: a prospective observational study. Crit Care 17: R64
Oh SJ, Kim JH, Chung DH. 2013. NOD2-mediated suppression of CD55 on neutrophils
enhances C5a generation during polymicrobial sepsis. PLoS Pathog 9: e1003351

141

240.
241.
242.
243.
244.

245.
246.

247.

248.

249.
250.

251.

252.
253.

254.
255.

256.
257.

Sugitharini V, Prema A, Berla Thangam E. 2013. Inflammatory mediators of systemic
inflammation in neonatal sepsis. Inflamm Res
Geijtenbeek TB, Gringhuis SI. 2009. Signalling through C-type lectin receptors: shaping
immune responses. Nat Rev Immunol 9: 465-79
Robinson MJ, Sancho D, Slack EC, LeibundGut-Landmann S, Reis e Sousa C. 2006.
Myeloid C-type lectins in innate immunity. Nat Immunol 7: 1258-65
van Kooyk Y. 2008. C-type lectins on dendritic cells: key modulators for the induction of
immune responses. Biochem Soc Trans 36: 1478-81
Ng WC, Liong S, Tate MD, Irimura T, Denda-Nagai K, Brooks AG, Londrigan SL, Reading
PC. 2014. The macrophage galactose-type lectin can function as an attachment and
entry receptor for influenza virus. J Virol 88: 1659-72
Camicia G, Pozner R, de Larranaga G. 2014. Neutrophil extracellular traps in sepsis.
Shock 42: 286-94
Montero-Barrera D, Valderrama-Carvajal H, Terrazas CA, Rojas-Hernandez S, LedesmaSoto Y, Vera-Arias L, Carrasco-Yepez M, Gomez-Garcia L, Martinez-Saucedo D, BecerraDiaz M, Terrazas LI. 2015. The macrophage galactose-type lectin-1 (MGL1) recognizes
Taenia crassiceps antigens, triggers intracellular signaling, and is critical for resistance to
this infection. Biomed Res Int 2015: 615865
van Liempt E, van Vliet SJ, Engering A, Garcia Vallejo JJ, Bank CM, Sanchez-Hernandez M,
van Kooyk Y, van Die I. 2007. Schistosoma mansoni soluble egg antigens are internalized
by human dendritic cells through multiple C-type lectins and suppress TLR-induced
dendritic cell activation. Mol Immunol 44: 2605-15
Batra S, Cai S, Balamayooran G, Jeyaseelan S. 2012. Intrapulmonary administration of
leukotriene B(4) augments neutrophil accumulation and responses in the lung to
Klebsiella infection in CXCL1 knockout mice. J Immunol 188: 3458-68
Kovach MA, Standiford TJ. 2012. The function of neutrophils in sepsis. Curr Opin Infect
Dis 25: 321-7
van Vliet SJ, Paessens LC, Broks-van den Berg VC, Geijtenbeek TB, van Kooyk Y. 2008.
The C-type lectin macrophage galactose-type lectin impedes migration of immature
APCs. J Immunol 181: 3148-55
van Vliet SJ, Gringhuis SI, Geijtenbeek TB, van Kooyk Y. 2006. Regulation of effector T
cells by antigen-presenting cells via interaction of the C-type lectin MGL with CD45. Nat
Immunol 7: 1200-8
Manz MG, Boettcher S. 2014. Emergency granulopoiesis. Nat Rev Immunol 14: 302-14
Kawakami M, Tsutsumi H, Kumakawa T, Abe H, Hirai M, Kurosawa S, Mori M, Fukushima
M. 1990. Levels of serum granulocyte colony-stimulating factor in patients with
infections. Blood 76: 1962-4
Cebon J, Layton JE, Maher D, Morstyn G. 1994. Endogenous haemopoietic growth
factors in neutropenia and infection. Br J Haematol 86: 265-74
Cheers C, Haigh AM, Kelso A, Metcalf D, Stanley ER, Young AM. 1988. Production of
colony-stimulating factors (CSFs) during infection: separate determinations of
macrophage-, granulocyte-, granulocyte-macrophage-, and multi-CSFs. Infect Immun 56:
247-51
Selig C, Nothdurft W. 1995. Cytokines and progenitor cells of granulocytopoiesis in
peripheral blood of patients with bacterial infections. Infect Immun 63: 104-9
Presneill JJ, Waring PM, Layton JE, Maher DW, Cebon J, Harley NS, Wilson JW, Cade JF.
2000. Plasma granulocyte colony-stimulating factor and granulocyte-macrophage
colony-stimulating factor levels in critical illness including sepsis and septic shock:

142

258.

259.

260.

261.

262.
263.

264.

265.

266.

267.
268.

269.

270.
271.
272.

relation to disease severity, multiple organ dysfunction, and mortality. Crit Care Med 28:
2344-54
Waring PM, Presneill J, Maher DW, Layton JE, Cebon J, Waring LJ, Metcalf D. 1995.
Differential alterations in plasma colony-stimulating factor concentrations in
meningococcaemia. Clin Exp Immunol 102: 501-6
Tanaka H, Ishikawa K, Nishino M, Shimazu T, Yoshioka T. 1996. Changes in granulocyte
colony-stimulating factor concentration in patients with trauma and sepsis. J Trauma 40:
718-25; discussion 25-6
Basu S, Hodgson G, Zhang HH, Katz M, Quilici C, Dunn AR. 2000. "Emergency"
granulopoiesis in G-CSF-deficient mice in response to Candida albicans infection. Blood
95: 3725-33
Satake S, Hirai H, Hayashi Y, Shime N, Tamura A, Yao H, Yoshioka S, Miura Y, Inaba T,
Fujita N, Ashihara E, Imanishi J, Sawa T, Maekawa T. 2012. C/EBPbeta is involved in the
amplification of early granulocyte precursors during candidemia-induced "emergency"
granulopoiesis. J Immunol 189: 4546-55
Stark MA, Huo Y, Burcin TL, Morris MA, Olson TS, Ley K. 2005. Phagocytosis of apoptotic
neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 22: 285-94
Hoogerwerf JJ, Van Der Windt GJ, Blok DC, Hoogendijk AJ, De Vos AF, Van 't Veer C,
Florquin S, Kobayashi KS, Flavell RA, Van Der Poll T. 2012. Interleukin-1-receptorassociated kinase M deficient mice demonstrate an improved host defense during gramnegative pneumonia. Mol Med
Bhan U, Ballinger MN, Zeng X, Newstead MJ, Cornicelli MD, Standiford TJ. 2010.
Cooperative interactions between TLR4 and TLR9 regulate interleukin 23 and 17
production in a murine model of gram negative bacterial pneumonia. PLoS One 5: e9896
Bhan U, Lukacs NW, Osterholzer JJ, Newstead MW, Zeng X, Moore TA, McMillan TR,
Krieg AM, Akira S, Standiford TJ. 2007. TLR9 is required for protective innate immunity in
Gram-negative bacterial pneumonia: role of dendritic cells. J Immunol 179: 3937-46
Cai S, Batra S, Wakamatsu N, Pacher P, Jeyaseelan S. 2012. NLRC4 inflammasomemediated production of IL-1beta modulates mucosal immunity in the lung against gramnegative bacterial infection. J Immunol 188: 5623-35
Kawata K, Illarionov P, Yang GX, Kenny TP, Zhang W, Tsuda M, Ando Y, Leung PS, Ansari
AA, Eric Gershwin M. 2012. Mincle and human B cell function. J Autoimmun 39: 315-22
Shenderov K, Barber DL, Mayer-Barber KD, Gurcha SS, Jankovic D, Feng CG, Oland S,
Hieny S, Caspar P, Yamasaki S, Lin X, Ting JP, Trinchieri G, Besra GS, Cerundolo V, Sher A.
2013. Cord factor and peptidoglycan recapitulate the Th17-promoting adjuvant activity
of mycobacteria through mincle/CARD9 signaling and the inflammasome. J Immunol
190: 5722-30
Balamayooran G, Batra S, Theivanthiran B, Cai S, Pacher P, Jeyaseelan S. 2012.
Intrapulmonary G-CSF rescues neutrophil recruitment to the lung and neutrophil release
to blood in gram-negative bacterial infection in MCP-1-/- mice. J Immunol 189: 5849-59
Brinkmann V, Zychlinsky A. 2012. Neutrophil extracellular traps: is immunity the second
function of chromatin? J Cell Biol 198: 773-83
Yipp BG, Kubes P. 2013. NETosis: how vital is it? Blood
Hsiao HM, Sapinoro RE, Thatcher TH, Croasdell A, Levy EP, Fulton RA, Olsen KC, Pollock
SJ, Serhan CN, Phipps RP, Sime PJ. 2013. A novel anti-inflammatory and pro-resolving
role for resolvin D1 in acute cigarette smoke-induced lung inflammation. PLoS One 8:
e58258

143

273.
274.
275.
276.

277.

278.

279.
280.
281.

282.
283.

284.
285.
286.

287.

288.
289.

290.

Aziz M, Jacob A, Yang WL, Matsuda A, Wang P. 2013. Current trends in inflammatory
and immunomodulatory mediators in sepsis. J Leukoc Biol 93: 329-42
Ward PA. 2012. New approaches to the study of sepsis. EMBO Mol Med 4: 1234-43
Donnelly LE, Barnes PJ. 2012. Defective phagocytosis in airways disease. Chest 141:
1055-62
Zaiss AK, Liu Q, Bowen GP, Wong NC, Bartlett JS, Muruve DA. 2002. Differential
activation of innate immune responses by adenovirus and adeno-associated virus
vectors. J Virol 76: 4580-90
Conrad CK, Allen SS, Afione SA, Reynolds TC, Beck SE, Fee-Maki M, Barrazza-Ortiz X,
Adams R, Askin FB, Carter BJ, Guggino WB, Flotte TR. 1996. Safety of single-dose
administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung.
Gene Ther 3: 658-68
Lee RT, Hsu TL, Huang SK, Hsieh SL, Wong CH, Lee YC. 2011. Survey of immune-related,
mannose/fucose-binding C-type lectin receptors reveals widely divergent sugar-binding
specificities. Glycobiology 21: 512-20
van der Poll T, van de Veerdonk FL, Scicluna BP, Netea MG. 2017. The immunopathology
of sepsis and potential therapeutic targets. Nat Rev Immunol
Robb CT, Regan KH, Dorward DA, Rossi AG. 2016. Key mechanisms governing resolution
of lung inflammation. Semin Immunopathol 38: 425-48
Lin JC, Chang FY, Fung CP, Yeh KM, Chen CT, Tsai YK, Siu LK. 2010. Do neutrophils play a
role in establishing liver abscesses and distant metastases caused by Klebsiella
pneumoniae? PLoS One 5: e15005
Poon IK, Lucas CD, Rossi AG, Ravichandran KS. 2014. Apoptotic cell clearance: basic
biology and therapeutic potential. Nat Rev Immunol 14: 166-80
Vandivier RW, Henson PM, Douglas IS. 2006. Burying the dead: the impact of failed
apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. Chest 129:
1673-82
Angsana J, Chen J, Liu L, Haller CA, Chaikof EL. 2016. Efferocytosis as a regulator of
macrophage chemokine receptor expression and polarization. Eur J Immunol 46: 1592-9
Ariel A, Maridonneau-Parini I, Rovere-Querini P, Levine JS, Muhl H. 2012. Macrophages
in inflammation and its resolution. Front Immunol 3: 324
Ariel A, Serhan CN. 2012. New Lives Given by Cell Death: Macrophage Differentiation
Following Their Encounter with Apoptotic Leukocytes during the Resolution of
Inflammation. Front Immunol 3: 4
Amini P, Stojkov D, Wang X, Wicki S, Kaufmann T, Wong WW, Simon HU, Yousefi S.
2016. NET formation can occur independently of RIPK3 and MLKL signaling. Eur J
Immunol 46: 178-84
Elliott MR, Ravichandran KS. 2016. The Dynamics of Apoptotic Cell Clearance. Dev Cell
38: 147-60
Elnemr A, Ohta T, Yachie A, Fushida S, Ninomiya I, Nishimura GI, Yamamoto M, Ohkuma
S, Miwa K. 2000. N-ethylmaleimide-enhanced phosphatidylserine externalization of
human pancreatic cancer cells and immediate phosphatidylserine-mediated
phagocytosis by macrophages. Int J Oncol 16: 1111-6
Kagan VE, Gleiss B, Tyurina YY, Tyurin VA, Elenstrom-Magnusson C, Liu SX, Serinkan FB,
Arroyo A, Chandra J, Orrenius S, Fadeel B. 2002. A role for oxidative stress in apoptosis:
oxidation and externalization of phosphatidylserine is required for macrophage
clearance of cells undergoing Fas-mediated apoptosis. J Immunol 169: 487-99

144

291.

292.

293.

294.
295.
296.
297.
298.

299.
300.

301.
302.

303.

304.

305.
306.

307.

308.

Boon JM, Lambert TN, Sisson AL, Davis AP, Smith BD. 2003. Facilitated
phosphatidylserine (PS) flip-flop and thrombin activation using a synthetic PS
scramblase. J Am Chem Soc 125: 8195-201
Gonzalez-Juarbe N, Bradley KM, Shenoy AT, Gilley RP, Reyes LF, Hinojosa CA, Restrepo
MI, Dube PH, Bergman MA, Orihuela CJ. 2017. Pore-forming toxin-mediated ion
dysregulation leads to death receptor-independent necroptosis of lung epithelial cells
during bacterial pneumonia. Cell Death Differ 24: 917-28
Kondylis V, Kumari S, Vlantis K, Pasparakis M. 2017. The interplay of IKK, NF-kappaB and
RIPK1 signaling in the regulation of cell death, tissue homeostasis and inflammation.
Immunol Rev 277: 113-27
Gomez-Simmonds A, Uhlemann AC. 2017. Clinical Implications of Genomic Adaptation
and Evolution of Carbapenem-Resistant Klebsiella pneumoniae. J Infect Dis 215: S18-S27
Clegg S, Murphy CN. 2016. Epidemiology and Virulence of Klebsiella pneumoniae.
Microbiol Spectr 4
Ravichandran KS. 2011. Beginnings of a good apoptotic meal: the find-me and eat-me
signaling pathways. Immunity 35: 445-55
Amara A, Mercer J. 2015. Viral apoptotic mimicry. Nat Rev Microbiol 13: 461-9
Damatta RA, Seabra SH, Deolindo P, Arnholdt AC, Manhaes L, Goldenberg S, de Souza
W. 2007. Trypanosoma cruzi exposes phosphatidylserine as an evasion mechanism.
FEMS Microbiol Lett 266: 29-33
Nagata S, Suzuki J, Segawa K, Fujii T. 2016. Exposure of phosphatidylserine on the cell
surface. Cell Death Differ 23: 952-61
Huynh ML, Fadok VA, Henson PM. 2002. Phosphatidylserine-dependent ingestion of
apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J Clin
Invest 109: 41-50
Silke J, Rickard JA, Gerlic M. 2015. The diverse role of RIP kinases in necroptosis and
inflammation. Nat Immunol 16: 689-97
Oberst A, Dillon CP, Weinlich R, McCormick LL, Fitzgerald P, Pop C, Hakem R, Salvesen
GS, Green DR. 2011. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3dependent necrosis. Nature 471: 363-7
Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M, Chan FK. 2009.
Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed
necrosis and virus-induced inflammation. Cell 137: 1112-23
Wang H, Sun L, Su L, Rizo J, Liu L, Wang LF, Wang FS, Wang X. 2014. Mixed lineage kinase
domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation
by RIP3. Mol Cell 54: 133-46
Kaczmarek A, Vandenabeele P, Krysko DV. 2013. Necroptosis: the release of damageassociated molecular patterns and its physiological relevance. Immunity 38: 209-23
Lee CH, Chuah SK, Tai WC, Chang CC, Chen FJ. 2017. Delay in Human Neutrophil
Constitutive Apoptosis after Infection with Klebsiella pneumoniae Serotype K1. Front
Cell Infect Microbiol 7: 87
Gong YN, Guy C, Olauson H, Becker JU, Yang M, Fitzgerald P, Linkermann A, Green DR.
2017. ESCRT-III Acts Downstream of MLKL to Regulate Necroptotic Cell Death and Its
Consequences. Cell 169: 286-300.e16
Zargarian S, Shlomovitz I, Erlich Z, Hourizadeh A, Ofir-Birin Y, Croker BA, Regev-Rudzki N,
Edry-Botzer L, Gerlic M. 2017. Phosphatidylserine externalization, "necroptotic bodies"
release, and phagocytosis during necroptosis. PLoS Biol 15: e2002711

145

309.
310.
311.

Angus DC. 2011. The search for effective therapy for sepsis: back to the drawing board?
JAMA 306: 2614-5
Chalupka AN, Talmor D. 2012. The economics of sepsis. Crit Care Clin 28: 57-76, vi
King EG, Bauza GJ, Mella JR, Remick DG. 2014. Pathophysiologic mechanisms in septic
shock. Lab Invest 94: 4-12

146

